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Neural induction is the earliest step in the formation of the human nervous system. 
However, the regulatory signals underlying neural induction are largely unknown due to 
ethical, technical and legal restrictions that limit access to live human cells during this 
stage. Dual SMAD inhibition induces ESC/iPSCs cells to acquire neural fate, providing an 
exceptional in vitro system to analyze neural induction. Transcriptome analyses enabled 
identification of sets of genes down-regulated during the initial 2 days of neural 
differentiation including pluripotency markers OCT4, NANOG and MYC. Subsequently, 
numerous genes are activated, including the neuroectodermal markers PAX6, ZEB2 and 
SOX11 and genes that have not being previously related with neural differentiation. Genes 
with similar expression profiles regulate biological processes such us cell-cell adhesion, 
required for the transition from pluripotency to neural competence. Statistical and 
mathematical approaches enable to infer time delay regulatory interactions of a set of 
transcription factors with high connectedness and model a gene regulatory network with 9 
principal hubs (JUN, MYC, FOS, PAX6, SP3, CDC6, SMAD2, HDAC6, and LEF1). The 
network modules regulate activation or inhibition of biological processes associated with 
neural induction, such us cell proliferation (MYC), cell cycle progression (CDC6) and 
regulation of CNS development (PAX6). Single cell RNASeq demonstrated that neural 
induction gave rise to a largely homogeneous neuro-ectodermal cells population. Inhibition 
of WNT signaling during neural induction leads to re-specification of neuroectodermal 
cells to a placodal fate, which subsequently differentiate into GnRH neurons. 
Transcriptome analysis revealed a unique set of genes activated and inhibited during neural 
induction in the presence of WNT inhibition, some of which may be essential for re-
specification to a placodal fate. These studies go some way to identifying genes and gene 
modules that pay a role during human neural induction thereby offering insight into a basic 
human developmental process and providing a foundation for understanding how specific 
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CHAPTER 1. General Introduction 
 
1.1. Neuroectoderm formation  
1.1.1. Differentiation of the inner cell mass 
Before implantation the early mammalian embryo undergoes a series of lineage segregation 
events that lead to the formation of trophectoderm (TE), primitive endoderm (PrE) and the 
epiblast (Epi). The TE and PrE give rise to extra-embryonic tissue responsible for the 
transmission of nutrients while the Epi forms the embryo proper. ESCs can be derived from 
the blastocyst and represent the Epi cell lineage (Schrode et al., 2013).  
The first lineages formed are the TE and the inner cell mass (ICM). Several studies suggest 
that cell position and polarization are implicated in the establishment of the two cell 
phenotypes. After fecundation the embryo undergoes a transition from transcriptional 
silence to embryonic genome activation (EGA). This process occurs at 2-cell stage in mice 
and from 4-8 cell stages in humans (Niakan & Eggan, 2012).  Re-localization of E-cadherin 
and β-catenin complexes during this period results in an increase of intracellular adhesion 
and compaction (morula stage). In parallel, intracellular components such as cytoskeletal 
elements, endosomes, microtubules, microvilli and EZRIN or aPKC/PAR protein 
complexes localize in the apical pole (Schrode et al., 2013). During the 8-16 and 16-32 
divisions, cells divide symmetrically in a perpendicular plane generating two polar cells, 
or asymmetrically in a parallel plane giving rise to one polar and one apolar cell. The polar 
cells are maintained in the outside and will specify into the TE, whereas apolar cells are 
directed to an inner position and will form the ICM around the 32 cells stage (Figure 1.1) 
(Lanner, 2011, Artus et al., 2014). The apolar/polar division frequency appears to be 
dependent on different factors such as the cell-to-cell contact, the nuclear size and the apical 
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domain size. The number of cells dividing with different mechanisms and the number of 
cells destined to become the ICM is compensated between the 8 cell division and the 16 
cell division (Chazaud & Yamanaka, 2016). It has been suggested that the cell division 
plane and consequent arrangement of polar and apolar blastomeres is related to the position 
of the cell in the morula. Other studies propose that down-regulation of polarity proteins 
such aPKC increase the cortical tension and directs the cells to an inner position and 
segregation of the prospective TE cells (Bruce & Goetz, 2010; Lanner et al., 2014). 
Additionally, recent studies suggest that the differential blastomeres contractility 
potentially results from asymmetric divisions. Apolar cells internalize as a consequence of 




Figure 1.1. Blastomeres asymmetrical division and trophectoderm, primitive endoderm and 
Epibalst differentiation, in pre-implantation mouse.  At 8 cells stage, the cells acquire polarity 
and divide asymmetrically in a perpendicular plane or symmetrically in a parallel plane. The polar 
cells (green) are maintained in the outside and give rise to the TE. The apolar cells are going to 
form the ICM, which later differentiate into the Epi (blue) or PE (red) (Bruce & Goetz, 2010).  
 
During the 3-3.5 days post-fertilization (dpf) in mice and 4-5 dpf in humans a fluid cavity 
called the blastocoel is formed as consequence of a continuous water and ion flux mediated 
by NA+/K+ ATPase and aquaporins (Artus et al., 2014). At this period the embryo 
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comprises the TE encapsulating the ICM and the blastocoel cavity (Niakan & Eggan, 2012). 
Besides polarity, the inner and outer blastomeres present differential gene expression 
patterns. Mutant mouse blastocyst lacking CDX2 failed to specify the TE, indicating that 
the transcription factor CDX2 is required for the formation and maintenance of the TE. 
Additionally, GATA3 and EOMES form part of the TE gene regulatory network. The ICM 
is marked by the expression of OCT4. It has been proposed that OCT4 and CDX2 interact 
by mutually repressing each other. For instance, studies with mouse ESC demonstrated that 
overexpression of Cdx2 leads to the reduction of Oct4, leading to differentiation towards a 
TE fate. Initially, zygotic OCT4 is expressed in all cells and becomes restricted to the ICM 
during the blastocyst formation (Lanner et al., 2014). OCT4 regulates expression of CDX2 
preventing cells from adopting a TE fate. In mouse, CDX2 is expressed in most 16 cells 
stage blastomeres. Later it is restricted to the outer cells prior to blastocyst formation and 
is necessary to repress OCT4 and NANOG expression (Schrode et al., 2013).  In the human 
embryo it remains unclear when OCT4 and CDX2 expression initiates. Human OCT4 
inhibition in the TE begins from 6-10dpf while in mouse it occurs at day 4.5dpf showing 
temporal species differences of transcription factor expression (Niakan & Eggan, 2012).  
 
Figure 1.2. Overview of the blastocyst differentiation in humans. Blastocyst lineage differentiation 
initiates with the segregation of the TE (CDX2 and GATA3) and the ICM (OCT4, NANOG and 
GATA6) at D6 dpf. In parallel, the TF GATA6 and OCT4 become mutually exclusive in a salt-and-
pepper manner in the ICM cells to give rise to the PrE and the Epi, respectively (adapted from Schrode 
et al., 2013). 
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Null TEAD4 mouse embryos lack expression of TE markers like CDX2 while ICM 
markers such OCT4 and NANOG are maintained. It has been shown that TED4 acts 
upstream to CDX2 possibly through interactions with the co-activators YAP and TAZ 
(Lanner et al., 2014). TED4 is expressed in all blastomeres but only promotes CDX2 
expression in the outer cells. The current model proposes that, in the ICM, YAP and TAZ 
are phosphorylated and degraded by the Hippo pathway affecting TEAD4 ability to activate 
its targets. In the outer cells the Hippo pathway is inactive allowing YAP/TAZ to bind 
TEAD4 and to activate target genes like CDX2 (Schrode et al, 2013). On the other hand, it 
has been suggested that nuclear exclusion of TEAD4 instead of YAP/TAZ in the ICM is 
responsable for ICM-TE patterning. However, Further experiments are necessary to 
confirm the model (Lanner et al., 2014). Null Tead4 embryos cultivated in low O2 generate 
TE suggesting that there might other signaling cascade or alternative YAP DNA-binding 
partners that compensate Tead4 function (Chazaud & Yamanaka, 2016).  
Besides transcription factor levels, TE and ICM patterning has being associated with 
differential TF kinetics. In the 8 cells stage mouse, Oct4 and Cdx2 exhibit differential 
nuclear fusion kinetics.  Cells with slow Oct4 kinetics undergo asymmetric division and 
therefore mainly contribute to the ICM, whereas cells with slower Cdx2 kinetics principally 
contribute to the TE. The disparities in fusion kinetics have being related to differences in 
the chromatin accessibility of the TE and ICM but the precise mechanisms remain unclear 
(Schrode et al., 2013; Lanner et al., 2014).  
1.1.2. Epiblast and primitive endoderm patterning 
The earliest event of ICM differentiation is the segregation of the PrE and the Epi. ICM 
cells lining the blastocoelic cavity will commit into the PrE (hypoblast) lineage, precursor 
 21 
of the extra embryonic tissue (yolk sac), whereas the remaining ICM cells will form the 
pluripotent Epi (primitive ectoderm) with the potential to give rise to the three embryonic 
germ layers during gastrulation (Pelton et al., 2001, Roode et al, 2012).  
The PrE/Epi lineage determination was initially attributed to the position of the cells among 
the ICM. Later studies demonstrated that ICM cell fate is determined before the prospective 
PE lines the blastocyst cavity. Nanog and Gata6 are the core TF involved in differentiation 
of the Epi and PrE respectively. The PrE and Epi genetic programs start at the 8-cell stage 
where GATA6 and OCT4 are co-expressed in all blastomeres. Around the 20 cells stage 
the PrE and Epi markers are down-regulated in specific cells of the late morula and become 
mutually exclusive (Artus et al., 2014; Schroter et al., 2015). After the mid blastocyst, cells 
expressing GATA6 and OCT4 are distributed along the ICM in a salt-and-pepper manner. 
Later, the ICM cell population commits to specific linages as the prospective Epi express 
pluripotency genes such as Nanog and Sox2 required to maintain the pluripotency; and the 
PrE precursors express a series of TF including Sox17, Gata4, and Sox7 (Ohnishi et al., 
2013). It has been shown that the Nanog and Gata6 expression levels fluctuate among ICM 
cells leading the cells to specify at different rates. It has been proposed that cells expressing 
both TF represent a transient phenotype that balances between the PrE and Epi lineages. A 
recent model defines three stable states where cells express Gata6 or Nanog exclusively or 
express both TF. The mechanism of differentiation into a specific lineage might be related 
to reduction of mRNA transcripts rather than selective increase of transcription rates. 
However, chromatin immunoprecipitation studies demonstrated that Nanog and Gata6 
increase and maintain their own expression by a direct positive feedback and interact by 
repressing each other (Chazaud & Yamanaka, 2016).  
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It has been proposed that the fate choice between cells co-expressing Nanog/Gata6 is 
mediated by FGF/MAPK signaling. Specifically, Fgf4 modulates the PrE/Epi proportions 
by promoting Gata6 expression and inhibiting Nanog (Ohnishi et al., 2013; Schroter et al., 
2015).  Interestingly, Gata6 expression remains until the early blastocyst stage in Fgf4 
mutants, meaning that other genes are necessary to trigger initial expression of Gata6. Fgf, 
Nanog and Gata6 are the main components of a gene regulatory network (GRN) in which 
specific levels in individual cells drive the ICM specification process. A recently developed 
GRN mathematical model predicts that early Nanog expression in the ICM promotes Fgf4 
secretion. Neighbor cells with specific extracellular concentration of Fgf4 are induced to 
differentiate into Epi or PrE depending on the Fgf4 local abundances (Schroter et al., 2015). 
Heterogenic populations result from the differential propagation of Fgf4 paracrine 
signaling (Artus et al., 2014; Chazaud & Yamanaka, 2016). These studies indicate that 
Fgf4 is expressed in Nanog positive cells only for the establishment of the salt and pepper 
array. Subsequently, Epi cells insulate themselves from Fgf4 signaling by inhibition of the 
Fgfr2 (Fgf4 receptor). Additionally, FgF4 activates ERK to down-regulate Nanog in the 




Figure 1.3. Differentiation of the primitive endoderm and epiblast from the inner 
cell mass salt and pepper array in mouse. At the 32-64 cell stage, the ICM Gata6 
and Nanog positive cells undergo a transition after which the prospective PrE cells 
(blue) express exclusively Gata6, whereas the prospective Epi cells (red) express 
exclusively Nanog. It has been proposed that inhibition of ERK induces Nanog 
expression in the Epi, which in turn induces Fgf4 expression and secretion to 
neighboring cells. Fgf4 induces ERK signaling, which inhibits Nanog expression in the 
PrE cells (Schrode et al., 2014).  
 
 
The first difference between ICM cells is differential expression of Fgf4.  Nevertheless, the 
initial events that promote heterogenic expression of the ICM cells remain unclear. Single 
cell studies have revealed gene expression heterogeneity at two cells stage before zygotic 
transcription in mouse. It is though that cell heterogeneity results from unequal distribution 
of mRNAs, which occurs during early cell division. However, this mRNA heterogeneity 
relation with differential expression has not been tested. Among the hypotheses that have 
not been rejected to explain the establishment of the salt and pepper pattern are: early cell 
division bias; stochastic gene expression and reduced phosphorylated ERK that induces 
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Nanog expression and promote FgF4 secretion (Chazaud & Yamanaka, 2016). In humans, 
exclusive expression of GATA and NANOG has being shown at the mid blastocyst stage.  
However, inhibition of FGF4 signaling in human embryos does not deeply impact the ICM 
patterning, highlighting possible regulatory differences between species. Potential 
candidates for driving ICM heterogeneity in humans are members of the transforming 
growth factor family TGFβ, which have been proved to maintain self-renewal in human TE 
stem cells. Nevertheless, the mechanisms of PrE derivation in humans and the alternative 
pathways involve in the ICM segregation remain unknown (Roode et al, 2012; Chazaud & 
Yamanaka, 2016).  
At the 64-cell stage PrE cells migrate and form a layer between the Epi and the blastocoel. 
The PrE cells that fail to locate within the PrE layer either change to an Epi fate or undergo 
apoptosis (Schroter et al., 2015). Prior to implantation in the uterus, the embryo exhibits 
three different linages resulting from different and sequential cell fate decisions: TE, PrE 
and Epi. The lineages have specific positions within the embryo, are molecularly distinct 
and have restricted differentiation potential (Artus et al., 2014).  
During the past few decades, several groups have extensively studied human development 
to the point of implantation at day 7 when the embryo must attach to the uterus to survive. 
In vitro studies have used mouse as a model to considerably increase the understanding of 
early post-implantation development but fail to uncover particular human development 
landmarks due to specie specific differences. Magdalena Zernicka-Goetz’s group has 
recently developed an outstanding technique that allows growth of human embryos until 
13dpf (Deglincerti et al., 2016; Morris, 2017). The study validates the expression of TE 
markers CDX2 and GATA3 and suggests GATA6 as a better marker for human TE due to 
its high level of nuclear expression. The Epi marker NANOG and the PrE marker GATA6 
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were shown to be exclusively expressed in a salt and pepper pattern at 6dpf, in contrast 
with mouse where PrE and Epi markers are sorted by the late blastocyst stage. Interestingly, 
the results depicted that hESCs closely resemble Epi cells at 10dpf rather than 6-8dpf as 
previously accepted. The next step in human central nervous system (CNS) development 
corresponds to the formation of the primitive streak, gastrulation and neurogenesis. 
Studying the human embryo in vitro is legally permitted until day 13 or until the formation 
of the primitive streak (Deglincerti et al., 2016; Shahbazi et al., 2016a). iPSCs genetically 
and phenotypically resemble to ESC in vivo. Thus, iPSCs provide a unique in vitro system 
to analyze the molecular events that regulate human development after this period (Lohle 
et al. 2012). 
1.1.3. Neuroectodermal induction by BMP, TGFβ and WNT antagonists  
During gastrulation the Epi cells initiate a complex developmental program that gives rise 
to the three germ layers of the mammalian embryo: the endoderm, mesoderm and ectoderm. 
In mouse E6.5 Epi cells located in the posterior side of the embryo undergo to epithelial 
mesenchymal transition and migrate through the primitive streak (PS). The cells that 
ingress through the PS to the interior of the embryo form the mesoderm and the endoderm. 
The Epi cells that are not recruited through the primitive streak differentiate into the 
ectoderm. Specific regions of the ectoderm differentiate into the epidermis, CNS cells, 
neural crest or placodes. In vertebrates the first event of neural differentiation is the 
ectoderm commitment into the NE. Differentiation of the NE depends on termination of 
the ESC transcription program, the initiation and maintenance of the NE transcription 
network and the suppression of other lineages fate. NE differentiation results from a series 
of regulatory events during the blastula and gastrula stages (Tresdell & LaBonne, 2006; 
Gaur et al., 2016).   
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The NE is formed in the dorsal region of the embryo in response to signaling from the 
adjacent mesoderm region called the “node” in chick, mouse and humans and the 
“organizer” in Xenopus. The node cells secrete small molecules that diffuse into the 
extracellular space of the adjacent ectoderm and bind BMP, TGFβ and Wnt ligands to 
inhibit them from occupy and activate their receptors. Ectodermal cells where BMP, TGFβ 
and Wnt have not being inhibited will adopt a non-neural ectodermal fate and subsequently 
an epidermal phenotype. Inhibition of BMP, TGFβ and Wnt allows expression of several 
dorsal ectoderm genes, which promote the induction of the NE and prevent the expression 
of non-neural genes. Additionally, signaling mediated by TGFβ family induces ectodermal 
cells to adopt a mesodermal fate (Andoniadou & Martinez-Barbera, 2013; Klein & Moody, 
2015). BMPs bind and activate type I and type II receptors and induce their hetero-
dimerization. Activation of BMP signaling induces phosphorylation of SMAD1, which in 
turn forms a complex with SMAD4b/SMAD4 and translocates to the nucleus to affect the 
expression of its gene targets. In the nucleus the complex binds to different transcription 
factors (TF) such as OAZ in in Xenopus to activate the epidermal transcription network. In 
the Xenopus embryo the BMP pathway is inhibited at an extracellular level by the secretion 
of several ligands that occupy BMP receptors; in the cytosol by Smad6 and Smad7 which 
prevent Smad4 from binding Smad1 and by Smurf1 and Smurf2, which target the Smad1-
Smad2 complex for degradation by the proteasome; and in the nucleus by the 
transcriptional repressor Ski (Figure 1.4) (Muñoz-Sanjuán & Brivanlou, 2002; Ozair et al., 
2013). Additionally, it has being demonstrated that in the chick ectoderm, BMP signaling 
is initially down-regulated at a transcriptional level and is further inhibited by BMP 
antagonists (Klein & Moody, 2015). 
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Figure 1.4. BMP pathway and SMAD inhibition. Molecules secreted from the 
node block extracellular BMP binding to type I/II receptors. In the cytosol, 
SMAD7/6 and Smurf1/2 prevent the formation of the SMAD complex. As a result 
of these interventions, SMADs cannot translocate to the nucleus to promote 




In vitro, ESC and iPSCs can be induced to differentiate to neural precursors by inhibiting 
BMP signal with small molecule BMP antagonists or by diluting endogenous BMP 
signalling by growing cells at low density. Nevertheless, the mechanism of neural 
precursors differentiation and maintenance by BMP inhibition is not well understood in 
ESC or in the embryo. Hence, the resemblance of the molecular events that drive neuronal 
induction between ESC and the embryo is not clear (Moody et al., 2013).  
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The Xenopus default model suggests that BMP inhibition is sufficient to induce neural 
differentiation in the competent Epi. However, studies in the chick embryo indicate that 
BMP inhibition is necessary to suppress epidermal phenotype, but an additional signal 
might be required to induce a neural phenotype. Potential candidates are FGF family 
members whose expression is up-regulated in the ectoderm and then restricted to the NE 
(Delaume et al., 2005; Marchal et al., 2009). In humans 22 FGF members have being 
reported, 18 correspond to secreted proteins that interact with 4 receptors (FGFR). In 
Xenopus embryo, neural tissue differentiation is inhibited chemically by inhibiting FGF. 
However, it has been demonstrated that chemical inhibition of FGF signaling reduces 
dorsal mesoderm tissue formation and therefore reduces the BMP inhibitory signals 
secreted from it. Additionally, overexpression of dominant-negative FGFR1 and FGFR2 
receptors, which block FGF3 and FGF4 signals leads to loss of pan-neural markers in 
Xenopus neural ectoderm explants. Over expression of dominant-negative FGFR4α 
receptor blocks FGF8 signaling and prevents anterior neural marker expression. Posterior 
neural development is disrupted by inhibition of the FGF pathway through disruption of 
MAP kinase signaling but has no effect on anterior neural tissue formation (Stern, 2005; 
Rogers et al., 2009). In chick, FGF genes are required to inhibit expression of BMP genes 
and in Xenopus and zebrafish to inhibit BMP downstream signaling by phosphorylation 
and inactivation of Smad1. Several studies propose that FGF is necessary for anterior-
posterior patterning of the neural plate (NP) and for inhibition of BMP signaling but any 
FGF independent role to initiate the nervous system development remains in question 
(Delaume et al., 2005; Stern, 2005). It has been suggested that FGF facilitates neural 
induction through its downstream effector Churchill (Churc), which inhibits the expression 
of mesodermal genes and promotes the expression of neural genes (Lee et al., 2014).  
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Canonical WNT signalling has also being implicated in multiple mechanisms of embryonic 
development including anterior NE induction, NP patterning, and neural crest and placode 
differentiation (McDonnlad et al., 2009). During Xenopus early development, maternal 
Wnt/β-catenin directly induces the expression of the closely related activators Siamois (Sia) 
and Twin. These signals combined with zygotic Nodal and TGF-β in the dorsal region of 
the embryo induce expression of the organizer genes. In mammals the Sia/Twin homologue 
DUXO has being demonstrated to be required for formation of the organizer. 
Simultaneously, the organizer secretes BMP and TGFβ antagonists like Chordin, Noggin 
and Cerberus, which specify the embryonic dorso-ventral regions and NE formation; and 
the Wnt antagonists Dickkopf1 (Dkk1), Frizzled 1 (Frzb1), Crescent, and Cerberus (Ding 
et al., 2017).  
WNT zygotic expression in the ventro-lateral mesoderm generates a β-catenin gradient 
elevated in the posterior region where it activates regulatory signals that inhibit 
transcription of anterior NE genes or activity of the maternal NE activators and induce 
expression of genes encoding for the posterior NE. On the other hand, extracellular WNT 
antagonists in the anterior region inhibit NE posteriorization and induce expression of TF 
that promote anterior neural fate and will give rise to the forebrain (Range et al., 2013). For 
instance, inhibition of WNT in Xenopus ectoderm generates a significant increase in head 
size and up-regulation of the signals leads to microcephaly or loss of anterior structures. 
Thus, the ability of WNT signalling to induce anterior-posterior axis formation has being 
extensively demonstrated. However, there is not sufficient evidence to demonstrate a direct 
role of WNT in neural induction (Ciany & Salinas, 2005; Rogers et al., 2009).  
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Additionally, it has being suggested that the transcription the factor Zic1 stabilizes neuronal 
fate by sensitizing the ectoderm for neural induction, however the mechanism remains 
unknown (Lee et al., 2014). 
1.1.4. Transcription factors involved in neuroectodermal differentiation 
NE differentiation is orchestrated by sets of TFs that are sequentially activated or inhibited 
in a specific spatiotemporal manner. These TF maintain NE precursors and regulate their 
transition to NE cells that constitute the NP and then to neural progenitors (neural stem 
cells). Several TF are required during neural fate acquisition. However, the exact 
mechanisms and the GRNs that control neuronal development remains largely unknown 
(Moody et al., 2013).  
In Xenopus, activation of the organizer genes via Sia and Twin is necessary for the 
secretion of BMP and WNT inhibitors, and to directly up-regulate the expression of NE 
genes. Among the organizer the TFs, Sia, Twin, Goosecoid, and Foxa4 are expressed in 
organizer precursor cells in the dorsal blastula and later in the organizer proper. Other  TFs 
such as Hesx1, Lim1, Xnot, Otx2 and XlPOU2; and the genes Chordin, Noggin, Cerberus 
are expressed only once the organizer is formed. Ectopic expression experiments 
demonstrated that Sia and Twin directly activate expression of Foxd4 in the blastula before 
the organizer and NE are formed during gastrulation. Additionally, Sia and Twin directly 
induce expression of Geminin (Gmnn) and Zic2 in the blastula. Blocking Foxd4 translation 
in Xenopus blastomeres leads to inhibition of Sox11 expression, suggesting that Foxd4 
directly regulates Sox11expression. Foxd4 is widely expressed in NE precursor cells and 
later is restricted to the anterior and midline region of the NP comprised of NE cells. 
Subsequently, Foxd4 expression is restricted to a small region of the midbrain. Once the 
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organizer has differentiated during gastrulation it secretes factors that inhibit BMP and 
WNT from the adjacent mesoderm and ectoderm inhibiting reversion to a non-neural fate. 
In the gastrula stage Gmnn, Zic2 and Sox11 expression is facilitated through Foxd4 and 
other organizer TFs (Klein & Moody, 2015, Gaur et al., 2016) (Figure 1.5). Expressing the 
human homologous FOXD4 and FOXD4L1 in Xenopus blastomeres explants 
demonstrated that the human proteins affect neural gene expression similarly to Foxd4, 
indicating possible functional conservation (Gaur et al., 2016). In the mouse embryo, Gmnn 
and Sox2 expression initiates in the inner cell mass and is up-regulated in NE progenitors 
during gastrulation. By day E7.5-8 Gmnn and Sox2 are widely expressed in the NE together 
with Zic1 and Sox3 (Sankar et al., 2016). Foxd4, Gmnn, Zic2 and Sox11 block non-NE 
induction by inhibiting BMP/WNT pathway genes and their targets (Klein & Moody, 
2015).  
 
Figure 1.5. Sia and Twn induction to gene targets.  At blastula stage, in cells fated to give 
rise to the ectoderm and mesoderm express Sia and twin, which activate Foxd4, Gmnn and 
Zic2. At this stage, FoxD4 promotes activation of Sox11. Once the mesoderm and endoderm 
are formed during gastrulation, NE genes expression is maintained by factors secreted by the 
organizer and enhanced by FoxD4 (Klein & Moody, 2015).  
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Additionally, these TFs maintain the NE in a proliferative state by inducing NE 
progenitor’s genes facilitating NE expansion. Zic2 regulates ESC development by 
recruiting the co-factor Mbd3-NuRD to enhancer regions to regulate chromatin state and 
gene expression. Zic2 knockout in mouse ESCs cultured with N2B27 media to promote 
neuronal differentiation leads to cell death indicating the important role of Zic2 during 
neural differentiation (Luo et al., 2015). 
Sox11 is up-regulated during the transition from NE to neural progenitor, and hence has 
being implicated in maintenance of pan-neural neural progenitors. In mouse and chick 
embryo, Sox11 is only expressed in neuronal progenitor cells and in developing neurons 
(Klein & Moody, 2015). In contrast, Gmn, Zic2 and Foxd4 have being implicated in the 
temporary inhibition of bHLH neural differentiation genes NeuroG and NeuroD. For 
instance, Gmnn and Foxd4 are down-regulated during the transition of cells from a 
proliferative NE to neuronal progenitors (Moody et al., 2013; Lee et al., 2014).  
Gmnn interacts directly with TFs and with chromatin modifying complexes in a specific 
spatiotemporal manner to activate or repress genes expression. It has been proposed that 
Gmnn interacts with SWI/SNF and Polycomb chromatin modifying complexes to bind 
specific chromatin locations (Lim et al., 2011). Gmnn expression is required to maintain 
NE multipotency by promoting deposition of repressive histone modifications at neural 
genes. Additionally, during neural progenitor fate acquisition Gmnn facilitates the 
deposition of histone marks associated with open chromatin histone-activating marks in 
TFs gene targets in mouse ESCs promoting neuronal differentiation (Sankar et al., 2016). 
It has been demonstrated that Gmnn promotes acetylation of several genes involved in 
neuronal differentiation such as Bcl1, Pou6f1 and Pax4. Moreover, Gmnn could have a role 
in repressing mesodermal genes expression by enhancing Polycomb repressor complex. 
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Gmnn expression is also required earlier in development as Gmnn-/- mouse embryos fail 
to form ICM and generate TE in its place (Yellayoshyula et al., 2010; Caronna et al., 2011).  
The conversion from NE progenitors to NE cells and eventually to neural progenitors 
requires cells to leave cell cycle and initiate expression of bHLH TFs. To promote this 
transition a different set of genes is activated. In Xenopus, the TFs Sox1, Sox2 and Sox3 
are up-regulated downstream of Foxd4, Gmnn and Zic2. Sox1, Sox2 and Sox3 TF are 
members of the SoxB1 family and their expression is required to maintain self-renewing 
progenitors during the CNS development. High expression levels of SoxB TFs reduce the 
expression of bHLH neural TFs and inhibits neuronal differentiation. Thus, the transition 
of NE cells to differentiating neurons requires down-regulation of the SoxB family 
members (Holmberg et al., 2008) (Figure 1.6). SoxB TFs function in parallel to maintain 
cell proliferation and to establish spatial identity of neural cells at the same time and 
possibly in the same cells. The balance between SoxB1 TFs activity determines whether 
cells are maintained as progenitors or differentiate into neurons. The factor’s binding 
partner might determine SoxB1 regulatory function, but the exact mechanism of functional 
diversity is not well understood (Neriec & Desplan, 2014). Additionally, SoxB1 TFs 
maintain NE fate by inhibiting expression of Vent2, a BMP target necessary for epidermis 




Figure 1.6. Sets of transcription factors sequentially activated during early neuronal 
differentiation. NE precursors (green) express FoxD4, which directly induces the expression 
of Gmnn, Zic2 and Sox11 and transiently inhibits the expression of SoxB1 and neural 
progenitor genes. Neural plate stem cells (orange) differentiation requires down-regulation of 
FoXD4, Gmnn and Zic2 TF and high levels of expression of SoxB1 and Sox11 genes. The 
transition between neural progenitor stem cells (NPSC) and differentiating neuronal 
progenitors (blue) depends on the inhibition of Sox family members and up-regulation of Zic 
and Irx TF (Lee et al., 2014).  
 
 
SoxB1 binding results in bivalent chromatin remodeling, hence Sox proteins might play a 
role regulating the accessibility of subsequently expressed TFs. The proposed mechanism 
of regulation indicates that Sox members bind to target promoters/enhancers to deposit 
activate chromatin marks and prepare them for activation by another family member 
(Bergsland et al., 2011). In the mouse embryo and ESC cells Sox2, Sox3 and Sox11 bind 
to the promoters of the same target genes in a temporal sequence. Sox2 binds NE cells 
genes and marks the sites for latter Sox3 binding. Subsequently, Sox3 binds neuronal 
progenitor’s genes to mark Sox11 binding sites (Nishimura et al., 2012; Moody et al., 
2013). Sox2 expression initiates in the mouse ICM and is up-regulated during late 
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gastrulation. Sox2 expression inhibits activation of proneural genes and is down-regulated 
during the final cell cycle before neural differentiation proceeds (Wegner, M., 2011; Niu et 
al., 2015). Interestingly, Sox2 is part of the set of TFs capable of directing reprogramming 
of differentiated cells to pluripotent stem cells (Takahashi and Yamanaka, 2006). Sox3 and 
Sox1 are activated once mammalian cells have committed to a NE fate and overlap Sox2 
expression at stage E7.5-8. Sox2 and Sox3 share high homology and are expressed in 
overlapping domains. Furthermore, Sox3 activity is compensated during diencephalon 
development when the Sox3 (open reading frame) ORF is replaced with the Sox2 ORF 
suggesting that their expression is redundant (Graham et al., 2003; Niu et al., 2015). Sox2 
and Sox3 are necessary to maintain neuronal progenitors but not sufficient to induce 
neuronal differentiation whereas Sox1 has the ability to induce neuronal fate acquisition in 
Xenopus ectodermal explants and mouse ESCs. However, Sox1 knockdown in mouse 
showed mild phenotype defects, indicating functional compensation from other SoxB1 
members (Suter et al., 2009; Archer et al, 2011; Adikusuma et al., 2017). Sox1 is the 
earliest NE marker in mouse and its expression correlates with NP differentiation, thus it is 
broadly accepted that Sox1 plays a key role driving the transition from pluripotent cells to 
NE. However, it has been reported that Sox1 expression is not detected in the initial NE 
cells derived from human ESC revealing profound species-specific differences during NE 
differentiation (Zhang et al., 2010; Chung et al., 2012).  
Subsequently, the TF Zic1, Zic3, Irx1-3 are up-regulated upstream of early bHLH 
proneural TFs. Zic1/Zic3 are both required to maintain neural progenitors in a proliferative 
state and for temporarily inhibit neural differentiation genes. Additionally, Zic and Irx 
genes inhibit expression of FoxD4 allowing posterior expression of neural differentiating 
genes. In Mouse, Zic3 is activated in the early gastrula NE at E6.75-E7.0 and might play a 
role in the formation of the primitive streak. Zic1 is enriched in the NE at stage E7.5-7.8 
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overlapping Gmnn and Sox3. Zic1 promotes neural progenitor differentiation; possibly in 
collaboration with Gmn and stabilizes neural fate by attenuating BMP and WNT (Aruga & 
Mikoshiba, 2011; Moody et al., 2013; Sankar et al., 2016). However, the mechanism by 
which Zic1/Zic3 TF promote neural progenitor maintenance and differentiation is not well 
understood (Inoue et al., 2007; Lee et al., 2014). Likewise, Irx1, Irx2 and Irx3 are activated 
during Drosophila, Xenopus and mouse NE differentiation prior to the expression of bHLH 
genes. Irx genes share 95% of amino acid identity and are highly conserved among 
vertebrates leading to the suggestion that Irx functions are redundant. Irx genes are 
expressed in overlapping and also unique spatial-temporal patterns during the development 
of the CNS where they are necessary for regional specification and patterning of neural 
progenitors, possibly by directly repressing BMP4 signaling (Cohen et al., 2000). Irx loss 
of function assays in Xenopus, result in posterior displacement of the forebrain and 
reduction of the midbrain and hindbrain demonstrating their requirement for proper 
anterior-posterior and dorso-ventral regionalization later in development. Additionally, 
studies have revealed that Irx3 and Sox3 interact directly by mutually repressing each other. 
However, the precise function of Irx TFs during NE cells regionalization is not well 
understood (Gomez- Skarmeta & Modolell, 2002; Rodriguez- Seguel et al., 2009; Sankar 
et al, 2016).  
NE differentiation has been analysed in a reduced number of studies using mouse and 
Xenopus as animal models. However, limitations to acquire NE differentiating cells in vivo 
have prevented studing the NE development in humans. Hence, it has been demonstrated 
that the expression of regulatory markers such us PAX6, NESTIN, ZNF521 and N-cadherin 
is conserved between species during NE differentiation (Nandadasa et al., 2009; Park et 
al., 2010; Kamiya et al., 2011). However, specie specific differences in the temporary 
activation of these markers and regulatory signals unique for each species are largely 
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unknown. It has been shown that PAX6 and SOX1 are activated in a different temporal 
manner during NE differentiation between human and mouse. For instance,  in human, 
PAX6 is the earliest NE marker identified in ESCs undergoing neural induction, whereas 
in the mouse embryo the paired box TF Pax6 is expressed in specific NE regions only 
before the closure of the neural tube (NT) (Nat et al., 2007; Suter et al., 2009). In mouse, 
Sox1 is the principal candidate for NE formation and fate commitment while Pax6 plays a 
later role in differentiation of radial glial cells (Figure 1.7). Furthermore, PAX6 is sufficient 
and necessary for neural induction in human but not in mouse. PAX6 over-expression 
induces hESCs to adopt a NE fate whereas PAX6 knockdown fail to differentiate into NE 
even in the presence of dual SMAD inhibition (2i), conditions that favour neural 
differentiation. It has been suggested that the PAX6 neural inductive effect is achieved by 
repressing pluripotency genes such as OCT4, NANOG and MYC. However, OCT4, 
NANOG and SOX2 knockdown in ESC induces the cells to acquire trophoblastic fate. 
Hence, inhibition of pluripotency genes is a pre-requisite but not sufficient for NE 
differentiation. It has been proposed that the transition between ESC and NE cells is 
initiated by pluripotency inhibition and is potentiated by PAX6 activation of NE and 
neuronal progenitor genes including SIX3, LHX2, FGF8, NR2F2, TBR2 and WNT5b 
(Zhang et al., 2010; Blake & Ziman, 2014). In the mouse embryo, Pax6 and Sox2 occupy 
several common promoters including Nestin. Hence, these two TF possibly cooperate 
during neural induction of hESCs. Additionally, mouse studies have shown that PAX6 is 
required to maintain NP differentiation by inhibiting the expression of genes that promote 
mesodermal and endodermal differentiation such as Brachiury, Hnf1a and Myf (Thakurela 
et al., 2016). However, the transcriptional regulatory events involved in human NE 
commitment remain to be investigated.  
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Figure 1.7. Differential expression of PAX6 and SOX1 in human and mouse. In 
humans, PAX6 activated during NE differentiation from ESC (green) and is considered 
the earliest neural marker, whereas SOX1 is first detected in the neural tube in foetuses 
(Zhang et al., 2010). In the mouse embryo, SOX1 favours the formation and 
maintenance of the NE, whereas PAX6 is detected in the neural progenitors of the 
differencing forebrain before the closure of the NT (Suter et al., 2009).  
 
1.1.5. Additional neuroectodermal markers 
Nestin is an intermediate filament (IF) protein type IV that together with microtubules and 
microfilaments constitutes the cytoskeleton. During the development of the CNS different 
IF types are express in a cell specific manner, marking distinct differentiation steps. Nestin 
expression initiates during NE commitment and is dramatically reduced during the 
transition from neural progenitor cells to post-mitotic cells. Hence, Nestin has been widely 
employed as a NE marker (Wiese et al., 2004; Mahler & Driever, 2007). A recent study 
conducted with mouse neurospheres demonstrated that Nestin knockdown results in 
inhibition of cell proliferation and reduction of EGFR signalling, indicating that Nestin in 
collaboration with EGFR signalling regulate cell proliferation in mouse neurospheres (Hu 
et al., 2016). Furthermore, Nestin deficient mice show a reduction of the neural tube cell 
number caused by increased apoptosis and reduced self-renewal ability, leading to 
embryonic lethality. However, microarray data analyses depicted similar gene expression 
patterns between the mutants and controls. Additionally, in the mutant mouse the 
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microtubules, microfilaments and IF networks structure and integrity was not affected. 
Thus, Nestin may exert its regulatory effects through interactions with other non-structural 
proteins, rather than through its role in cytoskeleton maintenance. For instance, Nestin 
knockdown in rat neuronal progenitors induces Cdk5 mediated apoptosis under oxidative 
stress. Hence, it has been proposed that Nestin serves as a scaffold to directly bind and 
sequester Cdk5 to regulate its activity (Park et al., 2010).  
Another factor that plays a key role during NE differentiation is ZEB2, a member of the 
ZHFX1 family that directly interacts with activated SMAD 1-3 proteins, ZEB2 knockdown 
hESCs initially differentiate into NE cells but eventually fail to express early and late neural 
markers, whereas ZEB2 over expression enhances NE differentiation. Thus, ZEB2 is 
necessary for NE progression and maintenance but is not required to initiate NE 
commitment. Additionally, ZEB2 is required to maintain NE fate commitment over 
mesendoderm differentiation. ZEB2 antagonizes the expression of Activin/Nodal and BMP 
signaling by direct interaction with SMAD proteins (Conidi et al., 2012; Tang et al., 2015). 
Activin/Nodal signaling maintains pluripotency in mouse Epi and hESCs thought direct 
up-regulation of NANOG mediated by its intracellular effectors SMAD2/3. In return 
SMAD, NANOG and OCT4 inhibit expression of ZEB2 and prevent differentiation of 
hESCs. Concomitantly, ZEB2 is directly up-regulated by SOX2 during this stage. Thus, 
ZEB2 is in parallel up-regulated and inhibited at the same time, resulting in reduced levels 
of ZEB2 expression, which are sufficient to reduce ability of SMAD to induce 
mesendodermal fate. Moreover, studies have proposed that NE differentiation is triggered 
as Nodal, Lefty and Cerberus inhibit SMAD from the node in the embryo Epi reducing the 
expression of NANOG and OCT4, which results in an increase in expression of ZEB2 
(Chng et al., 2010). Another member of the Zeb family, the TF Zeb1 is up-regulated in 
proliferative neural progenitor cells and down-regulated in post-mitotic neurons. Zeb1 
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plays an important role during mesenchymal-ephitelial transition by repressing E-cadherin 
expression and concomitantly inhibiting epithelial markers (Zhang et al., 2015; Aiger et 
al., 2017). 
Likewise, the zinc-finger protein Znf521 is considered to play a role during NE 
differentiation as its expression pattern correlates with NE fate acquisition. In the mouse 
embryo, Znf521 is absent in the ICM and is strongly up-regulated at E7.0-E8.0 in the NE. 
As gastrulation proceeds Znf521 expression is preferentially located in the rostral neural 
tube. Overexpression assays in mESCs demonstrated that Znf521 is sufficient to induce 
expression of NE markers even in presence of BMP4, whereas Znf521 down-regulation 
resulted in sustained expression of Epi markers and lack of NE markers. NE development 
was rescued by Znf521 induced expression, demonstrating that Znf521 is necessary and 
sufficient for the Epi-NE transition (Kamiya et al., 2011; Shen et al., 2011). Furthermore, 
chromatin immunoprecipitation (ChIP) assays depicted enrichment of Znf521 factor in the 
DNA regions of Sox3, Sox1 and Pax6, indicating possible direct regulation of the NE 
markers by Znf521. Additionally, mouse and human fibroblast transfected with a Znf521 
expressing lentivirus have been successfully induced to adopt rostral NSC characteristics. 
The reprogramed cells express NE markers such as Sox1, Sox2 and Pax6, were stable up 
to 60 passages and have the ability to differentiate into neurons and astrocytes (Shahbazi et 
al., 2016b). Kamiya et al, reported lethality in Znf521 mouse deficient embryo. However, 
a different study indicated that the deficient embryos formed NE and developed a CNS, 
suggesting the possibility of functional compensation by another gene in vivo. However, 
the mice showed reduced number of Sox1 positive cells, schizophrenic like behaviour and 
die after 10 weeks of birth. Together these studies demonstrated that Znf521 is necessary 
for proper neuronal differentiation (Ohkubo et al., 2014).  
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Finally, N- cadherins are highly up-regulated at NE stage and are commonly used as NE 
markers. Cadherins are cell-cell adhesion molecules necessary for a number of 
development processes. Initially the ectoderm express E-cadherins and they are 
progressively replaced by N-cadherins during NE differentiation while the non-neural 
ectoderm retains E-cadherin expression. Trans-membrane N-cadherins attach to cortical 
actin on the cell to maintain adherent junctions necessary for intracellular adhesion in NE 
cells (Kadowaki et al., 2006; Nandadasa et al., 2009). Down-regulation of N-cadherin in 
mouse ESC-derived NE cells caused disruption of the normal architecture of the NE cells 
and inhibition of rosette like structure formation. In Xenopus neural progenitors N-cadherin 
down-regulation results in loss of movements of the neural folds. Hence, N-cadherin plays 
a pivotal role maintaining the normal cellular architecture and movement during NE 
development (Nandadasa et al., 2009; Su et al., 2013).  
1.1.6. Neuroectoderm specification  
Neuronal progenitors or neural stem cells are generated from NE and undergo a limited 
number of symmetrical divisions and then asymmetrical divisions during neural 
differentiation (Dhanesh et al., 2016). As development proceeds, neural progenitors acquire 
some glial features, and become elongated to form radial glial cells (RG) with the cell body 
at the ventricular surface of the neural tube and radial fibers extending to the pial surface 
around E9-E10 (Bergstrom & Forsberg-Nilsson, 2012; Okano & Temple, 2016). 
Multipotent RG divide asymmetrically generating one basal progenitor cell and an 
immature neuron (intermediate progenitor cell). Subsequently, immature neurons migrate 
along the radial fibers to the cortical zone and become deep layer and later superficial layer 
neurons. Basal progenitors constitute transit amplifying cells that continue producing 
neurons from the subventricular zone. After generation of neurons RG cell subsequently 
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give rise to oligodendrocytes, astrocytes and ependymal cells (Kageyama et al., 2014; 
Imayosgi et al., 2015) (Figure 1. 8).  
Members of the bHLH family, Hes1, Hes5, Ascl1, Neurog2, Olig1 and Olig2 play an 
important role in maintaining neural progenitors and regulating fate choices. Hes1 and 
Hes5 are transcriptional repressors that promote neural progenitor self-renewal and inhibit 
expression of proneural genes. Ascl1 and Neurog2 are the best-studied proneural activators 
that promote neural fate commitment and neuronal subtype specification. Additionally, 




Figure 1. 8. Differentiation of neuroectoderm cells in the embryonic brain. NE cells divide 
symmetrically to form the NP and thicken the NT. NE cells acquire regional identity and become neural 
progenitors that initially renew by symmetrical division. Neural progenitors from the ventricular zone 
elongate to the apical zone and differentiate into RG cells. RG cells divide asymmetrically to give rise 
to an immature neuron that migrates to the cortical zone and differentiate into a deep layer neuron and 
then subsequently generate superficial layer neurons and basal progenitors. Basal progenitors proliferate 
in the subventricular zone to generate more neurons.  Later dividing RG cells differentiate into 
oligodendrocytes, astrocytes and ependymal cells (Kageyama et al., 2014).   
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Hes1 and Hes5 are down-stream effectors of Notch, a trans-membrane protein that 
regulates neural progenitor cell self-renewal and inhibits neural differentiation. Proneural 
TF induce the expression of Notch ligands Delta and Jagged from neighboring 
differentiating neurons. After activation Notch undergoes several cleavages and releases its 
intracellular domain (ICD). The ICD is transported to the nucleus and binds Rbpj DNA 
binding protein and the co-activator Mam1. The complex activates the expression of Hes1 
and Hes5, which inhibits neural differentiation and maintains RG cells. Hence, Notch 
signalling regulates neural differentiation of neighboring cells trough cell-cell lateral 
inhibition (Kageyama et al., 2005; Dhanesh et al., 2016). Hes1 and Hes5 have a WRPW 
domain that interacts with the co-factor TLE/Groucho to recruit histone deacetylases and 
repress the expression of target proneural genes including Ascl1 and Neurog2. For instance, 
Hes1 binds to the Ascl1 promoter to directly inhibit its expression and regulates Ascl1 
activity by binding E47 an Ascl1 co-activator to inhibit their protein-protein interactions. 
Later in development Hes1 expression induces acquisition of astrocyte fate. In contrast, 
another bHLH family member Hes6 promotes neuronal differentiation by binding Hes1 
and inhibiting its activity. Proneural bHLH TFs antagonize Hes1 by activating Hes6 
expression (Kageyama et al., 2005; Imayosgi et al., 2015).  
The bHLH activator type TFs such as Ascl1 and Neurog2 control early and late 
neurogenesis by regulating expression of pan-neural genes and expression of genes 
involved in neuronal commitment (Kageyama et al., 2015). Proneural genes Ascl1 and 
Neurog2 form a heterodimer with the co-factor E47 to regulate the expression of target 
genes. Particularly, Ascl1 regulates the expression of several TFs involved in 
differentiation of neurons, including Sox4, Gli3 and Dlx2. Additionally, Ascl1 activates 
expression of genes involved in cell cycle arrest such as Fbxw7, Gadd45g and Ccng2 and 
cell cycle progression such as Cdk1, Cdk2, and Skp2. Thus, Ascl1 regulates opposing 
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functions, inducing both cell cycle exit and proliferation. Furthermore, Ascl1 is sufficient 
to induce mouse and human ESCs to differentiate into neurons and to reprogram human 
fibroblast to acquire neuronal characteristics (Chanda et al., 2014). Interestingly, Ascl1 
promotes chromatin accessibility to its own target genes regulating temporal progression 
of its transcriptional program (Castro et al., 2011; Raposo et al., 2015). Additionally, 
proneural genes inhibit the expression of glial specific genes such as GFAP by sequestering 
their activators Smad1-p300 complex from glial promoters (Kageyama et al., 2005).  
bHLH TFs are broadly expressed in the population of actively dividing neural progenitors, 
overlapping the expression of NE markers like Sox2. However, Sox2 is homogeneously 
expressed, whereas bHLH TFs expression is variable among the cells. Imayoshi and 
colleagues found that Hes1, Ascl1, Ngn2 and Olig2 are expressed in an oscillatory manner 
in early neural progenitors differentiated from mouse ESCs. Hes1 and Ascl1 proteins 
expression oscillate every 2-3h while Olig2 proteins oscillate in a 5-8h period. It has been 
proposed that Hes1 oscillations initiate as Notch is activated and induce up-regulation of 
Hes1. Subsequently, Hes1 binds and repress its promoter inhibiting its own expression. 
Hes1 protein and mRNA are highly unstable and rapidly disappear leading to another 
expression cycle (Shimojo et al., 2008).  Hes1 oscillatory pattern is in opposite phase to 
oscillations of Ascl1, Neurog2 and its ligand Delta-like1 (Dll1). Thus, is possible that Hes1 
induces Ascl1, Neurog2 and Dll1 oscillations by periodically inhibiting their expression. 
Subsequently, during neural differentiation one of the three bHLH TFs becomes expressed 
in a sustained manner while the others are down-regulated. Hence, multipotent actively 
dividing neural progenitors express various bHLH TFs in an oscillatory manner, while 
sustained expression of a specific factor drives commitment to a particular fate. It has been 
suggested that transient inhibition of Hes1 and transient up-regulation Ascl1 or Neurog2 
before cell division bias neural progenitors to acquire neuronal fate. Neuronal fate is then 
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determined by a sustained expression of Ascl1 or Neurog2 and down-regulation of Hes1. 
On the other hand, up-regulation of Hes1 and Olig2 bias the neural progenitors to commit 
into astrocytes and oligodendrocytes fate respectively (Kageyama et al., 2014; Imayosgi et 
al., 2015). 
1.1.7.  Formation of the neural border zone  
During gastrulation the ectoderm is regionalized into neural, non-neural ectoderm and the 
neural border zone (NBZ) between the two regions. Interactions among neural and non-
neural ectoderm and signals from the underlying mesoderm and endoderm induce the 
differentiation of the NBZ, which will give rise to the neural crest (NC) and the pre-
placodal ectoderm (PPE) (Saint-Jeannet & Moody, 2014; Shigetani et al., 2016). Members 
of the Dlx, Msx, Pax and Zic families and TFAP2α, Gata and Foxi1 genes are widely 
expressed in the non-NE and overlap the expression of NE TFs SoxB1 and Zic in 
prospective NBZ (Dincer et al., 2014; Moody & LaMantia, 2015; Shigetani et al., 2016). 
As the NE cells divide to form the NP, SoxB1 TFs become confined to the NP, Zic members 
are confined to the NP and the medial NBZ, Dlx, Gata, Foxi1 and TFAP2α are restricted 
to the non-NE and Msx1 and Pax3 are expressed only in the NBZ.  
Dlx genes are required to promote the expression of NC and PPE genes and to inhibit the 
expression of NE genes. Dlx TF interact with Msx TF by inhibiting each other’s expression. 
Differential expression of these genes bias cell fate towards NC when Msx is up-regulated 
and Dlx expression levels are low and towards PPE when Dls is up-regulated and Msx 
levels are low (Phillips et al., 2006; Moody & LaMantia, 2015). Dlx5 activates expression 
of the PPE marker Six1, while Msx1 represses it. Msx1 induces expression of Pax3 and 
Zic1, which interact to activate NC genes. Alternatively, lack of expression of Pax3 and 
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expression of Zic1 induce the differentiation of the PPE. Foxi1 and TFAP2α genes are also 
necessary for NBZ formation. In Xenopus explants, Foxi1 loss of function leads to 
reduction in expression of Dlx, Six1 and FoxD3 (NC marker) and expansion of the Sox2 
positive NP. Likewise, inhibition of TFAP2α results in down-regulation of Msx1, Pax3, 
FoxD3, Six1 and Eya1 (PPE marker). Thus, maintained expression and cross-regulation 
between Dlx, GATA, Foxi and TFAP2α are required for the formation of the NBZ, the PPE 
and the placodes (Sato et al., 2005; Leung et al., 2016 Moody & LaMantia, 2015) (Figure. 
1.9).  
        
 
Figure 1.9. Scheme of the genetic interactions during the formation of the ectoderm sub-
domains. During gastrula stage, inhibition of BMP signaling allows activation of NE genes such 
us SoxB1 TF. NE cells proliferate to form the NP (blue). High levels of BMP promote the 
expression of several NBZ genes like Msxl1, Dlx, Gata1/3, Pax, Zic, Tfap2 and Foxi1/3, which 
interact with each other to repress NE TF (red edges) and to activate and maintain the NBZ genes 
(black edges). Once the NBZ has been formed, BMP is down-regulated to allow expression of the 
NC and the PPE, whereas high levels of BMP are required for epidermis differentiation. 
Differential expression of NBZ genes bias NBZ to differentiate into NC or PPE. The PPE is 
specified by expression of Dlx, Zic1, Gata and Tfap2 TF and down-regulation of Msx1 and Pax3. 
Additionally, low levels of FGF signaling from the underlying mesoderm and inhibition of WNT 
are required for PPE formation. The NC is differentiated by expression of Msx1, Pax3, Zic1 and 
WNT signaling and requires down-regulation of Dlx (Moody & LaMantia, 2015). 
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1.1.8. Differentiation of the placodes 
Once the NBZ has been formed, the PPE regulators Six and Eya are activated. Additionally, 
low levels of FGF signaling from the underlying mesoderm are required for PPE formation. 
FGF signals inhibit expression of PPE repressing TFs and induce expression of PPE 
markers. However, the underlying mechanisms by which FGF genes regulate the 
expression of PPE inhibitors and markers remain to be elucidated. Similarly, BMP 
signaling is necessary for the differentiation of the NBZ and it must be reduced to permit 
formation of the PPE (Grocott et al., 2012; Moody & LaMantia, 2015; Shigetani et al., 
2016). Another signal that needs to be reduced to allow PPE differentiation is WNT, which 
directly represses genes that promote PPE fate. Hence, the PPE is restricted to the NBZ 
surrounding the anterior neural plate where WNT is inhibited (Leung et al., 2016). In chick, 
PPE genes are activated in the NBZ in presence of low Fgf8 signaling accompanied with 
low BMP and WNT levels, whereas if WNT signal persists NC markers are activated 
(Moody & LaMantia, 2015; Shigetani et al., 2016). Additionally, retinoid acid (RA) is 
expressed in a U-shaped area similar to the PPE in the anterior NBZ. Attenuation of RA 
signaling increases the posterior limit of the PPE, suggesting a role in the control of the 
PPE boundary possibly through regulation of RA target genes Tbx1 and Ripply3. In regions 
where both targets are expressed, PPE genes are inhibited, while if only Tbx1 is activated 
PPE genes are induced. Thus, RA might restrict the PPE limits by inducing the expression 
of both targets in the posterior ectoderm (Janesick et al., 2012; Moody & LaMantia, 2015).  
Six1, Six2 and Six4 are highly expressed in the PPE domains and have been implicated in 
differentiation of the PPE and placodes. Six1 plays a central role in PPE development, since 
loss of function studies have demonstrated reduction in the expression of other PPE 
markers in Xenopus and Drosophila. Six1 loss in mouse affects the formation of the 
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olfactory placode but has no effect on formation of the PPE, possibly due to compensation 
from another factor (Chen et al., 2009; Grocott et al., 2012; Moody & LaMantia, 2015). 
However, induction of Six1 expression is not sufficient to induce PPE markers outside of 
the NBZ. Additionally, Six2 and Six4 are widely used as PPE markers, but their regulatory 
mechanism has not yet been described. Six activities can be modulated by binding of co-
factors that lack a DNA binding domain (Moody & LaMantia, 2015).  
The TF Eya1 and Eya2 are among the best-studied Six co-factors. Eya1 and Eya2 
expression patterns resemble the expression of Six1 in Xenopus, suggesting that they 
possibly have roles driving the differentiation of the PPE and the placodes. Furthermore, 
Eya1 directly binds Six1 and possibly other TFs to translocate into the nucleus and regulate 
expression of PPE target genes. Eya loss of function in Xenopus leads to abnormalities in 
the placode derivatives but the effects on PPE formation have not been addressed. Six1 can 
also function as a repressor when it interacts with other TFs such as Groucho to inhibit 
expression of epidermal and NC genes (Silver et al., 2003; Chen et al 2009; Moody & 
LaMantia, 2015). Several other genes that might bind to Six1 during PPE and placode 
development have been identified, but their regulatory functions and interactions have not 
yet been delineated. PPE transcriptional regulators including Six and Eya genes set the 
transcriptional landscape for the development of the distinct placodes and maintain the 
boundaries between PPE and the adjacent NC and non-NE. However, the molecular 
pathways that establish and maintain the ectoderm sub-domains are not fully understood 
(Moody & LaMantia, 2015).  
 Initially, the PPE has the ability to differentiate into any placode and later acquires 
anterior-posterior (A-P) patterning in response to local signaling from the mesoderm and 
ectoderm. The anterior PPE will give rise to the adenohypophyseal, olfactory and lens 
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placodes, the middle PPE will become the trigeminal placode and the posterior PPE will 
differentiate into otic and epibranchial placodes. In vertebrates, the placodes will give rise 
to the majority of the peripheral sensory nervous system (Grocott et al., 2012).  It is 
generally accepted that BMP, FGF, WNT and RA contribute to specification of placode 
identity. Differential expression of Six TFs expression might also contribute to the 
formation of the A-P patterning. Additionally, the TF Otx and Gbx2 are differentially 
expressed in the A-P domains, respectively, and might play a role in the differentiation of 
the PPE (Steventon et al., 2012). As a result of the A-P regionalization, different Pax 
members are induced in specific regions. Pax6 is expressed in the anterior placodes, Pax3 
in the ophthalmic placode whereas Pax2 and Pax8 are activated in the posterior placodes. 
Additionally, genes broadly expressed in the PPE become restricted to specific areas: Six3, 
Six6, Pitx3 are expressed in the most anterior placodes and Dlx, Irx, Tbx, Foxi3 in the 
posterior placodes (Grocott et al., 2012; Moody & LaMantia, 2015). Subsequently, specific 
combinations of additional genes are activated in each placode such as Emx2 and Ebf2 in 
the olfactory placode. Furthermore, genes that were expressed in the PPE are segregated to 
specific areas. Pax6 and Dlx5 are restricted to mutually exclusive domains comprising cells 
fated to the lens placode and to the olfactory placode, respectively. The transcriptional 
networks implicated in the differentiation of each placode will subsequently drive 
differentiation of specific neurons such as GnRH, which are derived from the olfactory 
placode (OP) and subsequently migrate to the hypothalamus during early embryogenesis 
(Provenzano et al., 2010; Moody & LaMantia, 2015).  
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1.2. Induced pluripotent stem Cells  
The initial steps of mammalian development have been studied with detail up to the point 
of implantation primarily based on data obtained from the mouse model. A recent study 
has reported in vitro implantation platforms for mouse and human that allowed insight into 
human early development. Many key events of development were recapitulated in vitro and 
expression of cell-type specific markers for the ICM, Epi, PE and TE in pre and post 
implantation embryos were analyzed and compared with those occurring in mouse. The 
study ended at 14 dpf or before the initiation of the gastrulation according to the 
international bioethical guidelines (Bedzhov et al., 2015; Deglincerti et al., 2016). Such 
studies evidenced the profound differences in architecture, cell diversity and tissue 
organization between mouse and human, highlighting the necessity to develop an in vitro 
system to study human development. The earliest step of the human CNS differentiation is 
the segregation of the NE from non-NE during gastrulation. However, the inability to 
sample live human live cells during this developmental stage limits our knowledge about 
the key TFs and developmental programs that govern human NE fate acquisition and 
differentiation and early aberrant regulatory events that might be involved in 
neurodevelopmental disorders (Marchetto et al., 2010). 
Spemann and Mangold first discovered neural induction when they reported that NE was 
formed from non-NE cells exposed to signals from the dorsally specified mesoderm in the 
amphibian embryo. Over the subsequent decades the molecular interactions and TFs that 
drive transition from pluripotent Epi cells to NE fated cells have been investigated. The use 
of Xenopus and mouse systems has led to the identification of a number of TFs (Moody et 
al., 2013). However, the human and mouse brains have profound differences, most notably 
their size and complexity. Humans have a larger and more complex brain, which is 
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accompanied by an elongated period of brain development (van de Leemput et al., 2014). 
Disparities are also evident at a molecular level, such as the distinct times of expression of 
the NE markers Pax6 and Sox1 during NP differentiation (Suter et al., 2009). Hence, the 
gene regulatory events that drive fate decisions during early neuronal development and 
particular cues and cell types that might be unique to humans are not fully recapitulated in 
the mouse model (La Manno et al., 2016; Yao et al., 2017). Thus, the TFs and genetic 
pathways involved in the inhibition of the pluripotency gene network and the activation of 
the NE program in humans remains largely unknown.  
ESCs and iPSC provide powerful in vitro system to analyze the TF and regulatory events 
that orchestrate human development and have an enormous potential for therapeutic 
applications. ESCs are derived from the ICM of the blastocyst, have competency to 
differentiate into all cells from the three germ layers and are capable of indefinite 
replication (Takahashi & Yamanaka, 2006). Human ESCs are similar to EpiESCs in their 
developmental potential. ESCs have the ability to replicate the progression during neuronal 
development from pluripotency to functional neurons. Differentiating ESCs express 
dynamic genetic programs that regulate pluripotency maintenance networks and activation 
of the TFs required for differentiation into specific cell lineages (Ardhanareeswaran et al., 
2017). Loss and gain of function approaches have been widely used to analyze the role of 
particular TFs during directed ESC differentiation to a specific lineage. Hence, ESCs 
provide an opportunity to identify specific TF that might be involved in human embryonic 
development in vitro (Hong et al., 2016). However, embryos with known genetic defects 
are rarely accessible for the analyses of neurodevelopmental disorders and ESCs are not 
optimal for tissue transplantation in patients due to the possibility of rejection (Shi et al., 
2016). Importantly, the use of human embryos for research purposes has been the center of 
several ethical and political controversies. iPSCs are capable of differentiating into any cell 
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type desired, have unlimited capacity to replicate and overcome many of the ethical 
concerns associated with ESCs.  
In 2006, Takahashi and Yamanaka reported that somatic cells could be reprogramed to 
acquire gene expression profiles and differentiation potential similar than ESC by the 
introduction of Oct4, Sox2, Klf4 and Myc. The TF Oct4 and Sox2 were previously reported 
to play a role in the maintenance of pluripotency in the ICM and in ESCs Klf4 and Myc 
were thought to enhance ESC proliferation and to maintain their phenotype (Takahashi & 
Yamanaka, 2006). Yamanaka and colleagues used retroviral integration systems to 
reprogram mouse fibroblasts and a year later they reported the reprograming of human 
fibroblast. iPSCs technology has vastly improved since then, and in order to avoid 
integration, different delivery methods are widely used, including adenovirus, Seindai 
virus, small molecules and RNAs, among others. These advances make iPSC technology 
more suitable to analyze human development, to model diseases, to test drug toxicity and 
particularly for patient specific cell therapy (Suh, 2017).  
The use of iPSC technology makes possible to obtain large amounts of different relevant 
cells that were previously unavailable, such as cells in different developmental stages 
including iPSC-derived neuro-ectodermal stem cells (NESCs). iPSCs can be obtained from 
easily accessible somatic cell types and from individuals with different genetic background 
including patients with a known disease phenotype. Patient specific cells with a mutation 
or multiple mutations can be derived and differentiated into disease relevant cell types to 
identify the pathological mechanism and the disease etiology (Shi et al., 2016; Suh, 2017). 
Furthermore, the development of gene editing technologies such as CRISPR–Cas9 enables 
introduction of disease-causing mutations in control iPSC and to remove disease-associated 
mutations from patient’s derived iPSC. Comparing the mutated iPSC with their isogenic 
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controls allows determining the possible phenotypic effect of disease-associated genes (Shi 
et al., 2016) (Figure 1.10).  
 
Figure 1.10. Human disease modeling scheme.  Human somatic cells are harvested from patients 
and are reprogramed by specific TF.  An isogenic control is generated by CRISPR-Cas9 genome 
editing technology. Derived iPSCs are induced to differentiate into specific cell types. 
Differentiated cells are used to analyze and identify specific gene expression patterns and cell 
phenotypes relevant for the disease (Shi et al., 2016).  
 
 
iPSC reprograming is recognized as a major epigenetic remodeling process and it is 
necessary to adjust the epigenetic state of the parental cell to a state compatible with 
pluripotency (Gao et al., 2017). However, many epigenetic marks in iPSCs have being 
found to differ from those in ESCs. These differences represent epigenetic memory, which 
may have a negative effect in the reprograming efficiency and capacity to differentiate into 
specific lineages (O’Malley et al., 2013; Brix et al., 2015). However, minor epigenetic and 
transcriptional memory and unbiased differentiation potential have being shown by genome 
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wide analyses performed with iPSCs derived from different somatic tissues from multiple 
individuals (Gao et al., 2017). Such studies have also demonstrated that the major source 
of variability between iPSC lines is the donor’s genetic background. For instance, genetic 
and epigenetic variability between iPSC and ESC might reflect the differences in the 
genetic background of the individual donors. It has been reported that epigenetic memory 
effects on gene transcription are reduced over multiple passages. Hence, the major cause 
of heterogeneity among iPSCs is the genetic differences between the donors, while the 
epigenetic memory or intrinsic variability of the iPSC system have minimal contributions. 
For experimental procedures, the incorporation of iPSC derived from multiple individuals 
is recommended to average and separate the genetic background effect of each cell line 
from global transcription (Rouhani et al., 2014; Suh, 2017). Additionally, incomplete 
silencing of the reprograming TFs has being a concern about using the iPSC system to 
model development and disease. However, several gene expression analyses have indicated 
that the reprogramming transgenes are inactivated during propagation (Xia et al., 2007; 
Nakanishi & Otsu, 2012).  
Currently, iPSCs and ESCs are broadly used as in vitro systems to gain insight into human 
neuronal development and to study neurodevelopmental and neurodegenerative conditions 
such as autistic spectrum disorder, Rett syndrome, Alzheimer’s disease and Parkinson’s 
disease (Begum et al., 2015). Such studies aim to recapitulate the multistep process of 
neuronal differentiation to confirm the identity of the TFs and genes involved in normal 
and aberrant development and to reveal novel TF that might play a role during 
differentiation. ESC and iPSC neural induction can be achieved in monolayer cultures, 
which are a reproducible and efficient means of obtaining a large number of highly 
homogeneous neural progenitors cells. Neural progenitors can then be differentiated into 
various neuronal subtypes such us GABAergic, glutamatergic and dopaminergic neurons, 
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whose morphology is relatively easy to analyze in adherent cultures. For instance, RG cells 
derived from ESC and iPSC display molecular and morphological characteristics of human 
embryonic RG and follow the RG cell intrinsic mechanism to differentiate first into cortical 
neurons and subsequently into late progenitors that can potentially differentiate into 
astrocytes (Figure 1.11) (Neely et al., 2012; Duan et al., 2015; Ardhanareeswaran et al., 
2017).  
 
Figure 1.11. Human pluripotent stem cell differentiation to cortical neurons and astrocytes. 
Pluripotent stem cells are induced to differentiate into NE by treatment with 2i over 8 days. NE cells 
express Pax6, Foxg1, Sox2 and Nestin TF, which are commonly used as NE and forebrain markers. 
NE cells adopt RG characteristics and express BLBP, GFAP, Vimentin and Sox2 markers after 
approximately 12 days of culture without inhibitors. Depending on the culture conditions, RG cells 
differentiate into cortical neurons (CN) expressing Tbr1, Ctip2 and Satb2 TF around 45 days of 
differentiation. With further culture the remaining RG adopt late progenitor (LP) phenotype that 
generate astrocytes, positives for S100β and GFAP markers (adapted from Duan et al., 2015).  
 
In Xenopus, BMP and TGFβ inhibition via Noggin, Chordin and Follistatin from the node 
is necessary for neural differentiation. Studies have shown that inhibition of BMP and 
TGFβ pathways (2i) leads to highly efficient conversion of ESCs and iPSCs to neural 
progenitors in adherent cultures (Muratore et al., 2014; Ardhanareeswaran et al., 2017). 
SB431542 and LDN193189 small molecule inhibitors are widely used to inhibit TGFβ and 
BMP signaling respectively. SB431542 inhibits kinase activity of ALK4 ALK5 and ALK7 
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receptors, which are necessary for SMAD2 and SMAD3 phosphorylation whereas 
LDN193189 blocks SMAD1, SMAD5 and SMAD9 phosphorylation by inhibiting ALK1, 
ALK2, ALK3 and ALK6 receptors (van Caam et al., 2017). The potential mechanisms that 
contribute to the generation of highly pure neural progenitors population are the inhibition 
of trophoblast lineage that is otherwise promoted by BMP; suppression of mesodermal fate 
that requires NODAL/Activin and BMP signaling; and destabilization of NANOG-
pluripotency program mediated NODAL/Activin inhibition (Chambers et al., 2009; 
Muratore et al., 2014). Down-regulation of NANOG via SMAD2/3 inhibition leads to the 
up-regulation of ZEB2, which promotes acquisition of NE fate. Likewise, down-regulation 
of OCT4 promotes expression of NR2F2, which induces NE markers expression. 
Additionally, it has being proposed that BMP inhibition promotes the expression of cell 
intrinsic NE determinants (Ozair et al., 2012).  
iPSCs have similar gene expression patterns during neuronal differentiation as ESCs, with 
the same differentiation time and under the same cell culture conditions. In principle, ESCs 
and iPSCs differentiation programs resemble the embryo developmental program and 
underlying gene regulatory signals. Thus, the iPSCs model system is widely used to 
recapitulate the progression of neuronal development and to identify the transcriptional 




1.3. Study aim and objectives  
The overall aim of the study is to discover the gene expression profiles and the GRN 
tranversed during neural induction of human iPSCs to NESCs. Ethical, legal and technical 
limitations prevent study of in vitro development of the human embryo after 13 dpf or the 
formation of the primitive streak. Following formation of the primitive streak, neural 
induction of the dorsal ectoderm during gastrulation is the first step in the formation of the 
CNS. However, restricted access to NE cells has limited the ability to obtain suitable 
transcriptome data to enable identification of genes and pathways that drive transition from 
pluripotency to neural competence. iPSCs due to their molecular, morphological and 
functional similarity to ESC in vivo provide a unique experimental system to analyze the 
molecular events and the lineage-biased states that regulate human development. Several 
molecules implicated in the ectoderm neural induction have been described in animal 
models but fail to uncover specific human development landmarks due to species-specific 
differences.  
Due to these limitations, a complete transcriptome analyses and a description of the GRNs 
that orchestrate NE differentiation in humans have not been reported. With this study we 
aim to provide a complete view of the genes that are differentially expressed during human 
NE induction from iPSCs. This approach allows us to validate previously described 
pathways and to detect novel genes with a potential role during NE differentiation. We 
aimed to use these data to construct a GRN, which topology would enable to identify the 
gene regulatory interactions at the initial stages of NE induction; and the potential 
biological processes that emerge from the specific gene expression patterns during this 
stage. In parallel, colleagues from the Price laboratory have reported the differentiation of 
cortical and GnRH neurons by using 2i and ‘2i plus WNT’ inhibition differentiation 
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protocols, respectively. We aimed to identify the early molecular differences that might 
bias iPSC neural induction to cortical and GnRH fates.  
The specific objectives of the project are:  
1. To use iPSCs as an in vitro system to uncover gene expression profiles activated 
during human neural induction.  
 
2. To identify the effect of WNT inhibition on gene expression profiles generated 
during neural induction. 
 
3. To derive a GRN that comprises the first gene regulatory interactions underlying 
NE fate commitment. 
 












CHAPTER 2. General Materials and Methods 
2.1. Neural Induction 
For the experiments in this study 3 iPSC lines and 1 ESC line provided by the Price 
laboratory were used. iPSC lines were derived from keratinocytes from neurotypic males 
from an age ranging between 35 to 55 years. The cells lines CTR M3 36S, CTR M2 42, 
CTR M1 04 are referred as iPSC1, iPSC2 and iPSC3 respectively, whereas the ESC 
SA001++ is referred as ESC. The iPSC lines were reprogramed by introducing C-MYC, 
KLF4, OCT4 and SOX2 TF in a polycistronic excisable vector. CTR M2 42 and CTR M1 
04 lines were transformed with a Human STEMCCA Cre-Excisable Constitutive 
Polycistronic (OKSM) Lentivirus Reprogramming Kit (Millipore, SCR545) while CTR 
M3 36S line was transformed with CytoTune-iPS 2.0 Sendai Reprogramming Kit (Thermo 
Fisher, A16517). 
ESC and iPSC plated in 6 well Nunc treated multidishes (Thermo Scientific, 140675) were 
washed once 1ml/well of HBSS (Life technologies, 14170-070) at room temperature. Cells 
were incubated for 5 min at with 1ml of Versene (Lonza, BE17-711E) for dissociation. The 
Versene was removed and cells were detached with a cell lifter and suspended on 1ml of 
E8 media (Life technologies, A1517001). Cells were counted with a TC10 automated cell 
counted (Bio-rad) and approximately 3,000,000 cells per well were seeded on Nunc 
multidishes with 3ml of E8. The dishes were coated previously to seeding with 1ml of 2% 
Geltrex (Life technologies, A1413302) in DMEM: F12 (Sigma; D6421) for 4 hours at 
37°C. Cells were incubated at 37°C, 5% CO2 and 5% O2 for 48 hours. The cells were 
examined in a microscope for quality control and the media was replaced every 24 hours. 
After this period a cell monolayer reached approximately 90% confluence and media was 
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substituted with N2:B27 medium: 1:1 ratio of N2 supplement (Life Technologies, 17502-
048) 1X final concentration in DMEM Medium (Sigma; D6421) + B27 supplement (Life 
Technologies; 17504-044) 1X final concentration in Neurobasal Medium (Life 
Technologies; 21103-049). The N2:B27 was used as base media and was supplemented 
with TGFβ and BMP small molecules inhibitors (2i) for neural induction and a second 
treatment with 2i plus WNT inhibition. For the treatments, either SB431542 (Sigma-
Aldrich, S4317) 10µM and LDN193189 (Sigma-Aldrich, SML0559) 0.1µM or SB431542 
10µM; Dorsomorphin (Sigma-Aldrich, F5499) 1µM and XAV939 (Sigma-Aldrich, X3004) 
2µM were used. During neural induction cells were incubated at 37°C, 5% CO2 and 20% 
O2 and checked for quality control and media replacement every 24h for 8 days (Figure 
2.1).  
 
Figure 2.1. Scheme of neuroectoderm differentiation, RNA extraction and transcriptome 
analyses. iPSC and ESC lines were culture with 2i (SB431542, dorsomorphin and XAV939) or 2i-
WNT (SB431542 and LDN193) media for 8 days. RNA was extracted at time points d0, d1, d2, d3, 
d4, d6 and d8 and used for transcriptome analysis through RNAseq, Q-PCRs and to model a GRN.  
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2.2. RNA extraction 
RNA was extracted at 7-time points during the first 8 days of neural induction. The first 
time point was day 0 just before the addition of neural induction media. Subsequently, RNA 
was extracted at days 1, 2, 3, 4, 6 and 8 after neural induction.  The media was removed, 
and the RNA was harvested by adding 1ml of Trizol reagent (Life technologies, 15596026) 
at room temperature to each 6 well. Cells were dislodged with a cell scraper, transferred to 
1.5ml tubes and lysed by pipetting 15 times. The samples were stored at -80°C until RNA 
extraction.  
RNA was isolated from each sample by centrifugation (12000g, 5 minutes) with 200µl of 
100% Chloroform. The top aqueous layer was placed in new 1.5ml tube with 500µl of 
100% isopropanol. Samples were mixed 10 times by pipetting and incubated 15 minutes at 
room temperature. After incubation, the RNA was precipitated by centrifugation (12000g, 
15 minutes).  The supernatant was removed, and the pellet was suspended in 1ml of 75% 
ethanol followed by centrifugation (12000g, 5 minutes). The ethanol was removed, and the 
pellet was air dried for 15 minutes at room temperature. The RNA was dissolved in 100µl 
of nuclease free water and purified with a Qiaquick RNA purification kit (Qiagen, 28106) 
according to manufacturer’s specifications. RNA was quantified with a NanoDrop 1000 
Spectrophotometer (Thermo scientific). Quality control was assessed by analysing each 
sample with the Agilent RNA 6000 nano Kit (Agilent technologies, 5067-1511) in 
combination with the Agilent 2100 Bioanalyzer system according to the manufacturer 
protocol to obtain the RNA integrity number (RIN) (Figure 2.2).   
 62 
 
Figure 2.2. Electropherogram of the RNA extraction from the iPSC1 line at the 
time point d0. This figure shows an example of the Electropherograms obtained 
through the bionalayser RNA analyses with a RIN number of 10. The main peaks 
represent the 18S (left) and 28S (right) ribosomal subunits. The small peaks observed 
at the left represent 5S ribosomal and tRNA. The presence of these peaks is indicative 
of a good quality sample with no degradation.  
 
2.3. RNAseq 
RNAseq libraries were prepared with the Truseq RNA Kit (standard methods by The 
Wellcome Trust Centre for Human Genetics of Oxford University). Briefly, mRNA 
fraction was purified from total RNA followed by cDNA synthesis. Subsequently, the 
cDNA was end-paired, A-tailed and custom indexing adapters were ligated. Samples were 
size selected and pooled for sequencing.  
Libraries were sequenced in collaboration with Larry Stanton and Steven Havlicek from 
the Genome Institute Singapore (GIS). Libraries were multiplexed at 8 samples per lane 
and sequenced in a Hiseq 2500 Sequencing System (Ilumina) to a depth of 20-30 million 
reads per sample. FASTQ files were aligned to a reference genome by our collaborators 
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Shankar Subramanian and Jun Min (UCSD). For additional statistical analyses I used the 
raw data obtained from our collaborators to identify differentially expressed genes and gene 
profiles through various “R” console programs and Prism platform. Detailed statistical 
analyses are described in the relevant chapters.  
2.4. Gene ontology 
Significantly DE genes that depicted ≥ 1 log2 fold changes between consecutive time 
points, between D0 versus D8 or between the two different neural induction treatments at 
any time point were used for gene ontology analyses (GO). Additionally, genes comprised 
in each of the gene expression profiles 22, 31, 32, 65 and 99 from a short time series 
expression miner (STEM) analyses were used for GO.  Gene sets were interrogated for 
enrichment of specific gene classes and functional terms using DAVID Gene Functional 
Classification Tool. DE gene lists were tested against a reference gene set comprised of all 
expressed genes between the conditions analyzed.  
2.5. cDNA synthesis 
A set of 14 primers was designed with Primer3Plus (v. 0.4.0) software. Gene sequences 
were extracted from the NCBI GenBank and the University of California and Santa Cruz 
(UCSC) genome and bioinformatics browser (Table 1). Genes were selected on the basis 
of their known role during neural induction.  
Complementary DNA (cDNA) was synthetized from 1µg of RNA using M-MLV Reverse 
Transcriptase enzyme (Promega, M1701) following manufacturer’s instructions. Briefly, 
RNA was incubated with Oligo (dT) primers (Promega, C1101) to a final concentration of 
0.02µg/µl for 5 minutes at 70oC and then cooled on ice. The following reagents were added: 
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M-MLV buffer to a final concentration of 1.5X; 0.75mM of dNTP mix (Promega, U1511); 
25 units of recombinant RNasin ribonuclease inhibitor (Promega, N2511); 200 units of M-
MLV reverse transcriptase and nuclease free water to a final volume of 20µl. Reactions 
were carried out at 50oC for 50 minutes. cDNA was diluted to a 1:5 ratio with nuclease free 
water.  
2.6. Real-time Polymerase Chain Reaction assays 
Real-time polymerase chain reaction (Q-PCR) assays were conducted by using 4µl of 
cDNA per reaction and adding the primers mix to a final concentration of 0.3µM and iQ 
Sybr Green supermix (Bio-rad, 178880) to a 1X final concentration. Amplifications were 
performed in a Bio-Rad PTC-200 Peltier thermal cycler detection system. Q-PCR reaction 
conditions were: 95oC for 15m for the initial denaturation and then 95oC for 30s, 60oC for 
30s and 72oC for 30s during 35 cycles. The melting curve analyses were performed from 
60oC to 95oC with readings every 1oC.  
The housekeeping gene GAPDH was used to normalize the genes expression levels 
between technical and biological samples. A number of housekeeping genes including 
ACTB, B2M, GAPDH, HMBS, HPRT1, RPL13A, SDHA, UBC and YWHAZ have been tested for 
efficiency and specificity in the iPSC lines by my colleagues at Price laboratory. The genes 
were assayed by determining the relative quantification of the genes expression between 
iPSC samples by Q-PCR to assess the gene stability. The gene GAPDH was select as 
reference gene since it shows low variability in expression levels between cells.  
Additionally, the RNAseq results indicated that the expression of this gene was maintained 
in similar levels during the 8 days of NESC differentiation and between the biological 
replicates (iPSC lines).  
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The Pfaffl comparative method of relative quantification was used to quantify gene relative 
expression of each sample at different time points.  
(Etarget) Ratio =   ∆CTtarget (control – sample) 
(Eref) 
∆CTref (control – sample)  
 ∆CTtarget = target gene cycle threshold 
 ∆CTref = mean of reference gene CTs  
E = PCR efficiency 
 
The Pfaffl method enables relative quantification of a target gene in comparison to an 
endogenous standard comprised of the reference genes. Neural induction and time course 
RNA extraction procedures were replicated 3 times for each cell line, which was considered 
a technical replicate. The technical replicates CT values were averaged and used to generate 
a biological replicate (iPSC line). The Q-PCR statistical analyses were performed with the 
averaged relative gene expression values of 3 biological replicates. The reference sample 
used to compare the gene expression of all cell lines was randomly designated as the time 
point 0 of the iPSC1 line. The means between samples were compared by a two-way 
ANOVA test with Bonferroni correction with 95% confidence interval with Prism package 






Table 1. Table of primers used for Q-PCR. 
Gene  Primer Sense 3’-5’ Primer Antisense 5’-3’ 
CDH1 TCC TGG GCA GAG TGA ATT 
TT 
GGCGTAGACCAAGAAATGGA 
FGF8 CAG GTC CTG GCC AAC AAG CTC CTC GGA CTC GAA CTC TG 
 
GAPDH AGC CTC AAG ATC ATC AGC 
AA 
CTG TGG TCA TGA GTC CTT CC 
GnRH1 CTT CTG CCC AGT TTC CTC 
TTC 
TTG ATT GAT TCT TTC CAA 
GAG ATA GT 
HESX1 TGC TTT TAC TCA AAA CCA 
GAT TGA 
CCA AAT CTG GAT TCT GTC 
TTC C 
NESTIN AGG ACA CCA TGA GGA ACA 
GC 
GCC ATG TTC TTG CTC ACG TC 
NPTX1 GTG ATA GGG CGC CAA GTT 
CT   
ATC AAT GAC AAG GTG GCC 
AAG 
OCT4 TTG GGC TCG AGA AGG ATG 
TG 
GTG AAG TGA GGG CTC CCA 
TA 
PAX6 GCC AGA GCC AGC ATG CAG 
AAC A 
CCT GCA GAA TTC GGG AAA 
TGT CG  
SIX3 AGC AGA AGG ACC GAG TTC 
TG 
CAA GAA CAG GCT CCA GCA C 
SIX6 GCT GCA GCC AAG AAC AGA 
CT 
CTG GAC GTG ATG GAG ATG G 
SMARCA2 CGC TGA GAA ACT GTC ACC 
AA 
CTGTCGCCCTGAACTGTTTC 
SOX11 TAC AGC CCC ATC TCC AAC 
TC 
CTC CGA CTT CAC CAG AGA 
GC 





 Approximately 100,000 cells were plated on each well of Nunclon delta surface 96 well 
plates (Thermo Fisher148761) following the methods described in the section 2.1. After 
confluence, cells were induced with either or both neutralization media depending on the 
experiment. Cells cultures were fixed at different time points with 50µl/well of 4% 
paraformaldehyde (PFA) (Thermo Fisher, 28906) in PBS 1X for 15 minutes at room 
temperature. The PFA was removed and the wells were washed 3 times with 150µl/well of 
1X PBS.  The cells were permeabilized and blocked by incubation with 50µl/well of 4% 
normal donkey serum (Sigma Aldrich, D9663) in 1X PBST for 1h at room temperature in 
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a nutator. Cells were incubated with specific dilutions of mouse monoclonal and rabbit 
polyclonal primary antibodies together (Table 2) in 50µl/well of blocking buffer at 4oC 
overnight. Wells were washed three times with 100µl/well of 1x PBS. The dilution of the 
primary antibodies was determined by following the providers recommendations and 
references in published literature. 5 serial dilutions were performed based on the datasheet 
and literature recommendations for each antibody. The optimal dilution was determined by 
identifying the concentration that provided the best staining and lowest background.  
Validation of the antibodies binding specificity was assessed by replacing primary 
antibodies with the same dilution of purified mouse IgG (Merck Millipore, CS200621) or 
rabbit IgG as controls (Thermo Fisher, 02-6102). Immunoreactivity was imaged using 
Alexa Fluor 594 conjugated donkey anti-mouse IgG (Invitrogen, A-21203) and Alexa Fluor 
488 conjugated donkey anti-rabbit IgG (Invitrogen, R37118) both diluted to 1:250 ratio in 
50µl/well of blocking buffer.  The nuclei were stained by incubation with Hoechst 33342 
(Thermo Fisher, H3570) diluted to a final concentration of 5µg/ml in 50µl/well of 1x PBS 
for 3 minutes at room temperature. Stained cells were washed 3 more times with 150µl/well 
of 1x PBS.  
Images were acquired with a 20X objective with the Cell insight CX5 High Content Screen 
Platform (Thermo Fisher, CX51110). Expression was quantified using the bioapplication 
Cell Health Profiling from the iDev software package (Thermo Fisher). Hoechst staining 
was used to assess cell viability. Specific staining intensity, shape and size parameters were 
established to identify positive and negative labeled cells. A total of 3 wells were analyzed 
per primary antibody pair with 61 acquired fields per well. The means of the percentages 
of positive cells at each time point were statistically compared by a two-way ANOVA test 




Table 2. List of antibodies used for immunofluorescence. 
Antibody Type    Host Dilution Supplier Catalog 
Number 
LEF1 Monoclonal    Mouse 1:200 Millipore Cs200635 
NESTIN Monoclonal Mouse 1:500 R&D Systems MAB1259 
NR2F2 Monoclonal Mouse 1:100 R&D Systems PP-H7147-00 
OCT4 Monoclonal Mouse 1:200 Santa Cruz Sc5279 
PAX6 Polyclonal Rabbit 1:200 Proteintech  12323-1-AP 
REST Polyclonal Rabbit 1:200 Millipore Cs200555 
SOX11 Polyclonal Rabbit 1:50 Santa Cruz Sc20096 
ZEB1 Monoclonal Mouse 1:300 Atlas Antibodies AMAb90510 
ZEB2 Polyclonal Rabbit 1:150 Atlas Antibodies HPA003456 
ZNF521 Polyclonal Rabbit 1:100 Atlas Antibodies HPA023056 
















Human development initiates with the asymmetric division of the fertilized oocyte to 
generate an 8-cell blastula. Subsequently, cells divide symmetrically and asymmetrically 
and form the TE and the ICM, which ultimately segregates into the PrE and the Epi. 
Following implantation, gastrulation occurs with the Epi cells migrating through the PS 
and node (mouse E6-E7, humans 13-17 dpf) (Artus et al., 2014; Zirra et al., 2016). During 
gastrulation, cells that do not invaginate through the PS remain as the most exterior layer 
that will give rise to the ectoderm. The consecutive steps of neural development proceed 
with induction of the ectoderm to form the NP in response to inhibitory BMP, TGFβ and 
WNT signaling from the adjacent mesoderm. Subsequent cell proliferation increases the 
thickness of the NP, which then folds to form NT at approximately 21 dpf in the human 
embryo (Klein & Moody, 2015). The NT is later separated into spatially and functionally 
distinct regions in response to specific concentrations of signaling molecules. Depending 
on their location and exposure to morphogens, the NT progenitors ultimately differentiate 
into specific post mitotic neuronal subtypes or glial cells (Imayosgi et al., 2015).  
Due to legal constraints, the human embryo can be studied in vitro only until day 13 or the 
formation of the PS. Thus, our knowledge of neural induction in mammals is based on 
studies based in model organisms, largely on mouse. Analyses of mouse development have 
significantly contributed to the identification of genes and pathways activated during NE 
development that play important roles directing fate commitment. Importantly, mouse 
studies have enabled identification of developmental cues that can be used to manipulate 
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in vitro differentiation of human ESCs and iPSCs to relevant phenotypes (Klein & Moody, 
2015; Zirra et al., 2016).  
The neuronal differentiation protocol used in Price laboratory includes 8 days of neural 
induction with 2i inhibitors. Further differentiation leads to formation of rosette structures 
(d14) followed by differentiation of neuronal progenitors and acquisition of cortical 
neuronal phenotype (d50). Inclusion of WNT inhibitors during 2i (Dorsomorphin, 
SB431542 and XAV939) induction leads to NESCs specification toward gonadotropin 
releasing hormone (GnRH) neurons. Importantly, the only step that differs between 
differentiation of cortical and GnRH neurons is the initial 8 days of neural inhibition; all 
subsequent steps of cortical and GnRH neuronal induction are identical. This presents an 
ideal experimental system to identify the common and unique molecular events that 
underlie neural induction of NESC specified to distinct cortical and GnRH neurons.  
3.1.1 Human neuro-ectodermal and neural progenitors gene expression 
patterns  
Up-regulation of NE markers PAX6, SOX1, NCAM, ZIC1 and ZEB2, and loss of 
pluripotency/self-renewal markers OCT4, NANOG and KLF4 occurs at day 5-7 after 
hPSCs exposure to neural induction media (Hu et al., 2010; Kamiya et al., 2014; Leemput 
et al., 2014; Huang et al., 2016). Additionally, the mesodermal markers CD4, GATA, 
RUNX ant T and the endodermal marker SOX17 retain similar expression levels in ESC 
compared with NE derived cells. Thus, analyses of gene expression patterns in human NE 
cells suggest that several genes and pathways are conserved across animal models (Huang 
et al., 2016). Interestingly, it has being demonstrated that PAX6 expression precedes SOX1 
during neural development in humans. However, Chambers et al (2009) described SOX1 
 71 
as the earliest NE marker in their hESCs 2i induced culture system. Direct regulation of 
SOX1 by SMAD signaling is a possible explanation for the differential expression of SOX1 
in specific culture conditions (Chambers et al., 2009). Additionally, SOX1 expression 
levels in neural progenitors might change in response to different concentrations of BMP 
inhibitors in the media (Neely et al., 2012).  
Recently, a microarray study by Huang et al (2016) revealed up-regulation of genes that 
have not been previously linked to neural differentiation, such as HEY1, BCL11A and SP8 
after 6 to 10 days of hESC neural induction. The authors speculated that the novel genes 
might have roles in less well-studied pathways implicated in neural differentiation. A 
number of genes involved in chromatin modifications such us TET2, KATB2 and SIRT1 
were differentially expressed after 6 and 10 days of neural induction. The dynamic 
expression of epigenetic modifiers might be related to gene expression changes during 
neural differentiation; however, the role of these genes and their regulatory interactions is 
unknown. Additionally, the study showed up-regulation of ZEB1 and SNAI2, TF that are 
necessary for epithelial mesenchymal transition (EMT), and down regulation of their 
epithelial gene targets including OCLN, CLDN7 and F11R, suggesting a potential role of 
EMT during neural differentiation. Likewise, ROR2 and WNT5B genes associated with 
WNT non-canonical pathway WNT/Ca2+ were up-regulated during neural progenitor 
differentiation. Inhibition of CaMKII a kinase down-stream WNT/Ca2+ pathway resulted 
in reduction of PAX6 expression and increased K18 epithelial marker expression. The 
authors suggest that WNT/Ca2+ pathway enhances neural differentiation through CaMKII 
phosphorylation by inhibiting epidermal fate acquisition (Huang et al., 2016).  
During chick and mouse development, NE cells adopt dorsal forebrain fate by default in 
absence of patterning signals, while maintaining potential to respond to morphogens and 
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differentiate into distinct regional types of neurons. Explant studies have shown that Wnt 
signaling plays a key-patterning role in inducing dorsal identity, whereas Shh defines 
ventral forebrain fate. Concomitantly, rostro-caudal patterning is orchestrated by WNT, 
retinoic acid (RA) and FGF signaling, which induce neural progenitors to adopt a posterior 
fate (Maden, 2007; Chi et al., 2016). Similarly, human and mouse PSCs induced to NE 
cells adopt a forebrain fate in absence of patterning morphogens. For instance, hPSCs 
derived NE cells induced by the 2i media express forebrain markers including PAX6, 
OTX2, HESX1, SIX3, RAX, LHX2 and FOXG1 at day 6 after induction (Huang et al., 
2016; Zirra et al., 2016). However, the progenitors preserve their potency and can be 
caudalized by addition of WNT or RA agonists to the media (Chi et al., 2016).  
As differentiation proceeds, NE cells derived from iPSCs and ESCs acquire cell polarity 
and reorganize to form rosette like structures that resemble a transverse section of the neural 
tube in the embryo. In humans, the rosette formation time line depends on the tissue culture 
conditions and generally ranges between 7 and 14 days after initiation of 2i induction. 
Studies have demonstrated that human and mouse progenitors express PLAGL1, DACH1 
and ZBTB16 rosette markers and pan neural progenitor markers including PAX6, NESTIN, 
SOX1 and SOX2, which are also expressed in the NT progenitors. Additionally, the rosette 
luminal cella express proteins such us N-CAD and ZO1 that are also present in the apical 
domain of embryonic NE cells in the NT (Elkabetz et al., 2008, Abranches et al., 2009). 
For instance, it has been shown that human neural progenitors within the rosettes represent 
RG with similar gene expression profiles and differentiation potential as neural progenitors 
from the NT, which are capable of differentiating into neurons, oligodendrocytes and 
astrocytes (Malchenko et al., 2014). The newly born neurons migrate to localize in the 
periphery of the rosette, resembling the differentiation of the NT neurons that localize 
outside of the proliferative ventricular zone (Abranches et al., 2009). Human early rosettes 
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derived from ESC are enriched in highly proliferative neural progenitors that exhibit a 
propensity for high self-replication and low differentiation. Later, these human neural 
progenitors progress to a mid RG rosette stage characterized by high propensity to 
differentiate into neurons and intermediate progenitors due to an increase in asymmetric 
division. Further culture leads to reduction of neural progenitors number and loss of the 
rosette integrity (Wilson & Stice, 2006; Ziv et al., 2015). Human RG progenitors derived 
from PSCs adopt a forebrain fate and differentiate into cortical neurons when induced in 
absence of morphogens by the default system. These neural progenitors predominately give 
rise to glutamatergic neurons but can also differentiate into inhibitory striatal medium spiny 
neurons (MSNs) and GABAergic neurons (Yuan et al., 2015; Chi et al., 2016).  Early and 
mid-radial glial rosette stages recapitulate many aspects of cortical radial glial development 
in the human embryo (Ziv et al., 2015). For instance, human PSCs derived RG cells 
differentiate into cortical neurons corresponding to deep and superficial cortical layers and 
subsequently adopt late progenitor phenotypes that give rise to astrocytes. Furthermore, 
human RG transplanted into mice lateral ventricles differentiate into neurons and astrocytes 
that migrate and integrate into the appropriate layers of the mouse cortex (Duan et al., 
2015).  
Subsequently, human neural progenitors differentiate into diverse cell types in response to 
concentration gradients of specific morphogens including WNT, RA, FGF, and SHH in 
vivo (Wilson & Stice, 2006; Ulloa & Briscoe, 2007). Accordingly, the patterning potential 
of these morphogens has been exploited to generate specific neuronal subtypes from human 
PSCs. For instance, treatment of hPSCs with SHH and RA at specific time points during 
neural development results in efficient induction of motor neurons (Hu et al., 2009; 
Chambers et al., 2009). Likewise, early exposure to SHH and FGF8 leads to generation of 
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functional dopaminergic neurons capable to integrate into mouse brain after transplantation 
(La Manno et al., 2016; Li et al., 2016).  
Accordingly, human PSCs have enormous potential and have been widely used to model 
diseases and to analyze development of neural progenitors to specific neuronal phenotypes. 
However, fewer attempts have been made to identify TFs and genes involved in NE 
differentiation. Hence, the molecular pathways and gene expression patterns that drive NE 
differentiation remain to be investigated. In this chapter, we report the first complete 
transcriptome analysis at different stages during iPSC NE differentiation. 
3.1.2. ESC/iPSC differentiation to GnRH neurons 
The developmental pathways that govern the development of the GnRH neurons in humans 
are poorly understood. However, Xenopus and mouse models and ESC studies have 
enabled insight into the molecular mechanism that drive formation of the NBZ, placodes, 
olfactory placodes and GnRH neurons (Ealy et al., 2016; Shigetani et al., 2016; Matsuoka 
et al., 2017). In Xenopus, expression of NBZ marker genes is promoted by BMP signaling. 
Interaction of these TFs markers leads to the formation of the NBZ and concomitant 
inhibition of neural factors. Subsequently, low levels of FGF family genes induce formation 
of the PPE fated to form placodes in the absence of WNT signaling, whereas, activation of 
WNT signaling during this stage leads to the formation of neural crest (Moody & LaMantia, 
2015; Shigetani et al., 2016).  Subsequently, different TFs become restricted to the anterior 
or posterior PPE. Possibly, these TFs interact with each other to promote the specification 
of placodal subtypes, which express different combination of these factors.  The olfactory 
placode (Emx2+ / Ebf2+) is derived from the anterior PPE and gives rise to GnRH cells that 
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migrate to the hypothalamus at around E.11 to E.16.5 in mouse (Wray, 2010; Moody & 
LaMantia, 2015).  
It has been recently reported that spatial temporal recapitulation of these developmental 
signals leads to the sequential generation of non-neural ectoderm and PPE in both human 
and mouse ESCs. Inhibition of TGFβ (using SB431542) increases the efficiency of 
induction of ectodermal derivatives, which in response to recombinant BMP4 and FGF2 
leads to the formation of non-neural ectoderm (DLX3+ /GATA3+ / AP2A+). Differentiation 
of PPE (EYA1+ /SIX4+) is achieved by subsequent inhibition of BMP and WNT signaling 
with small molecule inhibitors (Matsuoka et al., 2017). Different approaches used 
inhibition of TGFβ and WNT to derive non-ectoderm cells that acquire cranial placodal 
fate by addition of FGF (Ealy et al., 2016). Further differentiation with both protocols leads 
to acquisition of early otic neural progenitors (Dincer et al., 2013; Leung et al., 2013; Ealy 
et al., 2016).  However, induction of GnRH through PPE has not been reported. GnRH 
generation from ESC/iPSC was shown for the first time by inducing neural progenitors 
differentiation through 2i induction and subsequent treatment with FGF8 (Lund et al., 
2016; Poliandri et al., 2017). The transformation of neural progenitors to GnRH is directed 
by FGF8, however the molecular mechanism underlying this conversion remains to be 
elucidated. Overall, these studies demonstrate that placodal and GnRH neuronal 
differentiation both depend on the temporal modulation of WNT, BMP and FGF signaling.  
3.1.3. WNT signaling  
WNT signaling regulates a broad variety of biological processes during embryonic 
development and disease. Due to its critical importance in development WNT signaling is 
tightly spatiotemporally regulated. Deregulation of WNT leads to severe defects including 
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neurodegenerative diseases (Komiya & Haas, 2008; Munoz-Descalzo et al., 2015; 
Stanganello & Scholpp, 2016). There are 19 WNT glycoproteins in humans, which are 
modified in the endoplasmic reticulum and then transported and secreted into the 
extracellular milieu (Komiya & Habas, 2008; Huang et al., 2009a). A hallmark of WNT 
signaling is the formation of concentration gradients, which regulate fate by diffusing 
across cells that respond in a particular manner to specific WNT thresholds (Harrison 
&Pleasure, 2012; Stanganello & Scholpp, 2016). WNT morphogenetic activity regulates 
formation of distinct functional regions in the CNS such us regionalization of the PPE at 
the expense of neural crest with high WNT concentrations or ventralizing of forebrain 
progenitors (Harrison & Pleasure, 2012; Chi et al., 2016). Differentiation of distinct 
neuronal subtypes by regulating WNT concentrations has also been reported in in vitro. For 
instance, differentiation of ESCs in a chemically defined culture media without extrinsic 
signals leads to the generation of dorsal telencephalic glutamatergic and GABAergic 
neurons. However, the derived cells are ventralized and give raise to subpallial derivatives 
if exposed to WNT antagonist prior to terminal differentiation (Chi et al., 2016; Zirra et 
al., 2016).   
3.1.3.1.  WNT/ β-catenin canonical pathway 
WNT/ β-catenin signaling is involved in many processes during embryogenesis such us 
cell adhesion, neural patterning and cell proliferation. In the absence of WNT, β-catenin is 
anchored by the destruction complex comprised of APC, GSK-3β, PP2A, CK1 and AXIN. 
Within the complex, the scaffolding proteins CK1 and GSK-3β phosphorylate and target 
β-catenin for ubiquination and degradation in the proteasome. WNT signaling prevents 
formation of the β-catenin destruction complex and subsequent β-catenin degradation by 
sequestering AXIN and GSK-3β (Nuse, 2012; Peng et al., 2017). Signaling is activated as 
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WNT proteins bind the trans-membrane receptor Frizzled (FZD) and its co-receptors LRP6 
or LRP5. This complex recruits the scaffolding protein Dishevelled (DVL), which along 
with FZD regulate phosphorylation and activation of LRP6/LRP5 cytoplasmic tail. 
Subsequently, AXIN and GSK-3β are recruited to LRP6/LRP5 tail and translocated into 
the cell membrane. In the presence of WNT, stable β-catenin accumulates in the cytoplasm 
and migrates to the nucleus where it binds to TCF/LEF TFs to activate or inhibit expression 




Figure 3.1. Scheme of WNT canonical pathway. In the absence of WNT (left), the 
degradation complex recruits β-catenin in the cytoplasm.  β-catenin is phosphorylated 
by GSK3 and CK1 and then targeted for degradation. Binding of WNT proteins to the 
FZD receptor and LRP5/6 co-receptors leads to phosphorylation of DVL and 
recruitment of AXIN and GSK-3β to the membrane. Thereafter, β-catenin dissociates 
from the destruction complex, accumulates and localizes in the nucleus where it 




Three iPSC1 lines and an ESC were culture with 2i and 2i-WNT media for 8 days according 
to the protocols described in section 2.1.  
RNA extraction and RNAseq methods were carried as described in sections 2.2 and 2.3 
respectively.  
3.2.1. RNAseq statistical analyses 
Principal component analyses (PCA) and a heatmap depicting the distance between the 
samples were produced by our collaborators Shankar Subramanian and Jun Min (UCSD) 
using DESeq2 and ggplot2 packages for effective clustering and comparison between 
multiple genes. Any gene with the total raw read counts of zero across all conditions were 
removed.  
For the following analyses I  used the raw data matrix provided from our collaborators 
(UCSD). I regularized-logarithm (rlog) the count data using DESeq2 in RStudio console.  
I preformed the differential expression analyses by using the iPSC lines rlog mean with the 
DESeq2 function DESeqDataSet (dds) in RStudio to extract the log2 fold changes and 
Wald test p value Benjamini and Hochberg corrected. I used Dds analyses to compare gene 
expression between consecutive time points during neural induction and between the time 
points D0 and D8. I create the Heatmaps with the rlog-transformed values using the 
package pheatmap and rcolourbrewer in RStudio.  
I generate the volcano plots with DE genes from the 2 neural induction protocols at time 
points D8 and D4 with the calibrate package in RStudio. I created the gene plots by using 
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the ggplot2 package in RStudio. I used the Dds to compare gene expression between the 2i 
and 2i-WNT treatments at each time point. These analyses demonstrated that 146 genes are 
significantly differentially expressed between the 2 neural induction treatments at time 
point D8. I obtained a mean RPKM value of the 3 iPSC for each gene at each time point. I 
plotted the RPKMs of the set of DE genes for cells induced either with 2i or 2i-WNT media 
at d8 at each time point to determine the stage when the expression of these genes starts to 
diverge between both treatments. I compared the RPKMs with Prism package of GraphPad 
software.   
Additionally, I plotted the mean of the RPKMs values from the three-iPSC lines with Prism 
package of GraphPad software for a number of selected genes.   
3.2.2. STEM clustering  
Sets of genes with similar temporal expression profiles were cluster with short time series 
expression miner (STEM) tool by our collaborator Jun Min (UCSD).  Briefly, the RNAseq 
count values were rlog normalized with the DESeq2 package in R and the resulting data 
were used as input for STEM. STEM identifies significant gene expression profiles and 
then, by a clustering algorithm assigns genes that match these profiles determined by a 
correlation coefficient cutoff of 0.9 with respect to the significant model profile. The 
profiles with statistically significant number of genes are identified with a permutation test 
with Bonferroni correction.  
3.2.3. Q-PCR assay 
Q-PCR assays were performed as described in section 2.8. The genes analyzed in this 
chapter were PAX6, NESTIN, OCT4, SOX1, SIX6, SIX3, HESX1, NPTX1 and FGF8 and 
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the housekeeping gene GAPDH was used for normalization. Gene primer sequences can 
be found in table 1.  
A Pearson’s correlation analysis was performed with the RPKMs obtained from the 
RNAseq data and the Q-PCR relative quantification values. For these analyses, the gene 
PAX6 was randomly designated as reference to obtain linear expression values of all genes 
with the Pfaffl comparative method.  The Pearson’s correlation was calculated with Prism 
package of GraphPad software. 
3.2.4. Immunofluorescence 
Immunofluorescence assays were carried out with the iPSC1 line differentiated with 2i. 
Cells were fixed at time points d0, d4 and d8. PAX6, NESTIN, OCT4, ZEB1, ZEB2, 
NR2F2, ZNF521, REST and LEF1 expression patterns were analyzed with the antibodies 
described in the Table 2. Statistical analyses were performed as described in section 2.8. 
3.2.5. Super TOPflash reporter assay 
A XAV939 (Sigma-Aldrich, X3004) dose-response curve was performed in collaboration 
with Dr. Richard Killick laboratory (King’s College London). We used Super TOPflash 
assay to monitor the expression levels of WNT signaling in cells cultured with different 
concentrations of XAV939. TOPflash is a luciferase expression plasmid that contains 2 sets 
of 3 copies of TCF binding regions. Cells transfected with the plasmid show increase of 
luciferase activity when Wnt-β-catenin signalling is active and binds to TCF binding 
regions. Colleagues from Price laboratory have previously found that inhibition of WNT/ 
β-catenin signaling during 2i induction leads to the differentiation of GnRH neurons at 
expenses of cortical neurons (Kathuria et al., 2017). Hence, this experimental procedure 
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enabled to determine the appropriate concentration of XAV939 (2µM) necessary to inhibit 
WNT/ β-catenin signaling and induce GnRH neuronal fate.  
HEK239A cells were plated in a 96 well plate until they reached around 80% confluence. 
A transfection reaction was prepared for each well by adding 0.3µl of FuGENE transfection 
reagent (Promega, E2311), 100ng of M50 Super TOPflash luciferase reporter (Addgene, 
12456) and 100ng of a (plasmid cytomegalovirus promoter DNA) pcDNA Wnt3A 
expression vector (Addgene, 35908) to 50µl Opti-MEM Reduced Serum Medium (Gibco, 
31985062). An empty vector, pcDNA3.1 (Addgene, 52535), was added instead of the 
Wnt3A plasmid as a negative control. The transfection reaction was incubated at room 
temperature for 15 minutes. 50 µl of the transfection reaction were added to each 96 well 
and HEK293A cells were incubated at 37oC with 5% CO2 and 20% O2. After 7-hour post 
transfection, media was changed with 100ul of DMEM/F-12 supplemented with different 
doses of XAV939 (1nM, 3nM, 10nM, 30nM, 100nM, 300nM, 1µM, 3µM, 10µM and 
30µM) and incubated at 37°C, 5% CO2 and 20% O2 for 12 hours. DMEM/F-12 media 
containing 0.01% dimethyl sulfoxide (DMSO) was used as XAV939 negative control. 
After incubation, 100µl of ONE-Glo luciferase assay system (Promega, E6110) were added 
to each well and incubated for 3 minutes at room temperature. Luciferase reporter gene 
activity was detected in a GloMax Navigator luminometer (Promega, GM2000). Luciferase 
activity means were obtained from 3 wells per XAV939 dose.  The empty vector control 
was used to normalize the luciferase activity values to 1 to obtain the fold increase of each 
XAV939 dose and the DMSO control.  
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3.3. Results 
3.3.1. Overall similarity between iPSC lines  
The scope of this chapter is to identify the gene expression patterns generated during NE 
differentiation of iPSC in humans. It has been shown that NE markers such us PAX6, SOX1 
and ZEB2 are actively transcribed after 8 days of 2i from iPSC (Hu et al., 2010; Kamiya et 
al., 2014; Leemput et al., 2014; Huang et al., 2016). Hence the experimental approaches 
were carried on during this differentiation period to uncover the molecular signals that 
initiate and maintained NE differentiation in humans. Further cell culture drives the 
formation of neural rosettes at D12 approximately and subsequent differentiation of GnRH 
(2i-WNT) or cortical neurons (2i) at around D50. The differentiation of human neural 
progenitors has been extensively studied using pluripotent stem cells as and foetal tissue. 
However, the molecular mechanisms that regulate the formation of NE cells is widely 
unknown in humans. Thus, analysing this developmental stage was the focus of this study.  
Accordingly, 3 iPSC lines derived from different individuals as biological replicates were 
used to ensure the robustness and reproducibility of the experiments and results. 
Additionally, transcriptome data from an ESC line was obtained to estimate the variation 
between the gene expression profiles of the iPSC and ESC lines during differentiation. To 
determine if the genetic background and technical variability represent main sources of 
gene expression variation among the samples, a principal component analyses (PCA) was 
performed with the samples from all time points, cell lines and both treatments (Figure 3.2). 
The PCA results depicted the formation of 7 clusters along the PC1 on the x-axis, which 
captures 59% of the variance across the samples. Each cluster predominantly comprises 
samples from the same time point including iPSC lines and the ESC line. Clusters on PC1 
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are organized according to developmental time during neural induction. Samples collected 
at the same time point are tightly clustered in the PCA map independently of the cell line 
and the induction treatment. The second principal component (PC2) in the y-axis accounts 
for 10% of the variance. PC2 appears to separate the samples according to their degree of 
differentiation; i.e. iPSCs and NESCs cluster together and are separated from their 
intermediates states.  
 
Figure 3.2. Principal component analyses of all samples at all time points.  PC1 represents 59% of 
the variance across all samples and is plotted in the axis-x while PC2 represents 10% of the variance 
and is plotted in the axis-y. Samples from individual PSCs are show with different symbols. The size of 
the symbol indicates the method used for differentiation while the time points used for RNA extraction 
during NESC differentiation are shown in different colours.  
 
The samples distance was calculated as another approach to assess the overall similarity 
and differences among the samples; the distance is visualized in a heatmap (Figure 3.3). 
The results indicate that the samples collected at time points d0, d1 and d2 have similar 
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gene expression patterns and are distant from the samples at time points d3, d4, d6 and d8, 
which form another cluster. For instance, the early samples (d0, d1 and d2) are tightly 
clustered with other samples from the same time point including the iPSC and ESC lines. 
Similarly, among the latter cluster (d3, d4, d6 and d8), samples from d3 and d4 are closer 
to each other and samples d6 and d8 are also close together. Among the clusters the samples 
are clustered by time point independently of the cell line or treatment.  
 
                  
Figure 3.3. Heatmap of sample-to-sample distances. On the heatmap the samples are located in the 
same order from the top to bottom as from left to right. According to the colour key and the scale the 
distance between identical samples is depicted by dark blue (0) whereas the distance between different 
samples is represented in white (200).  
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3.3.2. Validation of neuroectodermal fate  
Expression of known NE makers was analysed to validate differentiation of iPSCs to 
NESCs after 8 days of neural induction. iPSCs were treated either with 2i or 2i-WNT media 
to promote cortical or GnRH neuronal fate acquisition respectively. Analysis of GnRH 
differentiation in animal models have demonstrated that modulation of BMP, FGF2, TGFβ 
and WNT signals leads to the formation of PPE and GnRH neurons (Dincer et al., 2013; 
Leung et al., 2013; Ealy et al., 2016; Poliandri et al., 2017). For instance, colleagues in 
Price laboratory have shown that GnRH neurons can be derived from iPSC by the inhibition 
of WNT signalling during 2i (Kathuria et al., 2017). Interestingly, inhibition of WNT 
during the 8 days of 2i induction is the only step that differs between the differentiation of 
cortical and GnRH neurons. Hence, we aimed to identify common and unique regulatory 
signals that might prime cells during NE induction to acquire GnRH or cortical identity.  
Gene expression of NE and neural markers was represented in heatmaps for visualization 
(Figure 3.4). The results indicate that these markers depicted highly similar gene expression 
patterns between cells differentiated with 2i and 2i-WNT. The results indicate that WNT 
inhibition does not significantly alter the expression of neural markers during 2i NE 
induction. For both treatments, the potency/self-renewal markers POU5F1 (OCT4), 
NANOG and MYC are down-regulated whereas KLF4 is up-regulated. The genes FOXD4, 
GMNN and ZIC2 are considered early NE progenitors since their expression initiates in 
the inner cell mass and is up regulated during NE differentiation in mouse and Xenopus.  
The data show that these genes depict a peak of expression at d2 and d3. Subsequently, the 
TF IRX1, IRX2, IRX3, ZIC1 and ZIC3 are expressed up-stream bHLH pro-neural markers 
and are required for the maintenance of neural progenitor cells in a proliferative state in 
Xenopus. These early neural progenitor markers show a peak of expression at d2. Human 
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and mouse NE markers PAX6, NESTIN, SOX2, SOX11, CDH2, ZNF521, ZEB2 and 
NR2F2 are up-regulated between d3 to d8. The bHLH proneural TF NEUROG2 and 
ASCL1 are up-regulated at d6 and d8 and the neural inhibitors HES1 and HES5 are up-
regulated from d3 and d4 respectively. Conversely, OLIG1 and OLIG2 are expressed in 
iPSC and d1 and are subsequently down-regulated.   
                                                                                                                                                        
 
                            
Figure 3.4. Heatmap of neuroectoderm markers expression. The heatmap depicts 
expression of NE markers in iPSC cells induced with 2i (left) and 2i-WNT (right) 
media at the days d0, d1, d2, d3, d4, d6 and d8 during differentiation. The colour key 
is scaled from 2 to -2 by row, where 2 (dark red) represents high gene expression and 




3.3.3. RNAseq validation 
Several studies have demonstrated that RNAseq and Q-PCR techniques are accurate and 
reliable approaches for the quantification of gene expression. However, the sensitivity of 
RNAseq method might vary depending on the reads depth, whereas Q-PCR sensitivity can 
be affected by the quality of the mRNA, the amplification efficiency and the choice of 
internal control genes among others (Pombo et al., 2017). Hence, we validated the 
transcriptome results obtained through RNAseq by comparison with data from Q-PCRs 
analyses. The results show that the temporal expression patterns of the analysed genes are 
similar between the Q-PCR data and the RNAseq assay (RPKMs) for 2i and 2i-WNT 
treatments (Figure 3.5). The pluripotency gene OCT4 is down-regulated, whereas the NE 
makers PAX6, NESTIN, SOX1, SIX6, SIX3, HESX1, NPTX1 and FGF8 are all up-
regulated during induction similarly to the results from the RNAseq assay. Additionally, 
the Q-PCR data indicated that SIX6 depicted higher expression values for the time points 
D4, D6 and D8 compared with the values obtained through RNAseq analyses. SIX6 is 
among the genes that depicted low expression levels (< 20 PRKMs). The results might 
indicate that Q-PCR technique show higher sensitivity of the for genes with low expression 
levels such us SIX6, whereas the expression patterns of genes with high expression values 











       
 
Figure 3.5. Comparison between real-time PCR and RNAseq data during 
neuroectoderm differentiation.  Q-PCR relative quantification data and RPKM values 
are shown in the Y-axis top and bottom respectively. The X-axis indicates the time point 
of RNA extraction. iPSCs induced with 2i treatment for Q-PCR and RNAseq assays are 
located on the left, whereas cells treated with 2i-WNT inhibitors are on the right. The 
statically significant differences are illustrated with letters to simplify visualization of the 
results. The difference between the means of the variables with the same letter is not 
significant. The variables with different letter are significantly different.  Details of the 
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Figure 3.5. Continued 
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Figure 3.5. Continued 
 













































































































































































Additionally, values obtained from RNAseq data were compared with Q-PCR relative 
expression values through a Pearson’s correlation to determine the accuracy of the results 
from both methods. To obtain linear values in the same scale from the Q-PCR data, PAX6 
was randomly assigned as a reference gene to quantify the expression values for all genes 
through the Pfaffl method.  The Pearson correlation was calculated by comparing the Q-
PCR expression values of each gene and the RPKM values obtained through RNAseq of 
the same gene with Prism software. A significant positive correlation (R=0.9, p < 0.0001) 
was observed between the 2 data sets (Figure 3.6). The correlation results demonstrate that 
the gene expression patters obtained by RNAseq data are linearly significantly associated 
to the patterns obtained by Q-PCR. Importantly, the high validation between assays 
demonstrates the stability of gene expression patterns among the three biological replicates.  
 
 
Figure 3.6. Correlation between RNAseq data and real-time PCR values. 
Relative quantification and RPKMs values for each gene at each time point are 
depicted with circles and represent the mean of the three iPSC lines.  
 
























The principal mechanism of modulating protein synthesis is the regulation of mRNA 
transcripts. However, the mRNA levels might not mirror the protein amounts due to 
regulatory mechanism that modify the mRNA fate. Hence, immunofluorescence analyses 
were performed to demonstrate that changes in gene expression were accompanied by 
comparative changes in protein expression. The results indicate that the pluripotency 
marker OCT4 is highly expressed at d0 and is not detected at d4 and d8 (Figure 3.7). 
Additionally, the expression of the NE markers PAX6, ZNF521, NESTIN, ZEB2, ZEB1, 
NR2F2 and LEF1 increased during the 8 days of neural induction (Figure 3.7). The results 
indicated that the pluripotency and NE markers are heterogeneously expressed since they 
are not positively stained in all the cells of the population. Mouse and rabbit IgG at high 
concentrations (1:50) were used as negative control to detect non-specific binding of the 
secondary antibodies, for the immunofluorescence assay. The threshold for positive cells 
detection was set considerably above the background to ensure no false positive cells were 
accounted as positive. Similarly, for the images acquisition, the exposure time was reduced 
to eliminate the background. Due to the stringency of the assay, a number of positive cells 
with low staining intensity might have been considered negative. Accordingly, the 
heterogeneous expression of the cell population might have been accentuated due to this 
artifact. Additionally, it is possible that the cell population might include cells individual 
cells that are transversed in different stages of the differentiation trajectory or acquiring 







   
        
 
Figure 3.7. Immunofluorescence analyses. A. Expression of NE markers and OCT4 
pluripotency marker at d0, d4 and d8. The cells nuclei are stained with Hoescht 33342. B. Results 









































                  




   
 





































































































































3.3.4. Differentially expressed genes and transcription factors  
Statistical analyses were performed to identify TF and genes differentially expressed 
between consecutive time points or between time points d0 and d8. Significantly 
differentially expressed (p < 0.05) genes were defined as those with > 1 log2 fold change 
expression levels between the 2 data sets. The analyses detected 4360 up-regulated genes 
and 4858 down-regulated genes during 2i NE induction. Among these genes, 459 correspond 
to TFs differentially expressed between consecutive time points and 108 unique TFs 
differentially expressed comparing d0 with d8. The identities of the differentially expressed 
TFs, time points, fold changes and p-values are described in the Appendix 3.2 (CD-ROM) 
for up-regulated and Appendix 3.3 (CD-ROM) for down-regulated genes.  
4650 up-regulated genes and 5180 down-regulated genes were identified during 
differentiation of iPSC with 2i-WNT. 434 TFs are included in the number of differentially 
expressed genes from sequential time points and 134 unique TF differentially expressed 
between d0 with d8. Statistical analyses are detailed in Appendix 3.4 (CD-ROM) for up-
regulated and Appendix 3.5 (CD-ROM) for down-regulated.  
476 common TFs are differentially expressed in 2i media versus with 2i-WNT media. TFs 
expression patterns from d0 to d8 are depicted in a heatmap (Figure 3.8). The heatmaps show 
that several TFs highly expressed during the initial 2 days of differentiation are subsequently 
down-regulated, whereas initially low expressed TF are up-regulated after the initial 2 days 
of induction. Additionally, a smaller number of TF have a peak of expression at d2, d3 and 
d4. Names of individual TF were omitted from the heatmaps due to the large number of 
genes contained in each data set. 
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Figure 3.8. Heatmap of transcription factors differentially expressed during neuroectoderm 
differentiation with 2i and 2i-WNT media. The heatmaps illustrate gene expression patterns of 
TF differentially expressed during neural induction at d0, d1, d2, d3, d4, d6 and d8 with 2i and 
2i-WNT induction media. Due to the large number of differentially expressed genes, the names 
of individual TF have been omitted. Gene names and statistical analyses details can be found in 
the appendix 3.2. to 3.5 (CD-ROM) . The key colour scale indicates high 2 (dark red) or low -2 
(dark blue) expression levels compared with each gene mean.  
 
Significantly up-regulated TFs with > 1.5 log2 fold changes between consecutive time 
points and > 1 RPKM values are depicted in heatmaps to facilitate visualization of their 
expression patterns. TFs that depicted peaks of expression during the different stages of 
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differentiation are represented in the Figure 3.9. Among these TFs are NE progenitor 
markers such as IRX2, IRX3, IRX5, ZIC1 and HESX1. TFs whose expression levels 
increase between consecutive time points to d8, are shown in a separate heatmap (Figure 
3.10) and comprise NE markers such as NESTIN, ZNF521, SOX1, SIX3, LEF1, NR2F2 
and forebrain progenitor markers including PAX6, OTX1, RAX, LHX2 and FOXG1.  
                     
 
              
 
Figure 3.9. Heatmaps of transcription factors differentially up-regulated with > 1.5 log2 fold 
changes between consecutive time points that show peak of expression levels during 
neuroectoderm differentiation. The heatmap illustrates the expression of 49 up-regulated TF during 
neural induction with both 2i and 2i-WNT induction media. The key colour scale indicates high 2 (dark 
red) or low -2 (dark blue) expression levels compared with each gene mean.  
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Figure 3.10. Heatmaps of transcription factors differentially up-regulated with > 1.5 log2 
fold changes from consecutive time points. The heatmap illustrates expression of 73 TFs 
up-regulated during neural induction with 2i induction media and 59 TFs induced with 2i-
WNT media. The key colour scale is the same as described in the heatmaps above. 
 
 102 
Several TF depict reduction in gene expression between consecutive time points but are 
significantly differentially expressed between d0 and d8. These TF (not included in the 
consecutive time points data) are illustrated in a heatmap (Figure 3.11) and include the NE 
markers SOX2, SOX11 SIX6 and HES5 TF.                                                                                                                               
                                                  
 
                                                                               
                         
Figure 3.11. Heatmaps of transcription factors differentially up-regulated with more than 
1.5 log2 fold changes from time points d0 to d8. The heatmap illustrates the expression of 54 
and 64 TF up-regulated during neural induction with 2i and 2i-WNT media respectively. The 
key colour scale is the same as described in the heatmaps above.  
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Transcription factors significantly down-regulated between consecutive time points with > 
1.5 log2 fold changes and > 1 RPKM values are represented in a heatmap (Figure 3.12) and 
include the pluripotency/ self-renewal markers NANOG and MYC.  
 
                        
 
                         
                 
Figure 3.12. Heatmaps of transcription factors differentially down-regulated with > 1.5 log2 
fold changes between consecutive time points. The heatmap shows the expression of 77 and 80 
down-regulated TF during neural induction with 2i and 2i-WNT induction media respectively. 
The key colour scale is the same as described in the heatmaps above. 
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Down-regulated TFs, whose expression does not change between consecutive time points 
but are nevertheless significantly differentially expressed between d0 and d8, are represented 
in a heatmap (Figure 3.13). The pluripotency marker OCT4 (POU5F1) is included in this 
map.   
                                                                                
                                                         
                           
                 
Figure 3.13. Heatmaps of transcription factors differentially down-regulated with > 1.5 log2 fold 
changes from time points d0 to d8. The heatmap illustrates expression of 54 TFs down-regulated 
during neural induction with 2i induction media and 71 TF with 2i-WNT media. The key colour scale 
is the same as described in the heatmaps above.  
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3.3.5. Gene ontology of differentially expressed genes 
The differentially up-regulated genes with > 1 log2 fold changes in expression between 
consecutive time points or between time points d0 and d8 were interrogated for enrichment 
of specific biological process. Gene ontology (GO) analyses were carried out with the 
complete list of genes and TFs significantly up-regulated during differentiation with 2i 
(4360 genes) and 2i-WNT (4650 genes) induction media. Biological process annotations 
are depicted in Figure 3.14. Consistent with previously described results, GO analyses show 
significant enrichment (fold enrichment > 1.7, p = < 0.05) of the biological process: 
“diencephalon development”, "forebrain development”, “telencephalon development”, 
“nervous system development”, and “neurogenesis and tube development”. The biological 
process terms, fold enrichment and p-values are similar between NESC differentiated with 
2i and 2i-WNT induction media. The sub-ontologies, p-values, number of genes for the 
corresponding term, fold enrichment and false discovery rate are described in the Appendix 









             
 
 
Figure 3.14. Gene ontology of genes differentially up-regulated during 
neuroectodermal induction. GO terms enrichment of genes up-regulated during 
NE differentiation with 2i (top) and 2i-WNT (bottom) induction media. The key 
colour scale indicates the log10-adjusted p-value, where the lower p-value is 




Similarly, GO analyses were carried out to interrogate the biological process enrichment in 
genes differentially down-regulated during NE differentiation with 2i (4858 genes) and 2i-
WNT (5180 genes) induction media (Figure 3.15). GO analyses showed significant 
enrichment (fold enrichment > 1.3, p = < 0.05) for “vascular development”, “ion transport”, 





































“mesenchyme development”, “cell motility”, “MAPK cascade” and “epithelium 




                 
 
 
Figure 3.15. Gene ontology of the genes differentially down-regulated during 
neuroectodermal induction.  GO terms enrichment of genes down-regulated during 
NE differentiation with 2i (top) and 2i-WNT (bottom) induction media. The key 
colour scale indicates the log10 adjusted p-value. The not significant terms are 










































3.3.6. Short time series expression miner (STEM) analyses  
The STEM analyses generated 100 gene expression profiles with a minimum of 2-fold 
difference between at least 2-time points, including 18 profiles with significant number of 
assigned genes (Figure 3.16). The profile 65 showing up-regulation (850 genes), profile 31 
down-regulation (1315 genes) and the profile 99 depicting biphasic expression (75 genes) 
were considered of interest since they might include genes necessary for pluripotency, 
neural differentiation or for coupling of these stages. Additionally, profile 22 was selected 
due to the high significance (359 genes) matched with this profile. 
 
 
Figure 3.16. Gene expression profiles generated by STEM for 2i and 2i-WNT treatments. The 
profiles are ordered from top left to bottom right by the number of genes in the profile. The significant 




3.3.7. Gene ontology of selected STEM profiles  
Genes comprising STEM genes expression profiles 22, 31, 32, 65 and 95 were interrogated 
for biological process enrichment (Figure 3.17). Gene ontology analyses of profiles 22, 32 
and 99, which have a reduced number of genes assigned (<75), did not show significant 
enrichment for any biological process.  1315 genes were assigned to the STEM profile 31 
during NE differentiation with 2i media and 1447 with 2i-WNT media. GO analyses show 
significant enrichment (fold enrichment > 1.3, p = < 0.05) for the biological processes 
“transport”, “regulation of cell proliferation”, “defense response”, “angiogenesis”, 
“regulation of cell adhesion” and “hypoxia” (Figure 3.19\8). The biological process terms 
that are common to 2i and 2i-WNT neural induction show similar fold enrichment (with 
differences in respective p-values).  The GO term ‘response to hypoxia’ appears to be 
specific to cells induced with 2i-WNT, since it does not appear enriched in profile 31 in 
cells induced with 2i media. The sub-ontologies, p-values, number of genes for the 
corresponding term, fold enrichment and false discovery rate are described in Appendix 




Figure 3.17. Selected gene expression profiles. Gene expression profiles of 5 












               
 
Figure 3.18. Gene ontology of the genes assigned to STEM profile 31. GO terms 
enrichment of genes that matched the profile 31 during NE differentiation with 2i 
(top) and 2i-WNT (bottom) induction media. The key colour scale indicates the 
log10-adjusted p-value, where the lower p-value is represented in dark red. The 




STEM profile 61 matched the gene expression levels of 850 genes during neural induction 
with 2i and 950 genes with 2i-WNT. GO analyses identified significant enrichment (fold 
enrichment > 2, p = < 0.05) for the biological processes “brain”, “forebrain” and 
“telencephalon development”, “synapse organization” and “neural precursor cell 
proliferation” (Figure 3.19). GO terms and fold changes are similar between cells 
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differentiated with both neural induction protocols. GO analyses details are described in 
the Appendix 3.12 and Appendix 3.13. 
  
 
               
 
Figure 3.19. Gene ontology of genes assigned to the STEM significant profile 65. 
GO terms enriched during NE differentiation with 2i (top) and 2i-WNT (bottom) 
induction media are shown. The key colour scale is the same as above.   
 
 
3.3.8. Gene expression profiles  
We examined the expression levels of mesoderm, endoderm and non-neural ectoderm 
markers, to determine if they are actively expressed in the iPSC cells acquiring NE fate. 
(Figure 3.20). NBZ markers were analysed since in the mouse embryo, inhibition of WNT 
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signalling in the region between the neural and non-neural ectoderm leads to the 
differentiation of the NBZ, which subsequently forms the PPC that gives rises to the GnRH 
neurons. Hence, NBZ markers expression was examined to determine if the differentiating 
cells depicted NBZ characteristics.  
The genes markers were selected since they are expressed in the different germinal layers 
of the embryo and in the NBZ. However, the function of these sets of genes during the 
formation, maintenance and regionalization of the mesoderm, endoderm, non-neural 
ectoderm and NBZ greatly differs. Hence, the selected genes might not be adequate to 
determine the formation of the 3 germ layers and the NBZ. For instance, the mesodermal 
markers T, MIXL1 and MESP1 are expressed during the initial stages of mesodermal 
differentiation from human ESC (Evseenko et al., 2010). Whereas, RUNX1 and GATA2 
are expressed in the later mesoderm and play a role as endothelial and hematopoietic 
promoters in human embryoid bodies (Shi et al., 2014). Furthermore, the regulatory 
function of several genes is context dependent. In fact, the mesodermal marker T is also 
able to induce the expression of endodermal markers FOXA2 and SOX17 if activated along 
with SMAD2/3 (Faial et al., 2015). The endodermal markers Gata4 and Foxd3 promote 
endodermal differentiation of ES in mouse, whereas Sox7, Sox17, Afp and Foxa2 are 
expressed at latter stages of endodermal formation (Zaret & Carroll., 2011; Wang et al., 
2013b; Kinoshita et al., 2015). The genes Tfap2a, Gata3, Msx2 and dlx3 are rapidly 
activated in mouse ESC induced to acquire a non-neural ectoderm fate by the inhibition of 
Wnt and Tgfβ and are among the genes that promote the separation of the non-neural 
ectoderm and the NE (Ealy et al., 2016). The NBZ markers were described in Xenopus and 
Tfap2a, Msx1 and Pax3 have been validated in human NBZ lines induced from iPSC/ESC, 
whereas Foxi1 and Dlx6 have been validated in chick and might depict differences with the 
expression in the human NBZ cells (Leung et al., 2016; Shigetani et al., 2016).  
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Expression of the selected number of genes activated in specific germ layers or NBZ were 
plotted to depict their gene expression patterns. Since the expression of these genes was 
similar between cells induced with 2i and 2i-WNT media, the expression showed is an 
average of the RPKMs results from the 3-iPSC induced with 2i and 2i-WNT media. The 
results indicated that the gene expression of the majority of the genes analysed was 
maintained at low levels (< 1 RPKM) during the time course of NESC differentiation, 
which might indicate that the majority of these genes are not expressed in the cells or are 
expressed in a reduces number of cells in the population. However, the endodermal markers 
FOXD3 and AFP show an initial expression higher than 2 RPKM at d0 , but the expression 
levels was rapidly subsequently down-regulated during NESC induction.  
 
      
 
Figure 3.20. Gene expression profiles of mesoderm, endoderm, non-neural ectoderm and 
neural border zone markers. Expression of each gene (RPKM) is represented with a 










































Similarly, the expression levels of genes that are activated in cell undergoing apical-basal 
polarity, rosettes, radial glia cells and cells acquiring forebrain fate were analysed to 
determine if these TF were precociously expressed during NESC induction (Figure 3.21).  
Gene expression profiling studies have demonstrated that a group of genes including 
PLAG1, DACH1, MMRN1, DMRT3, ZBTB16, LIX1 and LMO3 genes are highly 
expressed in rosettes derived from human iPSC/ESC, embryoid bodies and ESC in mouse 
(Elkabetz et al., 2008; Abranches et al., 2009; Koch et al., 2009; Lukovic et al., 2017). 
However, the function that some of these factors play during rosette formation is not well 
understood. For instance, LIX1 gene has been implicated in motor neuron survival in 
felines and proliferation of stomach mesenchymal progenitors in the chick embryo, but its 
function in neural rosettes has not been defined (Fife et al., 2010; McKey et al., 2016). 
Hence, mechanism  and stages in which these genes regulate rosette formation and their 
expression levels in rosettes might vary,  indicating that they are not ideal rosette markers. 
The profile analyses of rosette gens indicated that DACH1, ZBTB16, LMO3 showed an 
increase on their expression from day 2 to day 8 after neural induction.  Particularly, the 
gene LIX1 is highly up-regulated after day 2. Expression of these genes during NESC might 
indicate that they play a role this early stage of neural development or that a reduced 
subpopulation of cells might be precociously acquiring rosette identity. However, higher 
quantities of these markers might be necessary to induce rosette formation in the 
population. Neural differentiation of iPSC/ESC initiates with the formation of NESC that 
subsequently acquire cell polarity and reorganize to give rise to rosette like structures 
(Kageyama et al., 2014; Marchenco et al., 2014). The genes PARD6B and CDC42 form 
part of apical polarity complexes responsible for the apico-basal axis formation and 
construction and maintenance of apical junctions, whereas CRB2 localizes in the apical 
side of rosettes and interact with these apical-basal complexes and stabilise them. 
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Experiments in human ESC demonstrated that these genes are necessary for the 
differentiation of neural rosettes, since knowing down PARD6B, CDC42 and CRB2 leads 
to the disruption of rosette formation (Boroviak & Rashbass, 2011; Harding et al., 2014; 
Kedziora et al., 2016; Deglincerti et al., 2017). Similarly, studies have suggested that 
Uspx9 is necessary for embryonic progenitors in the mouse embryo, since ablation of the 
genes resulted in transient disruption of cell adhesion and apico-basal polarity 
(Premarathne et al., 2017). Our analyses indicated that the majority of these cell polarity 
markers are down-regulated during NESC induction, suggesting that the differencing 
NESC are not undergoing apical-basal polarization during this early stage. During rosette 
formation, neuro-ectodermal cells acquire glial features and become RG cells, which are 
able to form neurons, ependymal cells, astrocytes and oligodendrocytes (Kageyama et al., 
2014; Marchenco et al., 2014). The expression of FABP7 and SLC1A3 is required for the 
formation, proliferation and migration of RG cells and are widely used as RG markers (De 
Rose et al., 2012; Pollen et al., 2016).  The genes TNC and S100B were selected as a RG 
marker since its expression is detected in RG cells of the mouse neural tube (Hachem et 
al., 2007; Brozzi et al., 2009; Faissner & Reinhard, 2015).  The expression of Hes1 and 
Hes5 was analysed since these factors play a role in neural progenitors self-renewal and 
inhibition of proneural genes (Kageyama et al., 2005; Dhanesh et al., 2016).  The results 
indicated that the genes FABP7, HES1, HES5 and TNC are up-regulated during different 
stages of NESC induction. Importantly, cell polarization, formation of the neural rosettes 
and radial glia differentiation are mechanism that are tightly regulated during neural 
development. Hence, the heterogeneous expression of the selected markers during NESC 
differentiation, reflected the variability in the functions that these genes play during cell 
polarization and rosette and radial glia formation. Thus, heterogeneous expression  of the 
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selected genes, indicates thatthey are not optimal markers for these neural developmental 
stages. 
 The expression of forebrain markers during neural induction was analysed to validate 
previous observations that indicated that NESC are primed to acquire forebrain fate during 
early stages of neural development. We analysed the expression of OTX1, OTX2, HESX1, 
SIX3, RAX, LHX2, FOXG1 and EMX2. The results indicate that most forebrain markers 
are highly up-regulated after d2 and the TFs HESX1 and SIX3 depicted a peak of 
expression at d3. The selected markers play different roles during the formation and 
regionalization of the forebrain. For instance, OTX1 and OTX2 regulate the differentiation 
of the caudal forebrain, whereas FOXG1 is required for the differentiation of the ventral 
telencephalon (Larsen et al., 2010; Manuel et al., 2010). Hence, the high variability in the 




Figure 3.21. Gene expression profiles of rosette, polarity, radial glial and forebrain markers. 
Expression of each gene (RPKM) is represented with a different colour.  
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A recent microarray study reported up-regulation of the EMT marker ZEB1 and down-
regulation of its epithelial targets OCLN, F11R, MARVELD2, PPL, DSG2, EPPK1, 
SH3YL1, DMKN, TMEM30B and MAL2s during neural induction of hESCs (Huang et 
al., 2016). Hence, expression of EMT markers and ZEB1 targets is depicted in Figure 3.22. 
The results show that ZEB1 ad N-cadherin (CDH2) are highly up-regulated after d3, 
whereas E-cadherin (CDH1) is down-regulated. Additionally, ZEB1 epithelial targets 
DMKN, F11R, MAL2, CDH3, DSG2, OCLN, PPL, SH3YL1, MARVELD2, EPPK1, 
SYTL1, PKP3, SFN, TMEM30B are down-regulated and its mesenchymal targets FN1, 










Figure 3.22. Gene expression profiles of cadherins, epithelial mesenchymal transition 
and ZEB1 epithelial and mesenchymal targets. The expression of each gene (RPKMs) is 




Additionally, Huang et al., 2016 microarray study reported that the expression levels of 
genes WNT5B and RAR2, which are part of WNT/Ca2+ signalling, were up-regulated 
during neural differentiation of human ESC.  Likewise, the study shows significant changes 
in the expression of a number of DNA and histone modifiers. The authors suggested a 
potential role of WNT/Ca2+ signalling and the analysed epigenetic modifiers during 
neuronal differentiation of ESC. However, the mechanism in which these WNT/Ca2+ 
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signalling and modifiers regulate neural differentiation remained to be studied. We 
analysed the expression of these genes to determine if it reflected the results reported by 
Huang et al, 2016.  The results indicated that WNT5B and RAR2 are up-regulated during 
the course of NESC differentiation and that the epigenetic modifiers depicted similar 
changes in expression of those previously reported, validating Huang et al., 2016 data. 
Additionally, the gene expression profiles of the NE markers PAX6 and SOX1 were plotted 
(Figure 3. 23).  
 
 
   
Figure 3.23. Gene expression profiles of epigenetic modifiers, WNT/Ca2+ genes and 
PAX6 and SOX1. The expression of each gene is represented with a different colour. 
 
3.3.9. Dose response of XAV939 WNT signalling inhibition  
β-Catenin concentration in the cell cytoplasm is tightly regulated by the destruction 
complex comprised of APC, GSK-3β, PP2A, CK1 and AXIN.  The small molecule 
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inhibitor XAV939 blocks tankyrase 1 and tankyrase 2 enzymes that interact with the axin 
conserved domain and target it for ubiquitination. Hence, XAV939 selectively inhibits of 
β-catenin by stabilizing axin, which is the concentration-limiting component of the 
destruction complex (Huang et al, 2009a). A dose response curve was performed with 10 
different concentrations of XAV939 ranging from 1nM to 10uM, to determine the optimal 
concentration of the small molecule that most effectively inhibits WNT signalling. 
HEK939 cells were transfected with a WNT expression plasmid and a luciferase reporter 
TOPflash vector, which contains TCF binding regions. As a negative control, cells were 
transfected with an empty plasmid and TOPflash. The negative control and WNT 
transfected cells were tested with 10 different doses of XAV939 inhibitor during 24h. 
Additionally, WNT transfected cells were tested in the absence of WNT inhibition as a 
positive control. The results indicate that the negative control does not induce any change 
in luciferase activity, whereas the positive control shows elevated levels of activity.  
Importantly, luciferase activity is reduced in WNT transfected cells with increasing 
concentrations of XAV939 doses so for instance, luciferase activity is not detected in cells 




Figure 3.24. Luciferase activity in HEK939 cells transfected with a WNT 
expression plasmid and a TOPflash vector. From left to right, the negative 
control (-CTR) shows low levels of luciferase activity and the positive control 
(WNT) shows high levels of activity. WNT transfected cell luciferase activity 
is reduced in response to XAV939 doses from 1nM to 10µM.  
 
3.3.10. Differential gene expression between iPSC derived NESC induced with 
2i and 2i-WNT inhibitors.  
Differential gene expression analyses were carried out to compare expression of all genes 
between iPSC induced with 2i and 2i-WNT at each time point during NESC differentiation. 
The results show that no genes were significantly differentially expressed (p-value < 0.05) 
and >1 log2 fold changes between the 2 treatments at time points d1, d2, d3 and d6. We 
identified 3 genes differentially up-regulated for the cells induced with 2i and 1 gene 
differentially up-regulated for cells induced with 2i-WNT media at time point d4 
(Figure.3.25). The identities of the differentially expressed TF, fold changes and p-values 
are described in the Appendix 3.14 (CD-ROM) for 2i up-regulated and Appendix 3.15 (CD-













































Figure 3.25. Volcano plot of the differential expression of genes induced with 2i and 2i-
WNT neutralization media at time point d4. The X axis depicts the log2 fold change and the 
Y axis the –log10 p-value. The significantly DE genes with more than 1 log2 fold changes 
between conditions are represented with red dots. Genes with more than 1 log2 fold changes 
that do not reach significance (p-value < 0.05) between conditions are represented with orange 
dots. Genes whose expression levels are not significantly DE and have < 1 log2 fold changes 
in expression between the 2 treatments are shown with black dots. Genes that are up-regulated 
when differentiated with 2i media are located on the left and those that are up-regulated with 
2i-WNT are shown on the right.  
 
Additionally, 148 genes were differentially expressed (>1 log2 fold; p-value < 0.05) at d8. 
Among these genes (excluding TFs), 79 were up-regulated in cells induced with 2i media 
and 39 in cells induced with 2i-WNT media. To determine if the 2i-WNT up-regulated 
genes has been previously related with WNT signalling, enrichment for “pathways”, 
“protein domain” and “protein-protein iteraction” was determined through GO analyses. 
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The results indicated that the genes up-regulated in NESC induced with 2i-WNT media, 
have not been previously associated with WNT signalling. The DE genes are depicted in 
the Figure 3.26. TF are show in a different figure to facilitate visualization of the gene 
names. Only the name of the most significant differentially expressed genes with higher 
fold changes is included in the figure to facilitate their visualization. Names of the entire 
set of genes and statistical analyses details are included in the Appendix 3.14 (CD-ROM) 
for 2i up-regulated and Appendix 3.15 (CD-ROM) for 2i-WNT up-regulated. 
 
 
Figure 3.26. Volcano plot of differentially expressed genes (no TFs included) induced with 2i 




Additionally, we aimed to identify the sets of TF included in the list of DE genes between 
2i and 2i-WNT induced cells. For this, the ensemble gene ID of the genes DE was changed 
to Entrez ID with the "biomaRt" package in Rstudio. The list of DE genes was compared 
with a list of human TFs obtained from “http://www.tfcheckpoint.org” using the 
“VLOOKUP” formula in Microsoft Excel to identify TF.  The data comprising only TF 
was separated from the data containing all genes sets and the TF volcano plots were 
generated with “calibrate” package in Rstudio. However, the curated list of TF included in 
tfcheckpoint database might include genes are not TFs, such us BMP4 and WNT8B, which 
are incorrectly included in the TF volcano plots generated in this study. Among the genes 
differentially expressed at d8, 29 TFs are included. 24 TFs are differentially up-regulated 
in cells induced with 2i media and 5 TFs in cells induced with 2i-WNT media (Figure 3.27). 
Statistical analyses details are included in the Appendix 3.14 (CD-ROM) for 2i up-




Figure 3.27. Differential expression of transcription factors induced with 2i and 2i-
WNT neural induction media at time point d8. The volcano plot is organized as 
described above.  
  
 
3.11. Bulk expression analyses of the genes differentially expressed between 
cells induced with 2i and 2i-WNT media.  
The expression of all differentially up-regulated genes for the cells induced with 2i media 
were compared with the same genes expressed in cells induced with 2i-WNT media to 
identify any divergence in expression at earlier time points (Figure 3.28). Similar analyses 
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where performed for genes differentially up-regulated in cells induced with 2i-WNT 
compared with 2i media.  The results indicate that differences in gene expression emerge 
after d2.  
 
    
Figure 3.28. Bulk expression patterns of the genes differentially expressed in cells induced 
with 2i and 2i-WNT neural induction media. The gene expression profiles of cells induced 
with 2i media are shown in red and those of genes of cells induced with 2i-WNT media are 
depicted in black.  
 
3.12. Gene otology of the genes differentially express between cells induced 
with 2i and 2i-WNT media.  
The differentially up-regulated genes with > 1 log2 fold changes in expression between cell 
differentiated with 2i and 2i-WNT induction media were interrogated for enrichment of 
specific biological process. Gene ontology (GO) analyses were carried out separately for 
the up-regulated genes for each condition including 103 genes for 2i and 44 genes 2i-WNT 
conditions. Biological process annotations are depicted in Figure 3.29. GO analyses of 
genes up-regulated for 2i treatment show significant enrichment (fold enrichment > 2, p = 
< 0.05) of the biological process: “anatomical morphogenesis”, “tissue development”, 
“organ development” and “system development”. The p-values, number of genes for the 
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corresponding term, fold enrichment and false discovery rate are described in Appendix 
3.16 GO analyses of genes up-regulated in cells induced with 2i-WNT showed no 




                    
 
Figure 3.29. Gene ontology of genes differentially up-regulated in cells 
induced with 2i media compared with cells induced 2i-WNT media. The 
key colour scale indicates the log10-adjusted p-value, the lower p-value is 
represented in dark red. 
 
 
3.13. Expression profiles of placode and olfactory placode markers 
During the development of the embryo, the olfactory placode originates from the NBZ 
formed around the NP during gastrulation as a result of interactions of neural ectoderm 
with non-neural ectoderm. GnRH cells develop from the olfactory placodes and latter 
migrate to the hypothalamus. The canonical WNT signalling has been associated with the 
regionalization of the NBZ. For instance, absence of WNT in the NBZ leads to the 
formation of the PPE that gives rise to the olfactory placode, at expenses of the neural crest. 
We analysed the expression of NBZ and placode markers to determine if inhibition of WNT 
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signalling during NESC differentiation induces the differentiation NBZ and placodes like 
cells, which give rise to GnRH neurons at day 50 after neural induction. The expression of 
NBZ and placodal markers was analysed in cells induced with 2i and 2i-WNT neural 
induction media (Figure 3.30). The results indicate that the gene expression profiles of 
these markers are very similar between cells induced with both neural induction media.  
 
  
   
Figure 3.30. Temporal profiles of placodal marker expression. The expression of each gene is 
represented with a different colour. Profiles on the left represent gene expression patterns of cells 
differentiated with 2i media, whereas profiles on the right show the patterns in cells induced with 
2i-WNT media.   
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3.4. Discussion  
3.4.1. Gene expression patterns underlying neuro-ectoderm stem cells 
differentiation 
The implementation of iPSC and RNAseq technologies enable study of in vitro 
differentiation of a number of human cell types of the CNS. For instance, several studies 
have analyzed the molecular events that drive the development of NE cells to neural 
progenitors and to specific neuronal subtypes. However, the events underlying human 
neural induction, which constitutes the initial step of CNS development, is largely 
unknown. This study provides a unique insight into the initial molecular events that 
underlie the transition of PSCs to NESCs and contributes to the knowledge of gene 
expression patterns and signalling pathways accompanying neural induction. 
For this study, we used 3 iPSC lines generated from different individuals and 1 ESC line 
to account for the technical and genetic background differences among cell lines. PCA 
analyses revealed that the genetic background of each cell line and means of neural 
induction do not account for a significant component of the transcriptome variation during 
neural induction (Figure 3.2). The largest principal component of variance is correlated 
with the state of differentiation across all cell lines, indicating high reproducibility of the 
induction system and robustness of the expression levels among biological replicates. For 
instance, changes in gene expression patterns are smaller between consecutive time points 
than between distal time points. During the initial 48h of NE induction, changes in the 
expression patterns tend to be small and are clustered together (Figure 3.3). This period is 
succeeded by profound gene expression changes that continue throughout the remainder of 
neural induction. Gene product abundances and gene regulatory interactions, which are 
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reflected in the mRNA transcripts levels, control the biological processes occurring in the 
cell at specific stages of differentiation. Possibly, these gene expressions changes are 
associated with inhibition of pluripotency after d2 of induction and activation of the NE 
pathways that underlie the progressive restrictions in cell fate that drive neuronal 
differentiation.  
Several genes have been identified during neural development in animal models and in 
ESC studies, including PAX6, NESTIN, SOX11, CDH2, ZNF521, ZEB2 and NR2F2, 
which are considered the main markers and drivers of neural differentiation. We report that 
the expression of these markers is first evident at d2 after 2i neural induction and 
progressively increases until d8. Whereas, expression of NANOG, OCT4 and MYC, which 
are associated with maintenance of pluripotency and self-renewal in PSCs, is down-
regulated after d2 of induction (Figure 3.4). In animal models BMP and TGFβ inhibition 
by antagonists secreted from the node drive ectodermal cells to acquire NE fate. Following 
the developmental cues initiated by inhibition of BMP and TGFβ signaling leads to down-
regulation of pluripotency/self-renewal markers after 2 days and subsequent activation of 
NE markers, validating previous ESC/iPSC studies that have demonstrated the same 
outcome. These results suggest that neural induction in iPSCs occurs in a similar manner 
to that described in animal models, highlighting the utility of iPSCs system to gain insight 
into early human development. However, it is important to recognize that 2i induction 
directs iPSC to acquire NE fate without evidence of prior formation of dorsal ectoderm. 
Hence, 2i differentiation of NESCs does not entirely recapitulate neural induction in vivo.  
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Animal models have enable to identify genes and pathways that regulate neural and 
neuronal differentiation. Particularly, studies in mouse model are highly relevant since they 
provide an insight into the regulatory mechanism that drive the transition from pluripotency 
to neural fate in humans. However, only a reduce number of studies have focussed in 
identifying the gene expression patterns transverse during the early stages of neural 
differentiation in mammals. For instance, the majority of information about the genes 
activated during NE and their interactions comes from studies has carried on with the 
Xenopus embryo. These, analyses have considerably increase the knowledge of the 
mechanism that drive neural differentiation in vertebrates but are not an ideal system for 
understanding the neural development in mammals. A number of genome wide analyses 
acquisition in vivo in mouse and in vitro in mouse and human, have analysed the molecular 
mechanism that regulate the differentiation of neural progenitors.  However, there is a lack 
of information about the regulatory mechanism that orchestrate NE induction in mammals.  
Klein et al demonstrated that expression of FOXD4, GMNN and ZIC2 NE precursor 
markers is necessary to directly activate the transcription of early-actin genes required for 
neural induction in Xenopus. FOXD4 expression initiates at blastula stage and is 
maintained during early NE development to inhibit BMP signalling and enhance GMNN 
and ZIC2 expression. FOXD4 is subsequently repressed during early neural plate formation 
to enable transition from NE precursors to mature NE (Lee et al., 2014; Klein & Moody, 
2015). A recent study with ESC suggested that Foxd4 might play an important role during 
the transition from pluripotent cells to neural cells in mouse.  Foxd4 is transiently expressed 
after neural induction in mouse ESC, depicting a peak in NESC (Gaur et al., 2016, Sherman 
et al., 2017). Foxd4 knowdown in mouse ESC lead to an increase in the expressing of 
pluripotency markers, whereas its overexpression down-regulated the expression of these 
markers, suggesting that Foxd4 might enhance neural fate acquisition by inhibiting 
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pluripotency. Additionally, ectopic expression of Foxd4 in the ventral epidermis of the 
mouse embryo leads to the expression of Gmnn, Zic2 and a decrease in the expression of 
Sox11. The study suggest that Foxd4 regulate the acquisition of neural competence in 
ectodermal cells, similarly than is counterpart in Xenopus (Sherman et al., 2017). Similarly, 
Gmm plays an essential role in early mouse embryogenesis since Gmm-nule mouse embryo 
are early lethal (Lim et al., 2011). ChIPseq analyses enabled to demonstrate that Gmnn 
promotes histone acetylation in neural genes promoters such as Sall3 and Hoxa2. 
Additionally, Gmnn and Zic1 have associated chromatin locations and might cooperatively 
activate the expression genes that regulate neuronal development in mouse, including 
Ascl1, Pax7 and Irx3 (Sankar et al., 2016). Consistent with these reports, we show that 
GMNN and ZIC2 have a high peak of expression at d2 and are subsequently down-
regulated but remain expressed until d8 (Figure 3.4). However, the RPKM values of the 
factor FOXD4 (< 1 RPKM) indicated that the factor is either expressed at low levels or 
restricted to a subpopulation of cells. Perhaps, the expression of FOXD4 in human iPSC is 
not necessary for activation of ZIC2 and GMNN. Additionally, expression of FOXD4 
might be necessary in vivo to promote the transition from pluripotent cells to a neural fate 
but might not be required for iPSC in vitro since inhibition of BMP and TGFβ signalling is 
sufficient to promote neural-ectoderma induction. However, more studies are necessary to 
analyse the role of FOXD4 during neural induction in humans.  
Subsequently, down-regulation of Foxd4, Gmnn and Zic2  and overlapped activation of 
SOXB1 and SOX11 factors leads to the acquisition of NE phenotype in Xenopus (Lee et 
al., 2014). Similarly, in chick and mouse Soxb1 are expressed in NE precursors and in the 
cells of the neural plate. Overexpression of these genes prevents neural precursors to 
differentiate into neurons, suggesting that these factors are necessary to maintain 
pluripotency in NE cells. In mouse Sox2 and Sox3 are widely expressed in the neural plate, 
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whereas Sox11 activated latter during neural progenitors stage and differentiating neurons 
(Bergsland et al., 2011; Lee et al., 2014). We demonstrated that SOX2, and SOX11 are 
highly up-regulated after d3 and SOX3 is up-regulated at d6 and d8, in a similar manner to 
the chronological activation order described in Xenopus. As NE cells differentiate into 
neural progenitors, expression of the precursor markers IRX1, IRX2, IRX3, ZIC1 and ZIC3 
is up-regulated just prior to expression of bHLH factors (Moody et al, 2013; Lee et al., 
2014). Our results reveal that IRX1, IRX3 and ZIC1 expression is low during NE 
differentiation (<1 RPKM), whereas, the markers IRX2 and ZIC3 factors are up-regulated 
during d1, d2 and d3, overlapping expression of GMNN and ZIC2. Possibly, the role of 
IRX, ZIC1 and ZIC3 factors differ between humans and Xenopus during iPSC neural  
development due to amphibian- mammal’s differences. Furthermore, the expression of 
these genes could be related with particular development landmarks in humans, which 
might differ from mouse and Xenopus. Additionally, differentiation of NESC in vitro, does 
not entirely recapitulate the multistep process of neural differentiation in vivo.  For instance, 
the differentiating neural cells do not acquire endodermal phenotype previously to 
differentiating in neuro-ectodermal cells. Thus, the divergence in the expression of these 
genes could be related with differences in the neural differentiation program in vivo and in 
vitro. Overall, our results indicate for the first time that the temporal expression patterns of 
GMNN, ZIC2, SOX2, SOX3 and SOX11 factors previously described Xenopus model 
closely resemble their expression during human iPSC neural induction, whereas FOXD4, 
IRX, ZIC1 and ZIC3 factors are expressed in a different manner.  
Subsequently, activation of bHLH family factors is required for transition of NE cells to 
neural progenitors. ASCL1 and NEUROG2 promote expression of target genes involved 
in neuronal differentiation and cell cycle arrest, whereas OLIG1 and OLIG2 promote 
oligodendrocyte differentiation and HES1 and HES5 maintain RG stage by inhibiting 
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neural differentiation (Kageyama et al., 2005; Dhanesh et al., 2016). The results indicated 
that ASCL1, NEUROG2 and HES5 are up-regulated and OLIG1 and OLIG2 are down-
regulated during the 8 days of neural induction carried out in this study.  However, RNAseq 
data show a reduced expression value for these genes (<1 RPKM), indicating that the genes 
are either expressed in a reduced number of cells of the population or that the population 
express low levels of the genes, which might not be biologically significant. Reduced 
expression of pro-neural markers after 8 days of 2i induction suggest that the majority of 
derived iPSC maintain a NESC phenotype and have not acquired neural progenitor’s 
identity during this period. Interestingly, HES1 is highly up-regulated after d3 suggesting 
a potential function during NESC development. Possibly, high levels of HES1 are required 
to inhibit the premature expression of proneural markers as described during early RG 
stage. 
Additionally, we identify a large number of differentially up-regulated genes during 
specific stages of NE induction, including many TFs that could be used as novel NESC 
markers. Among these genes, a number of TFs such as HESX1, IRX5, HES3, POU3F4, 
KDM4B, IHX4, FOS, SORBS2, RGS9, CITED1, HES4, SOX6, OTX1, FOXA1, 
DMRTA2, LEF1, RAX, SOX21, GLIS3, MEIS1, VAX1, FEZF2, TOX3, ATOH8, 
SMAD6 and GLI3 play important roles during later stages in development of the CNS 
(Figures 3.9, 3.10 and 3.11). Other differentially up-regulated factors have not been related 
previously to the development of the CNS including FANK1, MECOM, KAT2B, TRIM24 
and ELF3. Activation of these TFs during NESC differentiation suggests potential roles for 
the maintenance of the neural transcriptional program or inhibition of genes and pathways 
that lead to differentiation of other lineages. Identification of these factors and their 
temporal expression pattern facilitates future studies to determine their precise role during 
early NE differentiation. The GO annotations of the entire set of up-regulated genes were 
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particularly enriched in terms related to development of the CNS including “diencephalon”, 
“telencephalon”, “forebrain”, “neuronal development” and “tube morphogenesis” (Figure 
3.14). Likewise, we identified a set of up-regulated genes with a similar expression pattern 
(profile 65) using STEM software (Figure 3.16). This approach enabled clustering, 
comparison, and visualization of sets of genes correlated with a gene expression profile. 
The profile 65 was selected since it comprises genes that are highly up-regulated from day 
0 to day 8 after neural induction. Hence, activation of these genes might be required for the 
transition of iPSC to a neural fate. Profile 65 was interrogated for enrichment of biological 
functions trough GO enrichment terms. Similar to the differentially up-regulated genes, GO 
analyses identified terms enriched for “brain”, “forebrain” and “telencephalon 
development”, “synapse organization” and “neural precursor cell proliferation” (Figure 
3.18). Individual genes and gene modules are often present in several GO terms reflecting 
their multiple roles in different biological processes. For instance, GO subcategories such 
as “neuron projection guidance” and “synapse formation” comprise modules of genes that 
coordinate structural changes in the actin filaments and microtubules, a biological process 
that also occurs during NE differentiation. Hence, genes present in GO terms associated 
with later developmental stages might also be involved in novel biological functions during 
NE induction.  
Additionally, we identified sets of down-regulated genes that form part of the ESC/iPSC 
transcriptional network, including the TFs ETV4, SKIL, ONECUT1, OVOL2 and HEY2 
(Figures 3.12 and 3.13). Other down-regulated TFs such us GLI1, VAV1, BARX1 and 
BNC2 have not been previously implicated in pluripotency. GO analyses indicated that the 
down-regulated factors are enriched for the terms “vascular development”, “ion transport”, 
“mesenchyme development”, “cell motility”, “MAPK cascade” and “epithelium 
development” (Figure 3.15). Likewise, STEM analyses generated an expression profile 
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(profile 31) comprising genes that are highly expressed in iPSC and are down-regulated 
during different stages of neural induction. Thus, the profile 31 was selected for further 
analyses since it might contain genes necessary for pluripotency maintenance but not for 
neural differentiation. The profile 31 was interrogated for cell biological functions 
enrichment by GO analyses. The analyses were enriched for the terms “transport”, “defence 
response” “angiogenesis” “regulation of cell proliferation” “response to hypoxia” and 
“cell-cell adhesion”. Genes and gene modules involved in these biological functions might 
play a role in the regulation of the pluripotency program. For instance, hypoxia conditions 
promote the activation of hypoxia inducible factors HIFs, including HIF1 and HIF2, which 
are necessary to initiate the metabolic switch from oxidative to glycolytic metabolism, 
which promotes the pluripotency program. For instance, HIF2 has been shown to regulate 
expression of pluripotency/self-renewal TFs, such as OCT4, enhancing pluripotency. 
Hence, hypoxic conditions improve the reprograming efficiency and iPSCs maintenance 
(Yoshida et al., 2009; Mathieu et al., 2014; Saito et al., 2015). Therefore, iPSC lines are 
maintained in hypoxic conditions until confluence is achieved and subsequently, the 
oxygen levels are incremented during NE induction to promote differentiation. Possibly, 
increase in oxygen levels is accompanied by down-regulation of “hypoxic response” genes 
included in the GO term. Additionally, cell-cell adhesion molecules such us E-cadherin 
contribute to the maintenance of pluripotency and cell survival in PSCs (Li et al., 2014; 
Pieters et al., 2014). Subsequent down-regulation of E-cadherin and up-regulation of N-
cadherin promotes neural differentiation and rosette formation.  Hence, the GO term “cell-
cell adhesion” comprising down-regulated genes is consistent with these reports. A number 
of genes included in the GO terms have known functions in pluripotent cells, whereas 
others are related to different developmental stages and cells functions. Additional studies 
will enable identification of the function of these genes during pluripotency. Interestingly, 
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the terms ‘angiogenesis’ and ‘response to hypoxia’ are only significantly enriched for the 
2i-WNT induced cells. However, genes enriched in these terms are also down-regulated 
during NE differentiation with 2i, but the number of genes highly correlated (R=0.9) to the 
profile was reduced and consequently these terms are not significant for cells undergoing 
2i neural induction. These differences are likely to be driven by WNT inhibition, however 
the differential expression of these genes between treatments at each time point is not 
significant and the biological meaning of them remains unknown.  
3.4.2. Gene expression patterns  
Analyses of gene expression pathways relevant during differentiation demonstrated low 
expression levels of mesoderm, endoderm, non-neural ectoderm and NBZ markers, 
suggesting that the majority of the cells are acquiring NE fate (Figure 3.20). Additionally, 
we report that the neural rosette and radial glial markers are first up-regulated after d2 of 
induction (Figure 3.21). However, the expression of cell polarity markers does not increase 
during the time course of neural induction suggesting that NESCs are not acquiring rosette 
morphology or RG phenotype, as validated by ZO1 immunofluorescence analyses at d8 
(Appendix 3.16). The precociously expressed rosette and RG markers might play a novel 
role during NE differentiation that has not been studied to date, or perhaps, higher levels of 
the markers or the expression of other gene products are necessary to trigger rosette 
formation and RG conversion. Animal and ESC studies have demonstrated that absence of 
patterning molecules during differentiation bias NE cells to acquire forebrain fate (Huang 
et al., 2016; Zirra et al., 2016). We report that the majority of analysed forebrain markers 
are highly express and continuously up-regulated after time point d3 of 2i differentiation, 
validating previous findings.  
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3.4.3. Neuroectodermal stem cells expression patterns described by Huang et 
al (2016) 
In a recent study, Huang et al (2016) demonstrated that the EMT marker ZEB1 was up-
regulated after 6 to 8 days of ESC NE differentiation, while ZEB1 epithelial targets were 
down-regulated, suggesting a novel potential role for EMT during neural differentiation. 
ZEB1, TWIST1, TWIST2, SNAIL1 and SNAIL2 TFs promote EMT by directly repressing 
expression of epithelial differentiation regulators and inducing expression of mesenchymal 
markers (Aigner et al., 2007; Kim et al., 2014; Lamouille et al., 2014). Our analyses show 
that ZEB1 expression is up-regulated from d3 of neural induction, whereas ZEB1 epithelial 
targets and mesenchymal targets are subsequently down-regulated and up-regulated, 
respectively. During EMT, E-cadherin expression is inhibited leading to the disruption of 
cell-cell contacts (Taube et al., 2010; Kim et al., 2014; Lamouille et al., 2014). Activation 
of N-cadherin, which is required to maintain NE cells architecture and for proper formation 
of the neural rosettes during neural induction, is also necessary for EMT (Nandadasa et al., 
2009). Hence, concomitant down-regulation of E-cadherin and up-regulation of N-cadherin 
are a hallmark of EMT. Our results show that E-cadherin is down-regulated at time point 
d3 whereas N-cadherin is up-regulated after this period. The results validate the data 
presented by Huang suggesting a potential role of EMT during neural induction (Figure 
3.22).  
Neural induction is accompanied by chromatin structural changes that modulate the 
accessibility of TFs to specific loci (Broccoli et al., 2015; Tang et al., 2015; Quiao et al., 
2016) but the epigenetic mechanisms that regulate neural induction are largely unknown. 
Huang et al (2016) reported significant changes in the expression of DNA and histone 
modifiers. Our results resemble the expression patterns of the modifiers, validating the data 
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(Figure 3.23). Mapping chromatin accessible sequences and regions enriched for specific 
histone modification would enable identification of the role of these modifiers. ROR2 and 
WNT5B were also up-regulated at d6 and d8 after differentiation (Huang et al., 2016). 
These genes are part of the WNT/Ca2+ signaling up-stream of CaMKII kinase and since 
inhibition of CaMKII caused down-regulation of PAX6 and up-regulation of the epithelial 
marker K18, then this suggests that WNT/Ca2+ signaling might play a role during neural 
induction by inhibiting epidermal fate. Our results validate these data showing that ROR2 
and WNT5B are up-regulated after d2 of neural induction. 
3.4.4. PAX6 and SOX1 expression 
Previous studies have suggested that PAX6 expression precedes SOX1 during human 
neural induction (Pankratz et al., 2007; Suter et al., 2009; Zhang et al., 2010). However, 
Chambers et al reported that SOX1 was activated and up-regulated after 24h of ESCs neural 
induction before PAX6 activation. Neely et al (2012) suggested that SOX1 expression 
variability is related to the concentration of BMP inhibitors used in the induction protocol, 
demonstrating that higher concentrations of DMH1 or Noggin lead to higher expression of 
SOX1. We show that SOX1 and PAX6 are both significantly up-regulated after d2 of 2i 
induction (Figure 3.23). Subsequently, PAX6 expression increases rapidly after this stage 
whereas SOX1 expression is down-regulated and remains low throughout neural induction. 
We are not able to relate these findings to the directly to the concentration of BMP inhibitor 
since the other studies used different small molecule SMAD signaling inhibitors. However, 
we show a novel expression pattern for SOX1, which depicts a peak of expression after d2 
of induction. These results highlight the importance of determining the factors that underlay 
SOX1 expression variability and their potential effect during neural differentiation in 
humans.  
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3.4.5. Differential expression between genes induced with 2i and 2i-WNT  
Embryonic generation of GnRH neurons depends on the sequential formation of the non-
neural ectoderm, NBZ, PPE and olfactory placodes, which subsequently gives rise to 
GnRH neurons that migrate to the hypothalamus. In vitro and in vivo studies demonstrated 
that modulation of WNT, BMP, TGFβ and FGF signals leads to the formation of PPE. 
However, the PPE cells subsequently acquire otic placode fate at expenses of olfactory 
placode. Hence, to date, PPE have not been effectively differentiated into olfactory 
placodes that can be induced to GnRH neurons. In the Price laboratory, generation of GnRH 
neurons is achieved by inducing iPSC/ESC lines with 2i induction media and WNT 
inhibitors. Since the only difference in the generation of cortical and GnRH neurons resides 
in the initial 8 days of neural induction, we hypothesize that during this period cells induced 
with WNT inhibitor are specified to acquire GnRH fate. 
The results indicate that there are 44 genes including 5 TF differentially up-regulated at d4 
and d8 in 2i-WNT compared with 2i induced cells (Figures 3.25, 3.26 and 3.27). Among 
the DE genes the factors PAX8, MAF, PDE6B, NPASS3, ZIC4 and PTN have been 
connected with different process of CNS development but not specifically with 
differentiation of GnRH neurons. Other genes are related to functions such as transport, 
proliferation and morphogenesis but GO analyses show that these genes are not enriched 
for any biological function term. Similarly, there are 103 genes, including 24 TFs 
differentially up-regulated in cells induced with 2i media compared with 2i-WNT media. 
Among these, POU3F2, ARX, LAMB1, FGFR2, DMRTA2, RARB, SALL3, CCK, 
CDH23, PLK2, SAG1and OTX1 play a role in brain development and other genes 
participate in distinct biological functions. GO analyses of this set of genes shows 
enrichment for broad terms such as “system development”, which include genes related to 
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several biological processes (Figure 3.29). Possibly the expression of these genes is 
necessary for the differentiation of cortical cells but not for the generation of GnRH 
neurons. However, due to the pleitropy associated with many of these genes, it is difficult 
to determine which biological process might trigger the acquisition of different neuronal 
phenotypes. GnRH neuronal differentiation has only recently been achieved in vitro; hence 
the regulatory interactions underlying different stages of development are largely unknown. 
Inhibition of WNT signalling during neural induction is sufficient to trigger the progressive 
transcriptional changes that re-specify NESC to differentiate into GnRH neurons. Early 
activation of the genes exclusively differentially up-regulated in 2i-WNT induced cells 
possibly prime NESCs to acquire GnRH neuronal fate. However, the molecular mechanism 
and gene interactions by which these genes drive early GnRH neuronal fate acquisition 
remain unclear.  
3.4.6. Limitations  
ESC and iPSC have huge potential for elucidating fundamental aspects of early human 
development even though some specific molecular events might differ from those 
occurring in the embryo. For example, Shin et al (2007) highlight these differences during 
neuronal differentiation by demonstrating that neural progenitors derived from hESCs and 
progenitors isolated form a foetal ventricular zone are accompanied by differential 
expression of a number of genes. Hence, the gene expression patterns obtained in this study 
give us an insight of the molecular events that underlay human neural induction but might 
not completely recapitulate all the events that drive development in the embryo. 
Importantly, it is critical to repeat the experimental procedures in different micro-
environmental conditions to validate transcriptome data presented in this study. It has been 
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demonstrated that ESC/iPSC respond differently to their microenvironment generating 
transcriptional signatures associated with the laboratories from where the data were 
derived. These differences might be related to the reprograming process, the stem cell 
culture conditions, the progenitors or the handling of the cells (Newman & Cooper, 2010). 
Hence, repeating the experiment in different laboratories would enable detection of the 
degree of variance in the gene expression patterns among laboratories and accurately 
identify the expression signatures traversed during neural induction.  
3.5. Conclusions 
The experimental approaches described here enabled capture of the complete transcriptome 
at different time points and unwrap the global expression patterns generated during NE 
differentiation. Accordingly, it appears that the plutipotency program is down-regulated 
during the initial 2 days of induction, followed by activation of the neural induction 
program. We demonstrated that the initial steps underlying neural induction are 
accompanied by activation of thousands of genes including NE markers that have been 
described in animal and ESC/iPSC studies and several genes and TFs that have not been 
previously related with neural induction or CNS differentiation. Hence, we have identified 
sets of genes and TFs that may orchestrate the molecular mechanisms that drive different 
stages of neural induction in humans. Importantly, we provide sufficient transcriptome data 
to be of use in future studies to infer specific signaling pathways involved in neural 
induction. Additionally, the results indicate that the molecular mechanisms that drive 
NESC specification to GnRH neurons are activated by d8 during neural induction and are 
accompanied by specific activation of 44 genes and down-regulation of 103 genes 
compared with NESCs fated to become cortical neurons. However, we did not identify 
specific gene modules that provided insight into how this specification occurs.  
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CHAPTER 4. Gene Regulatory Networks  
4.1 Introduction  
During neural induction, the gene products encoded by the genome coordinate different 
cell biological functions such as maintaining proliferative state, driving neural commitment 
and determining neuronal differentiation (Qin et al., 2015; Ardhanareeswaran et al., 2017). 
The transition between cell states depends on changes of gene product abundances at 
specific developmental times, which are coordinated by various gene regulatory events. 
Amongst the cell mechanisms of regulation, the most common and best-studied gene 
regulators are TFs. TFs are proteins with a DNA binding domain that bind to regulatory 
sequences (enhancers or promoters) of target genes to stimulate or repress their 
transcription (Qin et al., 2015; Yu et al., 2017). TFs orchestrate neural induction by 
activating and stabilizing expression of sets of genes that initiate and maintain neural fate 
whilst down-regulating expression of genes involved in pluripotency or differentiation 
toward alternative fates (Sankar et al., 2016).  
Recent implementation of high-throughput technologies facilitates determination of TF 
DNA binding sites by ChIP, ChIP-chip or ChIPseq analyses (Wang et al., 2015). 
Additionally, RNAseq analyses allows quantification of changes in expression of a large 
number of genes at specific time points, enabling determination of the identity of genes and 
TFs activated or inhibited during specific stages of differentiation (Hecker et al., 2009; 
MacNaeil & Walhout, 2009). The global transcriptome data obtained from these 
approaches enables prediction of TF gene targets based on a binding site preference and to 
infer potential regulatory interactions between them through various statistical and 
mathematical analyses (MacNaeil & Walhout, 2009; Kordmahalleh et al., 2017). The gene 
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regulatory interactions inferred are often captured in a gene regulatory network (GRN), 
which provides a mechanistic view of how these molecular regulatory events orchestrate 
the different biological processes required at specific stages during cell fate commitment 
(Li & Davidson, 2009; Vashishtha et al., 2015; Peter & Davidson, 2017). However, the 
regulatory interactions between genes are not always simultaneous and can occur with 
temporal changes in gene expression. Time delay interactions can be caused by differences 
in the transcription and translation completion kinetics related with the gene size and 
differences in gene product stability. Hence, several methods have being proposed to 
incorporate time delay in GRN modeling (Xu et al., 2007; Kordmahalleh et al., 2017).  
The GRN comprises nodes that represent genes (TFs can be specifically selected) and edges 
that represent the regulatory interactions between nodes. Genes that have large number of 
connections with other genes are named hubs and are frequently TFs that control expression 
of numerous targets (Blais & Dynlacht, 2005; Yu et al., 2017).  The sets of genes expressed 
in the same cells conditions and connected to a common TF can be considered as subunits 
of the GRN and are referred to as modules. For practical reasons modules are analyzed as 
autonomous units and are frequently associated with a specific cell regulatory function 
(Peter & Davidson, 2017; Charney et al., 2017; Yu et al., 2017). It has been proposed that 
the distinct biological processes carried out by the cell might require a level of 
compartmentalization, which is associated with a reduced number of direct connections 
between the modules in the GRN. Since not all the regulatory functions of the cell are 
required at all times, the activity of the modules and interconnectivity of the network 
(topology) changes over time during development (Blais & Dynlacht, 2005). The 
interactions between genes within the modules ultimately determine cell phenotype and 
behaviour. Hence, identification of the GRN and the modules that are active during specific 
developmental stages provides a systematic understanding of the different steps and 
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molecular mechanisms that underlie neural induction (Vashishtha et al., 2015; Yu et al., 
2017). 
As development proceeds, gene expression patterns continuously change in response to 
different regulatory signals. Changes in gene expression patterns are translated into changes 
in GRN topology. The gene expression patterns captured at a specific time point in the 
GRN constitute network states (Huang et al., 2009b; Gomez et al., 2012). During cell fate 
acquisition, cells traverse the network state space until they reach a state where the gene 
product interactions are stable (Figure 4.1.) (Huang et al., 2009b; Choi et al., 2012). The 
cell morphology, function and behaviour (phenotype) emerge as a property of these stable 
molecular interactions within the cell (Huang et al., 2009b; Vashishtha et al., 2015). The 
stable state is robust to changes in expression levels of individual genes of the GRN. 
However, perturbations such as mutations can generate genome-wide changes 
compromising the stable interactions between nodes and driving the cells to different state 
and therefore a different phenotype (Huang et al., 2009b; Ghaffarizadeh et al., 2017). Thus, 
the GRN inferred relations can be validated by testing the network predictions using 
specific intervention including small molecule inhibitors, gene knock-down and gene 




Figure 4.1. Representation of the regulatory interaction between 2 genes. The genes A and 
B interact by inhibiting each other expression, forming 4 possible gene expression profiles. 
When both genes are equally express the interactions are not stable due to mutual inhibition. 
When one gene express higher levels inhibits the other gene expression and forms a stable 
expression pattern. The cell phenotype emerges from the stable pattern (attractor state). The 
gene expression patterns are often represented as a point in a Waddington epigenetic landscape. 
Elevation in the landscape represents stability, thus unstable transient states during 
differentiation are shown as high points, whereas stable regulatory interactions between the 
genes are represented as basins (Huang et al., 2009b).  
 
GRNs enable visualization of the gene regulatory interactions inferred from high-
throughput analyses and provide systematic interpretation of the global expression patterns 
that emerge from these interactions. Furthermore, GRNs modeled from time course 
analyses allow identification of the consecutive gene expression patterns or states that the 
cell occupies during its trajectory between distinct cell states (Charney et al., 2017; Yu et 
al., 2017). Hence, the GRN can be interrogated to identify TFs that are potentially 
responsible for the expression of target genes, the active modules potentially related to a 
particular cell biological process and to predict GRN outputs due to specific interventions 
of the network topology (Bisguas & Acharyya, 2016). Such information is essential to 
understand the regulatory interactions that direct human development, the molecular events 
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underlying aberrant cell phenotypes and to identify potential therapeutic strategies for 
treating diseases (Choi et al., 2012; Lopes et al., 2012).  
4.2. Methods 
4.2.1. Gene regulatory network 
The different experimental approaches that I performed during this study enabled to obtain 
a large amount of transcriptomic data during different stages of NESC differentiation from 
iPSC trough RNAseq analyses. I used this data to generate differential expression analyses, 
co-relation analyses, PCAs, STEM profiling, genes expression heatmaps, gene expression 
profile and volcano plots. Additionally, the raw data generated from the iPSC1 line induced 
with 2i media was used by our collaborator Jun Min (UCSD) to model the gene regulatory 
network. I contribute with the GRN refinement by suggesting the exclusion of several genes 
with low expression levels (RPKMs) from the initial network, since these genes might not 
be biologically relevant. However, the GRN was entirely model by our collaborator. 
Briefly, Jun Ming used the DESeq2 function dds to rlog-transformed the data and 
performed differential expression analyses. A number of TFs differentially expressed at 
time points d1, d2 and d3 with respect to d0 were identified. A set of TF were selected due 
to high number or interactions with other genes determined from TRANSFAC database. If 
the TF was differentially expressed between more than one time points, the earliest time 
point of differential expression was selected for further analyses. The set of selected TFs 
were correlated (Pearson correlation R=0.95) to a subset of potential targets or interacting 
proteins, which were also differentially expressed at the same time point or with 1, 2 or 3 
days time delay. In parallel, our collaborator derived an interactome from the RNAseq data 
and compared these interactions with the potential interactions of the highly correlated TFs 
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and targets. Common TF-target or protein-protein interactions from the time delay 
correlation and the interactome were plotted in a GRN for visualization with GraphViz 
software and Cytoscape software (Figure 4.2).  
I interrogated the genes comprising the GRN for GO terms enrichment with DAVID as 
described in section 2.4 (Figure 4.5). 




Figure 4.2. Scheme of the gene regulatory network modeling. TFs (blue) differentially expressed 
(complete circle) from d0 (yellow) at d1, d2 or d3 after NE induction were identified and the earliest 
time point of differential expression was selected (red). The gene targets (green) are mapped to the TF 
only if their expression is correlated (arrows) at the same time (d1) or with 1, 2, or 3 days time delay 
(d2, d3, d4) and if the targets are differentially regulated (complete circle) at the correlation time point.  
 
 
4.2.2. MYC inhibition assay 
Approximately 100,000 iPSCs were plated on each well of Nunclon delta surface 96 well 
plates (Thermo Scientific, 167008) with similar conditions as described in the section 2.1. 
Cells were grown for 24 hours with E8 media until they reached confluence. Confluent 
iPSCs were treated with doses of 30µM or 10µM final concentrations of the MYC small 
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molecule inhibitor 10058-F4 (Sigma Aldrich, F3680) or 0.01% of dimethyl sulfoxide 
(DMSO) in E8 media for 24 hours. After incubation, cells were observed for quality control 
and survival.  
In parallel, 100,000 iPSCs were plated in Nunclon 96 well plates and grown for 24 hours 
in E8 media until they reached confluence. Confluent cells were treated with 30µM or 
10µM of 10058-F4 or 0.01% DMSO in 2i neural induction media, which was changed 
every 24 hours. After 24, 48 and 72 hours of MYC inhibition treatment, a set of cells was 
fixed with 4% paraformaldehyde and used for immunocytochemistry analyses following 
procedures detailed in the section 2.8.   
Additionally, 1,500,000 iPSCs were plated in Nunc 6 well multidishes and incubated in E8 
media for 24 hours until they reached confluence. Confluent cells were treated with 2i 
induction media and 30µM or 10µM of 10058-F4 or 0.01% DMSO. Cells were checked for 
quality control and media was changed every 24 hours.  RNA was extracted from 2i-
induced cells treated with each dose of 10058-F4 or DMSO after 24, 48 and 72 hours. RNA 
extraction was as described in section 2.2. cDNA was synthesized from purified RNA and 
was used to analyze relative expression of SMARTA, CDH1 and TFAP2C through Q-PCR 
analyses as described in section 2.7. The reference sample was provided by the DMSO 
treatment at d1. 
4.3. Results 
4.3.1.  Gene regulatory network 
The GRN genes are depicted as nodes and their regulatory interaction as edges. Gene 
interactions can be DNA-protein or protein-protein. Selected TFs and genes from the 
TRANSFAC database are represented in green and their targets in yellow. Lines represent 
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bidirectional protein-protein interaction and lines with arrows TF-gene target interactions. 
Blue lines indicate negative correlation, whereas red lines show positive correlation. 
Regulatory interactions without time delay are represented with solid lines. Longer dashed 
lines and shorter dashed lines show time delay of 1 and 2 days, respectively. Dotted lines 
show time delay of 3 days with respect of the selected TF (Figure 4.3).  
 
 
Figure 4.3. PAX6 gene module shows: selected TF and genes (green) and targets or interacting 
proteins (yellow) with positively (red) or negatively (blue) correlations and their protein-protein 
interactions (lines with arrows) or TF-target regulatory interactions (lines with arrows) with time 
delay correlation of 0 (solid lines), 1 (long dashes), 2 (short dashes) and 3 days (dotted lines) between 
them.   
 
 
The GRN comprises 9 highly connected nodes (hubs) including MYC (40), JUN (32), 
SP3 (21), SMAD2 (19), FOS (16), CD6 (14), LEF1 (11), PAX6 (8) and HDAC6 (6)  - 
connectedness is shown in parenthesis (Figure 4.4). A full-size image of the GRN has 
been included in the Appendix 4.1 (CD-ROM). 
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The genes comprised in the GRN were interrogated for GO enrichment for biological 
process terms. The results show that the genes were enriched for “localization”, “response 
to stimulus”, “biological adhesion” and “locomotion” (Figure 4.5). Sub-ontologies, p-
values, number of genes for the corresponding term, fold enrichment and false discovery 
rate are described in the Appendix 4. 2. 
 
 
Figure 4.4. Gene regulatory network from d0 to d6 during neural induction. The GRN 








             
 
Figure 4.5. Gene Ontology of the genes comprising the gene regulatory network. 
GO terms enrichment of the GRN genes. The key colour scale indicates the log10-
adjusted p-value, where the lower p-value is represented in dark red.  
 
 
Counts of MYC, PAX6, SMAD2 and DCD6 hubs show the expression patterns of these 
genes among the 3-iPSC lines (Figure 4.6). DE analyses indicate that MYC expression is 
significantly down-regulated at d1 while PAX6 expression is significantly up-regulated at 
d2 and expression of SMAD and CDC6 is significantly up-regulated at d3 and d2, 
respectively.  
    
Figure 4.6. MYC, PAX6, SMAD2 and CDC6 counts from time point d0 to d8. 
Expression patterns of iPSC1 (blue), iPSC2 (red) and iPSC3 (green) during 8 days of 
neural induction.  
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The main hubs and genes directly connected to them in the GRN were interrogated for 
enrichment of GO terms (Figure 4.7). The hubs SP3, HDAC6, FOS, JUN and LEF1 did not 
present significant enrichment for any biological function term. The MYC hub and 
associated targets were significantly enriched for the terms “programmed cell death”, “cell 
proliferation” and “regulation of response to stress”. PAX6 and associated gene targets in 
the GRN were enriched for the terms “regulation of RNA biosynthetic process”, 
“regulation of transcription, DNA template”, “central nervous system development”, 
“sensory organ development”, “neural tube development” and “dorso-ventral pattern 
formation”. SMAD6 hub and GRN targets were enriched for “regulation of gene 
expression”, “regulation of RNA metabolic process”, “regulation of RNA biosynthetic 
process” and “regulation of transcription, DNA-templated”. The hub CDC6 and its 
interacting genes were enriched for the terms “regulation of cell cycle process”, “cell cycle 
phase transition”, “G1/S transition” and “DNA replication”. Sub-ontologies, p-values, 
number of genes for the corresponding term, fold enrichment and false discovery rate are 
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described in the Appendix 4.3 for MYC network, Appendix 4.4 for PAX6, Appendix 4.5 
for SMAD6 and Appendix 4.6 for CDC6.  
 
 




                     
 
Figure 4.7. Gene Ontology of the genes interacting with MYC, PAX6, SMAD2 and 
CDC6 in the gene regulatory network. The key colour scale indicates the log10-adjusted 






                  
 
 
            
 
               
 
 
Figure 4.7. Continued 
 
 
4.3.2.  MYC inhibition assay 
The GRN comprising the hub MYC and interacting genes is depicted on Figure 4.8. 
Importantly, several genes that are not connected directly with MYC in the GRN have been 
removed to facilitate visualization. Inferred gene interaction of the GRN can be validated 
by testing the predictions of the model to a specific interference. Intervention of the network 
can be achieved by different strategies such us CRISPRi, CRISPa and small molecule 
inhibitors, been the later the most affordable and relatively simpler technique. We selected 
the MYC hub to test the GNR predictions due to the availability of a small molecule 
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inhibitor (10058-F) that targets MYC-MAX interaction, preventing the regulation of MYC 
targets.  MYC hub is highly connected with several nodes of the GRN. Hence, inhibition 
of MYC might affect the expression of the genes directly connected to the hub in the 
network.  
 
Figure 4.8. Gene regulatory network of MYC target genes or interacting proteins. The majority of 
MYC targets or interactive proteins are positively correlated (red edges) with the hub. 40 MYC 




Cells undergoing 2i neural induction were treated with 30µM or 10µM 10058-F MYC 
inhibitor or with DMSO and were fixed after d1, d2 and d3. The expression of pluripotency 
markers was analyzed by immunofluorescence for the pluripotency proteins, OCT4 and 
NANOG and for the NE markers, SOX11 and ZNF521. The results demonstrated that 
inhibition of MYC during d1, d2 and d3 of differentiation does not significantly change 











Figure 4.9. OCT4 immunofluorescence analyses. A. Expression of pluripotency marker OCT4 
at d1, d2 and d3 after 2i neural induction with 30µM, 10µM 10058-F or DMSO treatment. Cell 
nuclei are stained with Hoescht 33342. B. Statistical analysis of immunofluorescence. The error 






























Figure 4.10. NANOG immunofluorescence analyses. A. Expression of pluripotency marker 
NANOG at d1, d2 and d3 of 2i neural induction with 30µM, 10µM 10058-F or DMSO treatment. 
Cell nuclei are stained with Hoescht 33342. B. Statistical analysis of immunofluorescence. The 





























Figure 4.11. SOX11 immunofluorescence analyses. A. Expression of NE marker SOX11 at d1, 
d2 and d3 of 2i neural induction with 30µM, 10µM 10058-F or DMSO treatment. Cell nuclei are 
stained with Hoescht 33342. B. Statistical analysis of immunofluorescence. The error bars 































Figure 4.12. ZNF521 immunofluorescence analyses. A. Expression of NE marker ZNF521 at 
d1, d2 and d3 of 2i neural induction with 30µM, 10µM 10058-F or DMSO treatment. Cell nuclei 
are stained with Hoescht 33342. B. Statistical analysis of immunofluorescence. The error bars 






















The genes SMARCA2, CDH1 and TFAP2C are positively correlated to the hub MYC in 
the GRN. MYC and SMARCA2 are first differentially down-regulated at d1 with no time 
delay, whereas CDH1 and TFAP2C are first down-regulated at d3 with 2 days time delay 
compared with MYC. Q-PCR analyzes of these genes expression after 2i neural induction 
in the presence of 30µM or 10µM of the MYC inhibitor F10058-F or DMSO indicated that 
CDH1 and TFAP2C are significantly more highly expressed in cells treated with 10µM 
10058-F compared with 30µM and DMSO at d1. SMARCA2, CDH1 and TFAP2C are 
significantly more highly expressed at in cells treated with 30µM 10058-F compared with 
10µM or with DMSO at d2. CDH1 is significantly more highly expressed in cells treated 
with 30µM 10058-F compared with 10µM and DMSO at d3 (Figure 4.13). Statistical 
analyses details are included in the Appendix 4.8 (CD-ROM).   
 
              
 
Figure 4.13. Real-time PCR analyses of SMARCA2, CDH1 and TFAP2C. Expression of 
SMARCA2, CDH1 and TFAP2C was quantified by Q-PCR at d1, d2 and d3 of neural induction 



































































4.4. Discussion  
4.4.1. Gene regulatory network modules 
We report for the first time a GRN comprising the gene regulatory interactions transversed 
during the differentiation of NESC from iPSC. A number of activated and down-regulated 
genes during different stages of NESC differentiation have been previously described in 
mammals, particularly using mouse as a model. However, interactions between these 
factors have not been deeply explored either in human or in mouse. The GRN generated by 
our collaborator Jun Ming GRN enables visualization of potential protein-protein and TF-
target interactions among selected TFs that are differentially expressed during early neural 
induction (d1, d2 and d3) and a sub-subset of correlated genes that are differentially 
expressed at the same day or with 1, 2 or 3 days delay. To identify the potential biological 
functions regulated by the genes comprising the GRN I interrogated them for enrichment 
of GO terms. The results indicated that the biological processes “localization”, “response 
to stimulus”, “biological adhesion” and “locomotion” or genes included in these terms 
might play a role during neural induction.  
I identify 9 hubs with high connectedness among the GRN that are considered modules. 7 
modules highly interact with each other and include MYC, FOS and JUN, possibly 
generating feedback circuitry. Expression of these modules might regulate specific or 
multiple biological functions required by the cell at particular developmental stages. MYC 
interacts with 44 genes forming the largest module. 40 genes are positively correlated with 
MYC, reflecting that their expression is also down-regulated during NESC differentiation. 
MYC and correlated genes such us MTA1 and ENO1 are rapidly down-regulated at d1 after 
neural induction, whereas others are down-regulated at d2 and d3. GO analyses of the MYC 
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module indicate that the biological processes “programed cell death”, “cell proliferation” 
and “regulation of response to stress” are enriched for genes comprised in the module. 
These biological processes play important roles during different developmental stages, 
including neural induction. Perhaps, the genes involved in these terms are necessary for the 
maintenance of the pluripotency state in iPSCs but are subsequently down-regulated during 
neural induction. A GRN study conducted during the tumorigenic transformation of human 
primary cells, show that activation of MYC induces the expression of several gene modules, 
which regulate the biological processes that drive the cell to a cancerous phenotype, 
including rRNA synthesis and chromatin remodelling (Malysheva et al. 2016). Among this 
GRN, MYC is connected with several genes including SMARCA2 and SMAD7, which are 
also connected to the MYC hub in our GRN. However, no other genes and hubs are 
common between these GRN. Possibly, the gene modules and cell biological functions 
necessary for the differentiation of tumorigenic cells and the maintenance of iPSC are not 
highly interconnected during this stage of tumour development. Furthermore, the sets of 
TF and genes and the inferred regulatory interactions between nodes might vary between 
GRNs due to the variability of the statistical and mathematical methods used by both 
studies. Additionally, the MYC is essential in human and mouse for the efficient 
reprograming of iPSC and for the maintenance of pluripotent stem cells. For instance, a 
GRN modelled from PSC from the mouse embryo depicted MYC as a central hub in a 
pluripotency GRN that integrates multiple gene modules, which modulate various 
biological processes such us cell cycle, metabolism and epigenetic remodelling and 
inhibition of differentiation genes (Fagnocchi et al., 2016; Fagnocchi & Zippo, 2017). The 
genes connected with MYC in the mouse pluripotency GRN are not directly connected with 
the MYC hub in the network modelled from our data. However, several of the genes 
interacting with MYC in our GRN, such as FGF2, SMARCA2 and AHR are necessary for 
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pluripotency, indicating that the MYC module might play a role in pluripotency 
maintenance of iPSC. It is likely that the genes comprised in the both GRN differ due to 
the different mechanism used for selecting the genes to model the networks. Hence, the 
genes included in the mouse pluripotent GRN might have been excluded from our data 
prior to the netbook modelling. For instance, it is possible that down-regulation of these 
genes is not necessary for human iPSC differentiation toward NESC lineage. Therefore, 
these genes were not significantly down-regulated in our data set and were not included in 
the GRN. However, these genes might also play a role in the maintenance of pluripotency 
in human iPSC. Additionally, genes included in the mouse pluripotency network, which 
are not directly connected with MYC are also highly expressed at day 0 in our data set, 
including NANOG, SOX2 and OCT4. However, the statistical analyses used to infer the 
interactions of the GRN indicated correlation of these genes with other modules different 
than MYC. 
The PAX6 hub is up-regulated after d2 of neural induction similarly to the majority of 
genes (8) interacting with the hub. GO analysis of the PAX6 module show enrichment for 
the terms “regulation of RNA biosynthetic process”, “regulation of transcription, DNA 
template”, “central nervous system development”, “sensory organ development”, “neural 
tube development” and “dorso-ventral pattern formation”. These regulatory functions 
might be required for activation and maintenance of the neural induction program. For 
instance, the 8 genes interacting with PAX6 in the GRN have been implicated in different 
steps of CNS development. Possibly, activation and interaction of genes within the module 
is necessary to initiate the sequential regulatory signals that direct neural induction. PAX6 
is highly expressed in NE cells derived from ESCs and directly from human foetuses and 
it is required for the neural induction, as demonstrated by known-down studies in human 
ESC (Zhang et al., 2010; Blake & Ziman, 2014). It has been suggested that PAX6 promotes 
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neural induction by inhibiting the pluripotency factors OCT4, NANOG and possibly by 
activating NE genes. Our results suggest that PAX6 might interact with the TFs RAX, 
GLI3, MEIS2, LHX2 and NR2F2 at d2 after 2i neural induction to promote the transition 
between PSC and NESC. Importantly, the gene module might interact with other genes not 
included in the network to modulate differentiation. Genome editing techniques such as 
CRISPR/CAS9 and CRIPSPRi would enable silencing of these TFs at specific times during 
neural induction to test the GRN predictions. A recent study, show that Pax6 is the central 
hub a GRN necessary for the activation and maintenance of radial glial cells and cortical 
neurons differentiated from mouse ESC. The results indicated that Pax6 hub activates 
neuronal genes and inhibits mesodermal and endodermal genes to ensure unidirectionality 
of the differentiation program (Sun et al., 2015; Thakurela et al., 2016). However, the genes 
include in this study were not comprised in our data set and GRN. For instance, neuronal 
genes included in the radial glial GRN, such as ASCL and NEUROG2, are expressed at 
low levels during NESC differentiation. Perhaps, these GRN is activated posteriorly to 
NESC differentiation and proceeds the regulatory interactions of PAX6 module described 
in this study. Aditionally, PAX6 is the central regulator of the mammalian lens 
developmental program. Analyses of the regulatory interaction of Pax6 during mouse lens 
development indicated that the TF directly activates modules of crystalline genes, cell cycle 
exit genes, Wnt signalling genes and extra cellular matrix genes, biological processes that 
might be required for lens differentiation (Sun et al., 2015; Antosova et al., 2016). 
However, these gene modules might not be required for NESC differentiation from iPSC 
in humans since the genes comprised in the modules are not interacting with PAX6 in the 
GRN modelled form our data. 
Similarly, the SMAD2 hub is differentially up-regulated at d3 of neural induction. SMAD2 
shows a connectedness of 19 and target genes are up- or down-regulated at either d6 or d8. 
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GO analyses shows enrichment for “regulation of gene expression”, “regulation of RNA 
metabolic process”, “regulation of RNA biosynthetic process” and “regulation of 
transcription, DNA-templated” terms. SMAD2 module might modulate changes in RNA 
processing, which impact DNA transcription after d3 of neural induction. These changes 
might be necessary for NE induction or for inhibition of genes that induce differentiation 
to other cell phenotypes such as pluripotency, but the precise mechanism remains to be 
investigated.   
CDC6 is initially up-regulated after d2 and is subsequently down-regulated after d3. CDC6 
interacts with 14 genes, all of which are down-regulated at d4 and d6. GO analysis reveals 
enrichment for “regulation of cell cycle process”, “cell cycle phase transition”, “G1/S 
transition” and “DNA replication” terms. Several studies have demonstrated that cell fate 
decisions are tightly synchronized with specific cell cycle profiles (Sakaue-Sawano et al., 
2008). For instance, in mouse and human ESCs, pluripotency is associated with a truncated 
G1 phase that lacks G1 checkpoint regulation. Increase in the length of G1 phase through 
CDK inhibition leads to spontaneous differentiation of ESC/iPSC, possibly by increasing 
the time of exposure to specification signals (Ruiz et al., 2011; Soufi & Dalton, 2016). 
Moreover, ESC initiates cell fate decisions at G1 state. Pluripotent cells at early G1 
differentiate into mesendoderm due to elevated expression of SMAD2/SMAD3 during this 
phase. Cells at late G1 acquire neural-ectoderm differentiation competence due to 
accumulation of cyclin D, which activates CDCK4/6 leading to phosphorylation and 
reduction of SMAD2/3 (Pauklin & Vallier, 2013, Soufi & Dalton, 2016). Additionally, it 
has been shown that neural progenitor cells have an extended G1 phase and short S phase 
during neuronal differentiation. For instance, truncated G1 and elongated S1 in neural 
progenitors leads to reduced production of cortical neurons, indicating that completion of 
G1 might be necessary for establishing the molecular program that directs neural 
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differentiation (Lanctot et al., 2017).  Possibly, down-regulation of gene modules enriched 
for “cell cycle phase transition” and “G1/S transition” at d4 and d6 enhances neural 
differentiation by promoting elongation of G1 phase or by a different mechanism through 
regulation of cell cycle progression. However, the precise means by which this gene module 
inhibits or promotes neural induction remains to be elucidated.  
4.4.2. MYC inhibition 
Validating gene-gene relationships inferred from the GRN can be achieved by testing the 
network predictions using specific interventions (Olsen et al., 2014). The small molecule 
inhibitor 10058-F inhibits MYC-MAX interaction preventing regulation of their gene 
targets. I inhibited MYC activity during the first 3 days of neural induction to identify 
possible effects in the expression of other genes of the GRN. Since the MYC module is 
highly connected with other GRN modules, I hypothesized that inhibition of MYC may 
affect expression of other genes within the GRN. The results indicated that MYC inhibition 
does not affect expression of other pluripotency markers, NANOG and OCT4, or NE 
markers, SOX11 and ZNF521. However, inhibition of MYC leads to an increase in 
expression of SMARCA2, CDH1 and TFAP2C after 2 days and CDH1 by d3. These factors 
are significantly down-regulated after 2 (SMARCA2) and 3 days (CDH1 and TFAP2C) of 
2i induction and are directly connected with MYC in the GRN. Importantly, MYC 
expression is differentially down-regulated at d1. Hence, initial levels of MYC during the 
first day of neural induction might be necessary to enhance down-regulation of SMARCA2, 
CDH1 and TFAP2C. Premature inhibition of MYC with 10058-F during 2i differentiation 
might prevent these regulatory mechanisms. Hence, the results suggest that MYC exerts a 
regulatory effect up-stream of these genes, validating the inferred connection between 
MYC and SMARCA2, TFAP2C and CDH1 in the GRN. It seems that MYC function is 
 168 
compensated, possibly by other factors, at d3 for SMARCA and CDH1 inhibition but not 
for CDH1. Induction of MYC expression during the initial 3 days of 2i induction might 
provide additional data to infer MYC regulatory effects over the genes in the GRN module.  
4.4.3. Limitations 
GRNs are often modelled based heavily on known TF regulatory interactions. However, 
the gene expression patterns transversed during development are also regulated by post-
translational and epigenetic modifications. Incorporating these regulatory events in the 
GRN would vastly improve the GRN predictions; but requires elevated resources and 
extended periods of time due to the computational complexity of the models. Accordingly, 
epigenetic and post-translational modifications are rarely incorporated and are not included 
in the GRN modelled by our collaborators in this study. Hence, not all regulatory 
mechanisms that control the formation of specific gene product abundances are included. 
It is important to realize that this does not invalidate the network, just that certain 
interactions or edges may obscure undetected nodes. 
An enormous number of potential interactions arise from the data generated from high-
throughput technologies, increasing the complexity of the GRN topology. Filtering the data 
according to specific criteria is essential to reduce the dimensionality of the GRN. The 
GRN inferred by Jun Ming comprises only selected TFs that are highly connected with 
other genes. These interactions are based on prior knowledge of the regulatory functions of 
these factors and might exclude interactions with biologically relevant TF that are 
unknown. Additionally, the GRN nodes might interact with constitutively expressed genes 
that do not show differential expression during neural induction (these would be an example 
of undetected nodes – see above). Identification of genes that might be biologically 
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meaningful without prior knowledge of all relevant interactions remains challenging. 
Hence, the GRN shows potential causal relations between genes at different states of 
differentiation, but possible intermediate nodes are not evident in the network. 
Additionally, visualization of specific spatiotemporal states of the GRN may improve by 
integrating the time points and direction (up-regulation or down-regulation) of the TF 
differential expression. For future studies, I will to optimize the GRN topology by testing 
the GRN predictions through combinatorial gene activation and repression (using CRISPRi 
and CRISPRa). Additionally, I will perform ChIPseq and proteomic analyses would enable 
to continue the refinement of the GRN model.  
4.4.4. Conclusion 
Interdisciplinary collaboration between experimentalists and modellers enables 
computational modelling of GRN from large-scale transcriptional datasets. Accordingly, 
our collaborators Jun Min and Shankar Subramanian (UCSD) modelled a GRN from the 
high-throughput transcriptional datasets obtained from our experimental approaches. The 
GRN shows the potential causal relations of a set of selected TF with a subset of genes 
during different stages of NE differentiation. The regulatory interactions between these TF 
and genes lead to distinct network topologies at different stages of differentiation, 
representing dynamic changes in gene expression levels and connectivity. This network 
controls the different biological processes carried out during neural induction. I identified 
gene modules within the GRN and interrogated them GO analysis, which enabled 




CHAPTER 5. Single cell RNAseq  
5.1 Introduction  
The development of techniques for single cell isolation, and cDNA synthesis and 
amplification from a small amount of starting RNA, enable quantitative analyses of the 
transcriptome at a single cell resolution (Tang et al., 2010, Poulin et al., 2016). These 
approaches revealed that isogenic cell populations exposed to identical micro-
environmental conditions could depict heterogeneous gene expression levels (Elowitz et 
al., 2002; Tang et al., 2010; Fujita et al., 2016). It has been proposed that transcriptional 
bursting is the major driver of gene expression variability. Individual genes show different 
burst kinetics, resulting in different gene product abundances among cells within a 
population, which might impact cell fate commitment decisions. Measurement of bulk 
expression of the population can obscure fluctuations in gene expression of single cells 
(Koern et al. 2005). Hence, considering only the average expression of a population could 
mask subpopulations with different burst kinetics, which may be fated to acquire different 
phenotypes or may represent intermediate states of differentiation (Islam et al. 2011; 
Trapnell et al. 2014; Buettner et al., 2015) (Figure 5.1). Additionally, to identify the 
regulatory relations among genes underlying different stages of development, it is 
important to determine that the interacting genes are expressed in the same individual cells 
(Moignard & Gottgens, 2014). 
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Figure 5.1. Gene expression profiles from single and bulk cells analyses. A. Expression 
analyzes from bulk cells show that all cells in the population express similar levels of a transcript 
(top left) giving a unimodal distribution (mid left); whereas single cell analyses indicate that some 
cells among the population show low levels of expression and other high levels of expression (top 
right), leading to a bimodal distribution (mid right). B Single cell expression analyses separate the 
expression of different transcripts in individual cells (bottom right) from co-expression of these 
transcripts in the cell population (bottom left) (Moignard & Gottgens, 2014). 
 
5.1.2. Transcriptional bursts 
Gene transcription comprises a series of biochemical reactions that are determined by 
molecular concentrations, diffusion rates and TF dynamics. Hence, factors extrinsic to the 
gene such as cell size, cell cycle phase and the concentrations of molecules required for 
transcription might add variability to the process (Munski et al., 2012; Schoech & Zabet, 
2014; Nicolas et al., 2017). However, the main source of transcriptional fluctuation among 
cells is intrinsic transcriptional bursts, which lead to variation of mRNA transcript 
production due to irregular gene transcription. Integration of quantitative expression of 
gene transcripts with mathematical models has led to the formulation of 2 main models to 
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explain transcriptional bursting. The one-state model suggests that mRNA is produced and 
degraded in a constant rate proportional to the number of mRNA molecules, where a 
Poisson distribution characterizes the distribution of mRNA among the cell population 
(Corrigan et al., 2016; Nicolas et al., 2017). The two-state model of gene regulation better 
explains the distribution of genes whose expression does not follow a Poisson distribution, 
which is common in higher eukaryotes. The model assumes that short episodes of RNA 
synthesis are followed by transcriptional silence at a constant rate (Islam et al., 2011; Fujita 
et al., 2016; Nicolas et al., 2017). In this model, promoters have 2 states: the “on” state 
when the promoter is randomly activated, producing a burst of mRNA transcripts, and an 
“off” state when the promoter is inactive, and no transcription occurs (Munski et al., 2012; 
Corrigan et al., 2016; Soltani & Sight, 2016). The two-states model generates variable 
distribution of mRNA transcripts depending on the burst size (number of transcripts 
produced in each burst) and frequency (frequency of burst occurrence) at a specific time 
point. For instance, short “on” and long “off” periods produce occasional mRNA busts with 
high variance and a long tailed distribution; whereas long periods of activation or 
inactivation generate bimodal distribution with clearly delineated “on” and “off” 
populations (Munski et al., 2012; Nicolas et al., 2017).   
The molecular mechanisms that drive transcriptional variability are not well understood. 
However, several studies have identified a number of factors that might influence the burst 
shape including local genomic environment, the nucleosome occupancy in the 
transcription-starting site (TSS), histone marks and DNA regulatory elements (Raj et al., 
2006; Muramoto et al., 2010; Dar et al., 2012; Fukaya et al., 2016; Nicolas et al., 2017; 
Hendy et al., 2017) (Figure 5.2).  These mechanisms lead to changes in TF availability at 
the DNA binding sites, suggesting that TFs availability impacts transcriptional bursting 
(Nicolas et al., 2017). In addition, it has been demonstrated that at lower concentrations of 
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TFs, the dominant source of variability in transcriptional bursts of gene targets is the 
frequency, whereas at higher concentrations of TFs the main difference is the size (Carey 
et al., 2013).  
 
  
Figure 5.2. Regulatory mechanism of transcriptional bursting. Transcriptional burst size and 
frequency are influenced by the local chromatin environment; histone modifications; number and 
affinity of promoters (large square) core regulatory elements (cis) (small squares); formation of loops 
with distal regulatory elements; and the availability of TF. These molecular mechanisms are depicted 
in boxes, where the color represents their role in regulating the size (blue) and the frequency (pink) 
of transcriptional bursts (Nicolas et al., 2017).   
 
 
Additionally, the transcriptional bursting frequency might fluctuate among cells during 
distinct cell cycle phases and different sized cells (Soltani & Sight, 2017). During the S 
phase of the cell cycle the cell duplicates the number of gene copies, which might double 
the mRNA transcripts produced. A recent study analyzed the transcription kinetics of 
Nanog and Oct4 in mouse PSCs throughout the cell cycle and demonstrated that frequency 
of transcriptional burst is reduced after DNA replication to compensate additional DNA 
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copies of cells in S and G2 phases. These findings suggest that cell cycle progression might 
influence the frequency of transcriptional bursts (Padovan- Merhar et al., 2015; Ben-Moshe 
& Itzkivitz, 2016; Skinner et al., 2016).  Similarly, it has been show that larger cells 
increase the burst size to maintain the appropriate mRNA abundances despite the cell size 
(Padovan- Merhar et al., 2015).  
 
Variability in gene transcriptional bursting among individual cells might have significant 
biological functionality in relation of cell fate commitment (Chang et al. 2008; Yan et al. 
2013; Trapnell et al. 2014). The biological relevance of tissue heterogeneity has been 
highlighted in a recent study that demonstrated that heterogeneous populations as early as 
the 4-cell mouse embryo bias cell fate decisions. The TF Sox21 show the highest 
heterogeneous expression at this stage, with lower Sox21 expressing cells acquiring extra-
embryonic fate, whereas cells expressing higher level of Sox21 were maintained in a 
pluripotent state (Goolam et al., 2016).  
5.1.3. Gene expression changes during the cell cycle 
During mitosis (M), several nuclear processes are disrupted by the displacement of multiple 
components from the chromatin, including several TFs, epigenetic marks and RNA Pol II 
polymerase (Pol II), and the dissociation of enhancers-promoter interactions. Dissociation 
of these factors leads to interruption of RNA synthesis (Young et al., 2007; Hsiung et al., 
2016; Liu et al., 2017). However, specific regions of the mitotic chromatin remain 
associated with particular histone marks and TFs. Maintenance of these genes during 
mitosis is referred as bookmarking. TFs and epigenetic marks might pass to the newly born 
cell facilitating displacement and recruitment of other TFs, providing an inheritance 
mechanism (Wang & Higgins, 2013a; Liu et al., 2017). Subsequently, during late telophase 
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Pol II and global TFs are recruited to the newly formed cell nuclei and the cell restarts RNA 
synthesis (Prasanth et al., 2003; Hsiung et al., 2016). The transcription of genes expressed 
during interphase is progressively reactivated during G1 phase. However, a few genes 
important for cellular functions such as housekeeping are preferentially re-activated earlier 
during M/G1 transition (Fukuoka et al., 2012). Additionally, a recent study reported that 
during the first rounds of transcription after mitosis at G1, the majority of activated genes 
are transcribed at their highest levels during cell cycle. M/G1 transcriptional peak might 
occur heterogeneously among cells and might increase transcriptional differences among 
the cell population (Hsiung et al., 2016).   
 
Heterogeneous gene expression results in variability of mRNA and protein levels within 
the cell population leading to different rates of cell cycle progression among individual 
cells (Matson & Cook, 2017). Additionally, unequal distribution of RNA, proteins, 
metabolites and organelles might contribute to cell cycle differences among cells, which 
remains for more than two cell cycles. Hence, proliferation or exit from the cell cycle 
decisions are made individually by each cell of the population, leading to distinct 
subpopulations with different proliferation dynamics. A cell population might comprise 
proliferating, quiescent or senescent cells, which are evident only with single cell analyses 
(Sakaue-Sawano et al., 2008; Overton et al., 2014; Matson & Cook, 2017).  
 
Several studies have reported that cell cycle progression is strongly related with cell fate 
choice. The cell cycle machinery might orchestrate maintenance of pluripotency or cell 
specification to particular cell types during different phases. As mentioned in Chapter 4, 
transition trough G1 phase establishes a window of opportunity for cell cycle exit and 
differentiation. hESCs differentiate into mesendoderm during early G1 phase, whereas cells 
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in late G1 acquire neuroectoderm fate (Pauklin & Vallier, 2013, Soufi & Dalton, 2016). 
Furthermore, it has recently been reported that during S and G2 phases, the damage 
checkpoint factors ATR/ATM and cyclin B enhance TGF-β/Nodal activity, establishing an 
intrinsic propensity towards pluripotency in hESCs. These mechanisms might potentiate 
DNA damage repair since damage repair proteins are largely expressed in ESCs compared 
to differentiating cells; additionally, if the damage is not repairable, ESCs undergo 
apoptosis effectively since they have lower apoptotic threshold than differentiating cells. 
Restriction of ATR/ATM during G1 phase enables the inhibition of pluripotency, leading 
to differentiation. Hence, these studies demonstrated that the molecular mechanism 
underlying specific cell cycle stages direct selective preference toward pluripotency or 
differentiation in hESCs (Gonzales et al., 2015; Vallier, 2015) (Figure 5.3).  
 
 
Figure 5.3. Pluripotency and differentiation during the cell cycle. During early G1, cells tend to 
differentiate into endoderm due to the expression of SMAD2/3, whereas at late G1 accumulation of 
cyclin D and activation of CDK4/6 leads to phosphorylation of SMAD2/3 and acquisition of 
neuroectoderm lineage.  During S and G2 phases ATR/ATM kinases enhance TGF-β/Nodal signaling 
promoting pluripotency maintenance (Vallier, 2015).  
 
For this study we used single cell analyses to compare the expression patterns of individual 
cells at d8 after neural induction, to assess population heterogeneity and identify potential 
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cell sub-populations that may be primed to acquire different cell phenotypes or may 
represent novel transitional states in the NESCs population. 
5.2. Methods 
5.2.1. Single cell RNAseq 
A confluent well from a Nunc 6 well plated with around 3,000,000 cells that were neural 
induced using 2i for 8 days was used for a single cell RNAseq assay. Media was removed, 
and the cells were incubated for 4 minutes at 37°C with 1ml of accutase. After incubation, 
cells were detached from the well by pipetting 4 times. The accutase cell suspension was 
transferred to a 50ml tube containing 6ml of DMEM/F12 without phenol red (Thermo 
Fisher, 21041025). Cells were centrifuged at 900rpm for 2 minutes and the media was 
removed. Cells were re-suspended in 1ml of DMEM/F12 and filtered through a 4µm cell 
strainer (Falcon, 08-771-1). Cells were counted and diluted with DMEM/F12 to obtain 
approximately 500,000cells/ml. A final concentration of 500ng/ml of DAPI (Sigma 
Aldrich, D9542) was added to the cell suspension to check for viability. Cell sorting was 
performed in the cell sorting facilities of the Weatherall Institute of Molecular Medicine 
(WIMM) at the University of Oxford. Single cells were sorted using a BD FACS ARIA III 
instrument considering single cells, viability, size and granularity by the WIMM technician. 
Sorted single cells were collected into 4µl of Smart-seq2 lysis buffer containing 2.5mM 
dNTPs (Thermo-Fisher) and 2.5µM Oligo-dT30VN (Biomers.net) in a 4°C cooled 96 well 
plate. Libraries were prepared and sequenced by our collaborator Dr. Neil Ashley according 
to the standard procedures of the WIMM (Picelli et al., 2914).  Briefly, single cell cDNA 
synthesis was performed using SuperScript II (Invitrogen, 18064-014) and was amplified 
with the KAPA Hifi Hot Start Ready Mix KAPA (Biosystems, KK2601). Smart-seq2 
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cDNA was end-paired, A-tailed and commercial adapters and indexes were ligated with 
the Illumina Nextera XT Kit (Illumina, FC-131-1024). Samples were pooled and sequenced 
with the NextSeq® 500/550 High Output Kit v2 (FC 404-2005) in a NextSeq 550 system 
by our collaborator Jerome Nicod in the Wellcome Trust Centre for Human Genetics. 95 
Nextera samples were sequenced in one lane at a combined depth of 400,000,000 reads 
(approximately, 4,000,000 reads per cell). FastQ files were aligned to a reference genome 
trough the Tuxedo pipeline by our collaborator Leo Perfect (Price laboratory).  
5.2.2. Single cell analysis 
FASTQ files were aligned to the GENCODE human genome release 24 (GRCh38.p5) 
concatenated to the ERCC RNA spike-in FASTA file using Tophat (ref). The “no novel 
junctions” option was selected to restrict alignment to genes contained in the GENCODE 
human transcriptome annotation release 24. Cuffnorm was used to calculate FPKMs. A 
Pearson’s correlation analysis was performed with the RPKMs obtained from the bulk 
RNAseq data at d8 from the iPSC1 and the FPKMs from the single cell RNAseq data. The 
correlation was calculated with Prism package of GraphPad software. Raw read counts 
were extracted from the BAM files in R using the summarizeOverlaps function from the 
GenomicFeatures package in Bioconductor. The raw counts were adjusted for the size of 
the library and the gene and were log2 normalized with the dependency EdgeR in the 
package “scater 1.4.0” in RStudio. Quality control was assessed with the function QC 
metrics. The quality control figures, gene expression plots and PCAs were performed the 
package “scater” in RStudio with the functions plotQC, plotPCA and plotExpression. 
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5.3. Results 
5.3.1. Correlation between bulk RNAseq and single cell RNAseq data 
RPKMs obtained from bulk RNAseq analyses from the cell line iPSC1 at d8 were 
compared with the average FPKMs from the single cell RNAseq analyses from the same 
time point and cell line using a Pearson’s correlation. A significant positive correlation 
(R=0.56, p < 0.0001) was observed between the 19218 genes compared between the 2 data 
sets (Figure 5.4). The results indicate that the gene expression of the genes obtained by bulk 
RNAseq analyses is significantly associated to the single cell RNAseq data.  
 
Figure 5.4. Correlation between bulk RNAseq data and single cells RNAseq 
data. RPKMs from bulk RNAseq analyses and average FPKMs from single cells 



















5.3.2. Single cell RNAseq quality control  
Quality control (QC) analyses of single cell RNAseq data were performed to identify low 
quality cells including cells with a high percentage of reads corresponding to the RNA 
spike-ins, which suggest capture of a dead cell or a failure during library preparation. The 
average expression of the gene among all cells, the proportion of cells expressing the gene 
and the counts of control genes (genes constitutively expressed), mitochondrial genes and 
spike-ins are computed to determine low abundance genes and dropout rates (MacCarthy 
et al., 2017). 
Plotting the distribution of reads among genes identifies libraries where a reduced number 
of genes contain the majority of counts and libraries where counts are evenly distributed 
among the genes. The proportion of the library that accounted for the 6000 most highly 
expressed genes was analyzed. The results indicated that the majority of counts are evenly 
distributed among genes. However, for one cell the majority of counts corresponded to a 
reduced number of genes, which possibly are the RNA spike-ins. Hence, this cell was 
excluded from down-stream analyses (Figure 5.5). 
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Figure 5.5. Cumulative proportion of the library accounted for the 6000 most expressed 
genes. The cumulative proportion of the library (total counts) is shown in the Y-axis and the 6000 
most expressed genes are show in the X-axis. The cells are represented with different colors. The 
arrow shows the cell where the majority of counts correspond to a reduced number of genes.  
 
 
The 50 most highly expressed genes in healthy cells are often mitochondrial, ribosomal, 
constitutively expressed genes and RNA spike-ins (when used for RNAseq). Analyses of 
the expression of these genes thus enable verification that transcripts levels are behaving 
as expected. The results indicate that mitochondrial genes such us MT-CO1, MT-CO2 and 
MT-CO3; ribosomal genes including RPS19, RPS2 and RPL7; constitutively expressed 
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genes such us ACTB, GAPDH and UBC; and RNA spike-ins are among the highest 
expressed (Figure 5.6).  
 
                              
Figure 5.6. 50 most highly expressed genes. The percentage of the total counts is indicated 
in the X-axis and the genes names in the Y-axis. The circles show the percentage of counts 
among all cells and the bars represent the gene counts for individual cells. The 50 highly 
expressed genes account for the 16.6% of the total counts across all cells.    
 
 
5.3.3. Single cell RNAseq data analysis 
PCA and t-Distributed Stochastic Neighbour Embedding (t-SNE) analyses were preformed 
to reduce data dimensionality, determine the degree of heterogeneity in the dataset and 
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identify potential subpopulations. PCA is a linear dimensionality reduction method, 
whereas t-SNE is a non-linear method, both are widely used for single cell RNA analyses. 
The gene expression data from 93 high quality cells was used for these analyses. The PCA 
results indicated that the PC1 corresponds to 10% of the variance among cells and PC2 to 
2.5%. Neither component shows segregation of cells into obvious clusters among the 




Figure 5.7. Principal component analyses of the single cell RNAseq data. PC1 
is show in the X-axis and indicates the 10% of variance among cells. The PC2 is 
show in the Y-axis and represents 2.5% of variance. Each cell is represented as a 
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The t-SNE analyses shown the multidimensional data mapped to 2 dimensions, with no 
obvious clustering among the cells in the population (Figure 5.8).  
 
 
Figure 5.8. t-SNE analyses of the single cell RNAseq data. Dimension 1 is show 




Cells in different cell cycle phases generate different levels of mRNA transcripts and have 
different gene expression profiles. Hence, we analyzed the expression of genes that regulate 
the cell cycle to identify potential differential expression across the cells. The results 
indicate that expression of the genes CCNB2, CDK1, CCNB1, CDC6, CDK2 and GMNN 














Figure 5.9. Expression of cell cycle genes in individual cells. Violin plots show the expression 
of the cell cycle regulators CCNB2, CDK1, CCNB1, CDC6, CDK2 and GMNN represented with 
different colors. Individual cells are shown as dots in the plots. The Y-axis shows the gene 




A PCA showing the expression levels of CDK1, CDK2, CCNB1, CCNB2, CDC6 and 
GMNN cell cycle regulators was generated to determine if the heterogeneous expression 
of these genes across the cell population is related the to degree of separation of cells across 
PC1 or PC2 (Figures 5.10, 5.11, 5.12, 5.13, 5.14 and 5.15.). The results suggest that the 
majority of cells with high expression values of these genes are slightly segregated from 





Figure 5.10. PCA depicting expression levels of CDK1. The color key shows CDK1 
expression, where purple indicates low expression and yellow high expression. Individual 
cells are represented as dots in the plot. PC1 is show in the X-axis and PC2 Y-axis. 
 
 
Figure 5.11. PCA depicting expression levels of CDK2. The color key shows CDK2 
expression, where purple indicates low expression and yellow high expression. Individual cells 
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Figure 5.12. PCA depicting expression levels of CCNB1. The color key shows CCNB1 
expression, where purple indicates low expression and yellow high expression. Individual 
cells are represented as dots in the plot.  
 
 
Figure 5.13. PCA depicting expression levels of CCNB2. The color key shows CCNB2 
expression, where purple indicates low expression and yellow high expression. Individual 
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Figure 5.14. PCA depicting expression levels of CDC6. The color key shows CDC6 
expression, where purple indicates low expression and yellow high expression. 
Individual cells are represented as dots in the plot.  
 
 
Figure 5.15. PCA depicting expression levels of GMNN. The color key shows GMNN 
expression, where purple indicates low expression and yellow high expression. Individual 
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Expression of neuroectodermal markers was analyzed to determine if all cells of the 
population at d8 express these genes. The results indicated that the majority of cells express 
high levels of PAX6 and SOX11. However, a number of cells show an absence of SOX11 
expression, indicating a bimodal distribution. The expression of ZEB2 and ZNF521 is 
detected in a range from 0 to high expression levels across the population. The expression 
of the genes NR2F2 and NESTIN is bimodally distributed, where the majority of cells show 
high expression levels and another cluster shows low or no expression (Figure 5.16). 
 
 
Figure 5.16. Expression of neuroectodermal markers in individual cells. Violin plots show 
expression of the neuroectodermal markers ZEB2, SOX11, ZNF521, NR2F2, PAX6 and 
NESTIN, represented with different colors. Individual cells are shown as dots in the plots. The 





Similarly, expression of neuroectodermal precursors was analyzed in individual cells. The 
results indicated that expression of IRX3, ZIC3 and FOXD4 is not detected in the majority 
of the cells. Expression of the genes ZIC2 and SOX3 is detected in a range from zero to 
high, whereas expression of GMNN is bimodally distributed (Figure 5.17). 
 
 
Figure 5.17. Expression of neuroectodermal precursor markers in individual cells. Violin 
plots show expression of the neuroectodermal precursor markers GMNN, ZIC2, SOX3, IRX3, 
ZIC3 and FOXD4 represented with different colors. Individual cells are shown as dots in the 
plots. The Y-axis shows the gene expression levels (log2 counts adjusted for the library and gene 
size).  
 
Analyses of expression of pluripotency markers in individual cells indicated that the genes 
NANOG, OCT4 and ZFP42 are not expressed or detected in low levels across all cells in 
the population, whereas no expression was detected for UTF1. MYC expression is 
bimodally distributed among the cells in the population.  The expression of the genes ZIC2 
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and SOX3 is detected in a range from zero to high expression, whereas expression of 
GMNN is bimodally distributed (Figure 5.18). 
 
 
Figure 5.18. Expression of pluripotency markers in individual cells. Violin plots show 
expression of the pluripotency markers MYC, NANOG, OCT4, ZFP42 and UTF1 represented 
with different colors. Individual cells are shown as dots in the plots. The  Y-axis shows the gene 




Additionally, expression of genes most highly up-regulated from time points d6 to d8 in 
the bulk cells analyses, was analyzed to determine if expression of these genes increased 
in all cells of the population. The results show that expression of DMRTA2, ABCG2, 
ALDH1A1 and CCK is not detected in the majority of cells and that high expression levels 
are detected only in a minority of cells. The gene TNFSF15 is expressed at low levels or 




Figure 5.19. Individual cells expression of the genes most highly up-regulated from time 
point d6 to d8 in bulk analyses. Violin plots show expression of DMRTA2, ABDG2, 
ALDH1A1, CCK, TNFSF15 and WNT2B the genes most highly up-regulated from d6 to d8 in 
bulk analyses. The Y-axis shows the gene expression levels (log2 counts adjusted for the library 




Single cell RNAseq studies have shown that seemingly homogeneous cell populations 
comprise cells with variability in gene expression, protein abundances and potency to 
differentiate into specific phenotypes (Shalek et al., 2013). Cells captured at the same time 
might include subpopulations with intermediate differentiation states or subpopulations of 
cells fated to distinct phenotypes, which can only be identified by single cell studies. Hence, 
we performed single cell RNAseq analysis to assess transcriptional heterogeneity in iPSCs 
derived NESCs, which might be masked in the bulk cells analyses.  
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Dimensionality reduction techniques such as PCA and t-SNE enable intuitive visualization 
of similarities and differences among individual cells within a population (McCarthy et al., 
2017). The results indicate that after 8 days of neural induction the NESC population is 
highly homogeneous. Variance across PC1, which explains 10% of the variance across 
cells, appears to be driven by differential expression of genes that regulate cell cycle 
progression. The cell cycle regulators CCNB2, CDK1, CCNB1, CDC6, CDK2 and GMNN 
are either highly expressed or lowly expressed forming 2 adjacent clusters along PC1. 
Possibly, cells comprising the NESC population are progressing through different phases 
of the cell cycle, which leads to bimodal distribution of expression levels of these genes. 
Global transcriptional variability during cell cycle occurs because genes are activated or 
inhibited in a specific order during different cell cycle phases. For instance, during mitosis 
global transcription is interrupted leading to a decrease of mRNA transcript abundances. 
The expression of the majority of genes is re-activated during early G1 depicting a peak of 
expression (Fukuoka et al., 2012; Hsiung et al., 2016). As the cell cycle proceeds, three 
waves of expression during G1/S, G2/M and M/G1 phases regulate the molecular events 
that drive progression to the next phase (Bertoli et al., 2013). During S phase, DNA is 
replicated, which might lead to the production of double the amount of mRNA transcripts 
(Padovan- Merhar et al., 2015). Hence, variable gene product abundances are produced 
during particular stages of the cell cycle, and this seems to represent the major partition of 
the NESC population. Correlation results suggest that the expression of single cells at d8 
after neural induction closely resemble that of the bulk transcriptome captured at the same 
stage. Single cell data depicted high homogeneity among the cell population, aside from 
that represented by changes in cell cycle phase, thus bulk data can be interpreted without 
the confound of population heterogeneity.  
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Similarly, analyses of NE markers revealed variability in gene expression patterns across 
NESC at d8. Immunofluorescence analyses (section 3.3.3) of ZEB2, ZNF521, NR2F2, 
PAX6 and NESTIN show that the majority of cells are expressing high levels of these 
proteins. However, a reduced number of cells in the population are either expressing low 
levels or not expressing these factors, suggesting that the heterogeneous expression of these 
specific genes among the population is reflected at a protein level. However, a percentage 
of cells with low intensity staining levels might have been incorrectly count as negative, 
due to the high intensity threshold set during the data analyses to discriminate positively 
stained cells from non-specific staining. Additionally, transcriptional burst and fluctuation 
of different biochemical processes including transcription, translation kinetics, mRNA and 
protein stability and degradation rates might contribute to the differential expression levels 
observed trough immunofluorescence assays. Alternatively, the population might include 
cells at different developmental stages or acquiring different phenotypes, thus expressing 
different levels of these genes.  
The bimodal distribution of the genes expression at an mRNA levels, determined from 
single cells RNA sequencing, could be related to variability of the transcriptional bursting 
frequency. For instance, a recent study demonstrated that the transcriptional burst 
frequency of a set of genes bound to the polycomb repressive complex (PRC) was lower 
compared with active genes not bound by PRC. Genes with lower frequency of variation 
including Klf4, Tbx3 and Lefty2 show bimodal distribution, whereas genes with higher 
bust frequency such us Oct4 and Sox2 depicted unimodal distribution in mESCs (Kar et 
al., 2017). Possibly, bimodally distributed NE markers have low frequency transcriptional 
bursts and cells were captured and cluster together during a long “on” activation period or 
“off” transcriptional inactive periods. It is also feasible that the cell population comprises 
two sub-populations primed to acquire different fate or transitioning between distinct 
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neural differentiation stages. Additionally, the majority of single cell RNAseq data presents 
high frequency of dropout events, where no gene counts are observed in a cell where the 
gene is actually expressed. Dropout events occur when low starting amounts of mRNA 
transcripts are “lost” during library preparation and are consequently excluded from 
sequencing data (Kharchenko et al., 2014; McCarthy et al., 2017; Vallejos et al., 2017). 
Therefore, high dropout events are more frequent in, but not exclusive to, genes with low 
expression. Dropout events could also contribute to the bimodal expression of the NE 
markers observed in the d8 NESCs. However, immunofluorescence assays show that 
SOX11, NR2F2 and NESTIN proteins are not detected in all cells of the population, 
suggesting that heterogeneous expression of these genes is not entirely caused by technical 
noise. Similarly, the NE markers ZEB2 and ZNF521 show variable expression with 
continuous changes from high to low transcript amounts. Possibly, these genes depict 
different transcriptional bursts sizes among the cell population. Additionally, expression of 
these genes might be activated gradually during differentiation, leading to variable 
expression in cells transitioning through different developmental stages. However, the 
global gene expression patterns across the population are homogeneous, indicating that 
cells are not forming defined clusters that might drive differences in cell fate decisions and 
suggesting that cells are progressing through similar developmental trajectories.  
Single cell analyses show that the NE precursor factors IRX3, ZIC3 and FOXD4 and the 
pluripotency markers NANOG, OCT4, ZFP42 and UTF1 are not expressed in the majority 
of cells at d8 in human iPSC derived NESCs, as observed in the bulk transcriptome analysis 
at the same stage. Additionally, the NE progenitors SOX3 and ZIC2 are expressed from 
high to low levels at d8 across single cells, whereas GMNN and the pluripotency marker 
MYC showed a bimodal distribution, which might result from differences in the 
transcriptional burst shape, cell cycle progression or developmental stages. In bulk cell 
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analyses GMNN, ZIC2, SOX3 are highly expressed at d8, whereas MYC is expressed at 
low levels. 
The RNAseq data from bulk analyses on the cell line iPSC1 show that the genes DMRTA2, 
ABDG2, ALDH1A1, CCK, TNFSF15 and WNT2B are the most highly up-regulated from 
d6 to d8. Interestingly, single cell data analyses at d8 from the same cell line show that 
these transcripts are either not detected or expressed in low levels in the majority of 
individual cells. The results indicated that the gene expression data from single cells and 
bulk cell is highly co-related. Thus, the expression of these genes at a single cell level might 
reflect the gene expression of the individual cells of the population evaluated trough bulk 
analyses. The results suggest that the averaged gene expression depicted in bulk analyses 
might mask the transcriptional events occurring in subpopulations of cells. GRN modelling 
is largely based on bulk expression data, assuming that differentially expressed genes are 
activated or inhibited in the majority of cells. Hence, these results highlight the importance 
of determining that the nodes of a GRN are expressed in the same cell, to validate the 
inferred regulatory connections and refine the GRN. Therefore, single cell RNA 
sequencing analyses during different time points of NESC differentiation would enable 
determine if the GRN nodes interacting with no time delay are expressed in the same cell, 
allowing to greatly refine the GRN interactions.  However, due to the elevated cost of single 
cell RNA sequence assays, these analyses were not performed this study.  
5.5. Limitations 
The development of bioinformatics tools to analyse single cell datasets enables 
determination of level of gene expression at a specific time point in a single cell, but this 
level of resolution comes with an increase in technical noise (McCarthy et al., 2017). Thus, 
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quality control and normalization are critical to estimate and reduce the technical noise of 
the dataset. However, tools to identify and remove dropout events are limited. Hence, the 
major technological challenge of single cell RNAseq analyses is to improve sensitivity and 
accuracy to separate technical noise from intrinsic heterogeneous expression. These 
techniques are being developed and will vastly improve single cell clustering and data 
visualization analyses. Similarly, an important source of biological noise is the cell cycle, 
which generates variability in the gene expression as cells progressing through different 
cell cycle phases, which might obscure other meaningful biological signals in the data. 
However, current methods to remove the cell cycle effect generate a significant risk of 
removing other components of interest (Barron & Li, 2016). Additionally, cell isolation, 
reverse transcription, cDNA synthesis, library preparation and sequencing are expensive 
techniques, which restricts the number of cells, time points and treatments that can be 
feasibly analyzed.  
5.6. Conclusions 
After 8 days of neural induction the NESC population is highly homogeneous with no 
evidence of clustering. The principal source of variability among cells appears to be related 
to cell cycle progression. Additionally, we show that even if the expression levels of the 
bulk analyses are highly correlated with the averaged quantification of single cells 
transcripts, bulk analyses mask substantial differences occurring at single cell level. These 
differences should be considered for inferring relations among genes in a GRN to confirm 




CHAPTER 6. General Discussion  
The scope of this study was to discover the gene expression patterns underlying neural 
induction in human iPSCs and ESCs; and to identify TFs that orchestrate acquisition of 
NESC fate. Most emphasis in PSC studies has been on analyzing the differentiation of 
neural progenitors to specific neuronal phenotypes focusing on neuronal subtypes 
associated with developmental disorders. Neural induction is the first step of CNS 
development and there is abundant evidence to suggest that fate specification occurs during 
this stage. Hence, the gene expression and regulatory interactions generated during NE 
differentiation control the progressive restrictions in cell fate that drive cell competence 
towards neural and neuronal differentiation. However, the molecular events that cause 
human ESC/iPSCs to become neural progenitors have not been deeply studied (Neely et 
al., 2012; Moody et al., 2013; Kamiya et al., 2014). Knowledge of the initial gene 
expression patterns that drive neural induction in iPSCs greatly improves our knowledge 
about this critical stage of development in humans and identifies the first molecular events 
that drive both normal neurodevelopment and aberrant differentiation leading to 
neurodevelopmental disorders.    
For this study, neural differentiation was induced in 3 iPSC and 1 ESC line by 
recapitulating the developmental cues identified from animal models. Mouse NE 
differentiation initiates with inhibition of a BMP and TGFβ from the “node” to the dorsal 
region of the ectoderm (Klein & Moody, 2015). Similarly, neural induction in ESC/iPSC 
is initiated by inhibiting SMAD signaling trough the addition of small molecule inhibitors 
(2i). The resulting data indicated that ESCs and iPSCs lines with different genetic 
background and iPSC lines reprogramed with distinct methods generated similar transcript 
levels and gene expression patterns during neural induction (Figure 3.2). These results 
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demonstrate that the protocol used in this study is highly reproducible for generating 
NESCs and that iPSC constitute a remarkable tool to recapitulate in vitro molecular 
mechanisms that drive pluripotent stem cells toward a neural fate.  
After 2i induction ESC/iPSC, which represent Epi cells during human development, 
maintain transcription of pluripotency markers and genes that regulate cell biological 
functions necessary for pluripotency until d2 after induction (Figures 3.12 and 3.13). 
Following down-regulation of pluripotency genes, thousands of genes are activated 
including NE markers, genes related with other stages of the CNS differentiation and other 
genes that have not been previously related with the CNS development and could be used 
as novel NE markers (Figures 3.10 and 3.11). Activation of this large number of genes is 
necessary to initiate and maintain NESCs differentiation, inhibit the pluripotency program 
and inhibit pathways that drive differentiation towards other phenotypes. The neural 
induction program comprises genes that are up-regulated from d2 to d8 and also genes that 
have peaks of expression during different time points during neural induction (Figure 3.9). 
GO analyses of genes associated with specific expression profiles, indicated that these gene 
modules regulate different cell molecular functions during neural induction that are 
necessary to promote the transition from pluripotency to neural fate (Figure 3.14). These 
gene modules are additionally required during other developmental stages such as forebrain 
development and synapse formation. Among these genes GMNN, and ZIC2 have a peak of 
expression at d2, SOX11 is up-regulated from d3 and SOX3 is highly expressed at d8 
(Figure 3.4). In Xenopus, FoxD4 induces the expression of Gmnn and Zic2 and later the 
expression of Sox11 (Lee et al., 2014). In mouse, Foxd4 shows a peak of expression in 
NESC and might regulate nueral fate acquisition by inhibiting pluripotency markers and 
promoting the expression of Gmnn and Zic2, similarly than in Xenopus (Gaur et al., 2016; 
Sherman et al., 2017). Similarly, Gmm promotes neural differentiation in mouse by 
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promoting histone acetylation in neural genes and by activating neural development 
regulators in association with Zic1 (Lim et al., 2011; Sankar et al., 2016). The study results 
suggest that the sequential activation of these genes expression and their function is 
conserved across species during embryonic development. However, in humans these 
markers are likely to be induced by different factors since FOXD4 is not expressed during 
NESCs induction. In Xenopus, transition between NE progenitors and NE cells depends on 
inhibition of Sox3, Sox2 and Sox11 family members and up-regulation of Zic and Irx 
factors that promote expression bHLH proneural factors in neural progenitors (Lee et al., 
2014). Studies in mouse and chick embryos suggest that Sox1, Sox2 and Sox3 factors are 
expressed in most neural precursors and are necessary to maintain the cells in a progenitor 
state, whereas Sox11 is activated later in neural progenitors and differentiating neurons 
(Bergsland et al., 2011; Lee et al., 2014). The results show that IRX1, IRX3 and ZIC1 
genes were not detected during neural induction in human PSCs, whereas IRX2 and ZIC3 
have a peak of expression at d2 and are subsequently down-regulated. Additionally, SOX2, 
SOX3 and SOX11 are activated during different stages of NE induction and remain active 
in NESCs at day 8 (Figure 3.4). The results indicate that the sequential expression of IRX, 
ZIC and SOX family factors are activated in a different manner than in Xenopus, suggesting 
specie-specific differences and highlighting the necessity to use human cells to analyze 
human neural development. However, similarly than in mouse and Xenopus, the TF SOX1, 
SOX2, SOX3 and SOX11 are actively expressed in NESC. Factors required for both 
pluripotency and neural differentiation such us SOX2 and NESTIN show high levels of 
expression during the course of neural induction, validating their role in the maintenance 
of pluripotency and promotion of neural differentiation in humans (Figure 3.4).  
Further culture of NESCs leads to formation of rosettes around d12, whose morphology 
and cell composition resembles that of the neural tube. The gene expression data show that 
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at d8 cells do not express polarization markers necessary for the formation of rosettes 
(Figure 3.21). Hence, activation of the genes necessary for polarization and rosette 
formation are possibly activated subsequent to NESC formation. However, we report for 
the first time that several rosette and RG cell markers and neuronal sub-types markers are 
precociously activated during early (d2) neural induction.  
During gastrulation in the Xenopus embryo, the area between the NE and non-NE 
differentiates into the NBZ at the expense of the neural crest due to inhibition of WNT 
signaling. The NBZ gives rise to the PPE, of which the most anterior region will form the 
olfactory placode. GnRH neurons differentiate from the olfactory placode and migrate to 
the hypothalamus (Moody & LaMantia, 2015). In humans, the regulatory events that drive 
differentiation of GnRH neurons are largely unknown. For instance, only a single 
alternative study has reported a protocol to generate GnRH neurons from ESC (Lund et al., 
2016).  In this study we aimed to identify the initial molecular signals that drive NESCs to 
acquire GnRH fate. Colleagues in Price laboratory have demonstrated that the addition of 
WNT inhibitors during neural induction leads to the generation of positive GnRH neurons 
after approximately 50 days (Kathuria et al., 2017). We identify a set of 44 genes 
differentially up-regulated exclusively in NESCs fated to become GnRH neurons, which 
might play a role in the adquisition of GnRH neuronal phenotype (Figures 3.26 and 3.27). 
Additionally, 103 genes were up-regulated exclusively in NESCs destined to differentiate 
in cortical neurons. Inhibition of these genes might also be necessary to initiate the GnRH 
induction program.  
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6.1. Gene regulatory networks 
The genome encodes thousands of genes, whose expression continually changes during 
different stages of development. Expression of these genes is tightly regulated to generate 
specific amounts of gene products necessary to control the cellular functions required for 
each developmental stage (Karlebach & Shamir, 2008). GRNs govern the expression of 
genes and the product abundances at specific time points and can be modeled from time 
series transcriptome data by mathematical and statistical analyses to identify regulatory 
gene interactions during induction. We show the first GRN modeled during NESCs 
differentiation, which comprises 9 main hubs with high connectedness (JUN, MYC, FOS, 
PAX6, SP3, CDC6, SMAD2, HDAC6, and LEF1) and incorporates with time delay co-
relations (Figure 4.4). The GRN connectivity (topology) continuously changes in response 
to regulatory signals that control gene expression, generating different expression patterns 
during differentiation. The genes and gene modules activated during neural differentiation 
regulate cell biological functions necessary for neural differentiation and pluripotency 
inhibition. Among these modules, the MYC hub regulates different molecular functions 
including cell proliferation, CDC6 regulates cell cycle progression and PAX6 regulates the 
CNS development among others (Figure 4.7). It has been suggested that PAX6 promotes 
neural differentiation by inhibiting pluripotency markers such as NANOG and OCT4 and 
possibly by activating TFs required for NE differentiation (Zhang et al., 2010; Blake & 
Ziman, 2014). We identify 8 genes within the PAX6 module, whose activation at d2 
potentially initiates the consequent steps that drive initiation of neural induction and 
inhibition of pluripotency (Figure 4.3).  
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6.3. Single cell analyses 
NESCs are positive for known NE markers such us PAX6, SOX11 and ZEB2. Single cell 
RNAseq analyses enabled identification of expression variability across NESCs at d8. The 
data indicated that the NESC population is highly homogeneous (Figures 5.7 and 5.8). The 
largest percentage of variance (10%) appears to relate to the cell cycle phase in which cells 
were captured (Figures 5.10 to 5.15). Nevertheless, genes did show heterogeneous 
expression, which is also reflected at a protein level (Figures 5.16 to 5.19 and 3.7). These 
results highlight the importance of single cell analyses in GRN modeling to determine that 
those genes proposed to interact within the network are expressed in the same cell. 
Heterogeneous expression across the cell population might be related to variability in the 
transcriptional burst shape, the cell cycle phase in which cells were captured, dropout 
events, variability in the developmental stage across individual cells and due to the 
generation of 2 sub-populations primed to acquire different fate. However, the global gene 
expression patterns suggest that cells are progressing through similar developmental states.  
6.3. Future experiments 
Transcriptome analyses during induction enabled identification of thousands of genes 
differentially activated and inhibited during different stages of neural induction. 
Identification of these genes permits determination of the potential roles and pathways of 
TFs of interest by inhibiting their expression trough different techniques such us shRNA 
gene knockdown, small molecule inhibitors or CRISPR-CAS9, and analysing the 
subsequent effect of inhibition on gene expression and neural induction. Likewise, it would 
be interesting to generate transcriptome data under the same conditions of this study from 
iPSC lines with penetrant mutations associated with neurodevelopmental disorders risk. 
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For instance, we have a SHANK3 mutated (highest monogenic cause of autistic spectrum 
disorders) cell line isogenic to the ESC line used in this study. Comparing the expression 
patterns of the mutated and control lines would enable identification of potential early 
molecular events that distinguish normal from aberrant neural induction. Additionally, it 
would be interesting to analyze neural induction in 3D cultures, which provide spatial 
organization that promotes exposure to the biochemical signals from the 
microenvironment, extracellular matrix and neighbouring cells thereby offering a more 
complete recapitulation of in vivo development. However, 3D cultures are less reproducible 
since their microenvironment can vary depending on several factors including the scaffold 
material mechanics, topography and biochemistry and the delivery and transportation of 
soluble factors and oxygen (Carletti et al., 2011; Hollister, 2013). Cells among the 3D 
culture are exposed to different spatial and physical constraints and biochemical cues, 
leading to variability in cell proliferation and differentiation and generating heterogeneous 
cell populations (Edmondson et al., 2014). Hence, it is not suitable to use bulk cells 
analyses to analyse the transcriptome of cells comprised in 3D cultures and it can be 
difficult and expensive to preform immunofluorescence analyses and single cell isolation 
depending on the scaffold material and topography (Antoni et al., 2015). Additionally, 
modelling a GRN from transcriptome data from 3D culture isolated cells isolated remains 
challenging due to the low read coverage of single cell RNAseq analyses. Nevertheless, as 
these technologies improve they will offer an exciting alternative to 2D monocellular 
cultures. 
Similarly, it would be important to continue the GRN refinement by testing the GRN 
predictions by perturbing the network. CRISPRi technologies could be used to repress 
expression of PAX6 and OTX2 and CRISPa to activate expression of MYC in iPSC derived 
NESCs and quantitatively assess the response of the perturbation in the expression of their 
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interacting gene targets. CRISPRi and CRISPRa offer the additional benefit of being well 
suited to modulation of expression of several genes simultaneously. Similarly, connectivity 
between TFs and gene targets inferred in the GRN could also be validated by ChIP-seq 
analyses to determine if their regulatory interactions are direct, and potentially to identify 
novel interactions of the TFs with other genes that are differentially expressed during 
differentiation. Additionally, including constitutive expressed genes and less connected 
genes that might interact with the network modules may improve the GRN model.  
High-throughput RNAseq data enables modelling a GRN that provides a global view of 
the gene regulatory interactions and potential cellular biological functions underlying 
neural induction. However, RNA transcription is also regulated by epigenetic 
modifications. Combining, transcriptome and epigenetic data sets to model a GRN would 
enable a deeper insight into the molecular events that drive NESCs development. Thus, the 
GRN model would significantly improve by the incorporation of epigenetic regulatory 
interactions. Post-translational modifications of histones tails and DNA methylated 
cytosines can be detected by using specific antibodies through ChIP-seq analyses. 
Additionally, Assay for Transposase-Accessible Chromatin with high-throughput 
sequencing (ATAC-seq) method could be used to identify open chromatin regions at 
specific time points during NESCs induction. These data would enable determination of 
the epigenetic status during neural induction. This may identify distinct cellular states prior 
to changes in the transcriptome. Alternatively, such studies might illuminate the epigenetic 
mechanisms that regulate the expression of specific genes among the GRN and determine 
the sequential epigenetic changes necessary for neural induction. The function of individual 
genomic elements identified can be screened by using modified CRISPR to deliver specific 
chromatin modifying activities (Enriquez, 2016).  
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Additionally, single cell analyses demonstrated that averaging the gene expression values 
of cell populations could obscure variability in the expression of individual cells across the 
population. However due to the elevated cost of the RNA sequencing assays we did not 
performed these analyses during different stages of differentiation. Hence, further 
experiments should include single cell RNAseq during the 7-time points of NESCs 
differentiation to verify that the genes interacting in the GRN are expressed in the same 
cell. It would be interesting to analyse the gene expression profile of NESCs induced with 
2i-WNT inhibition protocol at d8 to determine if the 44 differentially up-regulated genes 
compared with 2i treatment are expressed in the same cells or generate sub-populations that 
might bias the cell fate. Additionally, inhibition of the expression of the 5 TFs differentially 
up-regulated in NESCs fated to differentiate to GnRH neurons might enable determination 
of the mechanism by which these factors promote GnRH fate acquisition.  
6.4. Conclusion  
In this thesis I report for the first time a complete overview of the gene expression patterns 
underlying neural induction of human iPSC/ESCs. Identification of genes and pathways 
underlying iPSC transition from pluripotency to neural competence would enable 
identification of the molecular pathology of neurodevelopmental disorders caused by 
known mutations and provide an insight into the gene regulatory events that direct normal 
and aberrant human neurodevelopment. Inhibition of the pluripotency program occurs 
during the initial 2 days of 2i neural induction, followed by activation of thousands of genes 
that orchestrate NE fate acquisition. Among these genes several NE precursors, NE and 
forebrain markers were identified, validating previous findings from animal and ESC 
studies. Additionally, we report activation of genes that have not been previously related 
with CNS development and that could be used as novel NE markers. The potential 
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regulatory interactions between genes activated during NESC induction were captured in a 
GRN, which enables clear visualization of the potential causal relations between genes at 
different stages of induction. We identified GRN modules and with similar expression 
profiles, which potentially regulate the biological processes required for the transition from 
pluripotency to NE fate. Additionally, we report that WNT inhibition during neural 
induction leads to the specific activation of 44 genes, which may prime NESCs to 
differentiate into GnRH neurons. Down regulation of 103 genes activated during 2i 
(cortical) differentiation might also be necessary for cells to acquire GnRH phenotype. 
Additionally, we demonstrated that the differentiation protocol generates a highly 
homogenous population of NESC at d8. However, a number of genes depicted 
heterogeneous expression, which must be considered to validate that GRN inferred 
interactions occur between genes expressed in the same cell. Hence, with this study we 
provide for the first time a complete systematic description of the genes that orchestrate 
neural induction from human ESC/iPSCs. This provides valuable insight into mechanisms 
that may be used to control the fate specification of iPSC derived neuroectodermal stem 
cells and also cast light on the biological processes that might underwrite the initial stages 
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Appendix. 3.1. Description of the statistical analyses results from the Q-PCR assays (CD-ROM). 
The table includes the differences between means, the significance and the adjusted p-value of the two-
way ANOVA test preformed to determine the significance of the difference between time points. 
 
Appendix. 3.2. Description of the statistical results of the differentially up-regulated transcription 
factors of cells induced with 2i media (CD-ROM). The table includes the details of the statistical 
analyses preformed to identify differentially expressed genes. The number of genes in the list is higher 
that the number established of total TF differentially expressed since some TF are up-regulated between 
more than one time point. The data is organized in chronological order. The last comparison in the table 
represents the analyses between time point d0 and d8.  
 
Appendix. 3.3. Description of the statistical results of the differentially down-regulated 
transcription factors of cells induced with 2i media (CD-ROM).  The table includes the details of the 
statistical analyses preformed to identify differentially expressed genes. The number of genes in the list 
is higher that the number established of total TF differentially expressed since some TF are down-
regulated between more than one time point. The data is organized in chronological order. The last 
comparison in the table represents the analyses between time point d0 and d8.  
 
Appendix. 3.4. Description of the statistical results of the differentially up-regulated transcription 
factors of cells induced with 2i-WNT media (CD-ROM). The table includes the details of the 
statistical analyses preformed to identify differentially expressed genes. The number of genes in the list 
is higher that the number established of total TF differentially expressed since some TF are up-regulated 
between more than one time point. The data is organized in chronological order. The last comparison in 
the table represents the analyses between time point d0 and d8. 
 
Appendix. 3.5. Description of the statistical results of the differentially down-regulated 
transcription factors of cells induced with 2i-WNT media (CD-ROM). Details of the statistical 
analyses preformed to identify differentially expressed genes. The number of genes in the list is higher 
that the number established of total TF differentially expressed since some TF are down-regulated 
between more than one time point. The data is organized in chronological order. The last comparison in 
the table represents the analyses between time point d0 and d8. 
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Regulation of ion transport 73 1.27E-05 1.671 4.08E-02 2.32E-02 
Hindbrain development 29 1.08E-05 2.456 3.48E-02 1.97E-02 
Spinal cord development 22 5.46E-06 3.022 1.77E-02 9.93E-03 
Positive regulation of phosphorus metabolic 
process 
121 5.23E-06 1.491 1.69E-02 9.50E-03 
Epithelial tube morphogenesis 51 3.18E-06 1.978 1.04E-02 5.79E-03 
Embryonic camera-type eye development 14 2.86E-06 4.590 9.30E-03 5.19E-03 
Neuron recognition 14 2.86E-06 4.590 9.30E-03 5.19E-03 
Positive regulation of neurogenesis 62 2.84E-06 1.843 9.25E-03 5.17E-03 
Tube morphogenesis 55 2.83E-06 1.928 9.20E-03 5.14E-03 
Negative regulation of neurogenesis 46 8.36E-07 2.165 2.73E-03 1.52E-03 
Cellular response to BMP stimulus 33 6.18E-07 2.600 2.02E-03 1.12E-03 
Neurons 20 2.88E-07 3.835 9.41E-04 5.24E-04 
Tube development 83 2.81E-07 1.769 9.17E-04 5.10E-04 
Regulation of synapse organization 29 2.13E-07 2.947 6.96E-04 3.87E-04 
Regulation of cell motility 100 2.04E-07 1.677 6.68E-04 3.71E-04 
Synaptic signaling 85 1.59E-07 1.778 5.19E-04 2.89E-04 
Cell projection morphogenesis 115 8.84E-08 1.635 2.89E-04 1.61E-04 
Blood vessel morphogenesis 74 7.78E-08 1.899 2.54E-04 1.41E-04 
Regulation of cell migration 97 4.34E-08 1.748 1.42E-04 7.89E-05 
Telencephalon development 48 9.91E-09 2.439 3.24E-05 1.80E-05 
Vasculature development 91 6.31E-09 1.857 2.06E-05 1.15E-05 
Response to growth factor 
 
99 5.02E-09 1.810 1.64E-05 9.12E-06 
Synapse assembly 35 2.99E-09 3.067 9.78E-06 5.44E-06 
Cell-cell adhesion via plasma-membrane 
adhesion molecules 
48 2.91E-09 2.528 9.53E-06 5.30E-06 
Diencephal n development 25 1.93E-09 4.033 6.31E-06 3.51E-06 
Regulation of neurogenesis 108 6.37E-10 1.820 2.08E-06 1.16E-06 
Positive regulation of nervous system 
development 
80 5.36E-10 2.053 1.75E-06 9.74E-07 
G-protein coupled receptor signaling pathway 96 4.51E-10 1.913 1.47E-06 8.20E-07 
Neuron projection guidance 51 8.72E-11 2.686 2.85E-07 1.59E-07 
Cell migration 156 5.15E-11 1.671 1.68E-07 9.36E-08 
Cell motility 170 4.84E-11 1.628 1.58E-07 8.80E-08 
Neuron projection development 129 3.48E-11 1.789 1.14E-07 6.33E-08 
Epithelium development 147 4.11E-12 1.760 1.35E-08 7.48E-09 
Cell morphogenesis differentiation 122 3.73E-12 1.884 1.22E-08 6.78E-09 
Regulation of nervous system development 126 1.64E-12 1.883 5.36E-09 2.98E-09 
Cell-cell signaling 193 8.00E-13 1.642 2.61E-09 1.45E-09 
Cell surface receptor signaling pathway 301 2.68E-13 1.464 8.75E-10 4.87E-10 
Eye development 71 6.52E-14 2.596 2.13E-10 1.18E-10 
Brain development 118 3.40E-14 2.040 1.11E-10 6.18E-11 
Neuron development 153 3.14E-14 1.840 1.02E-10 5.69E-11 
Forebrain development 77 1.69E-14 2.541 5.52E-11 3.07E-11 
Sensory perception 93 2.69E-16 2.455 7.26E-13 4.00E-13 
Pattern specification process 85 6.45E-17 2.618 3.63E-13 2.00E-13 
Central nervous system development 157 9.28E-20 2.075 3.03E-16 1.69E-16 
Sensory organ development 106 2.12E-20 2.577 6.92E-17 3.85E-17 
Nervous system development 334 2.13E-31 1.811 6.96E-28 3.87E-28 
 
Appendix. 3.6. Description of the significant GO results of the differentially up-regulated genes of 
cells induced with 2i media. Details of the GO analyses including the terms, the number of genes per 












Positive regulation of synapse assembly 18 9.29E-06 3.410 4.30E-02 1.76E-02 
Cellular response to growth factor stimulus 84 6.61E-06 1.634 3.07E-02 1.25E-02 
Central nervous system neuron development 20 6.40E-06 3.223 2.98E-02 1.21E-02 
Synaptic signaling 79 5.57E-06 1.673 2.60E-02 1.05E-02 
Trans-synaptic signaling 79 5.57E-06 1.673 2.60E-02 1.05E-02 
Hindbrain development 30 3.64E-06 2.551 1.71E-02 6.89E-03 
Stem cell differentiation 22 3.34E-06 3.126 1.57E-02 6.32E-03 
Epithelial cell differentiation 73 1.64E-06 1.771 7.70E-03 3.10E-03 
Enzyme linked receptor protein signaling 
pathway 
121 1.33E-06 1.534 6.28E-03 2.52E-03 
Regul tion of synapse assembly 22 1.27E-06 3.299 6.00E-03 2.41E-03 
Tube morphogenesis 55 9.48E-07 2.000 4.47E-03 1.79E-03 
Embryonic eye morphogenesis 14 9.13E-07 5.039 4.30E-03 1.73E-03 
Regulation of cell motility 96 6.19E-07 1.661 2.92E-03 1.17E-03 
Epithelial tube morphogenesis 52 3.61E-07 2.111 1.70E-03 6.82E-04 
Neuron migration 30 2.74E-07 2.867 1.29E-03 5.18E-04 
Eye morphogenesis 32 2.03E-07 2.787 9.59E-04 3.84E-04 
Regulation of signal transduction 287 1.82E-07 1.311 8.61E-04 3.45E-04 
Regulation of cell migration 93 1.43E-07 1.731 6.75E-04 2.70E-04 
Telencephalon development 46 6.32E-08 2.365 2.99E-04 1.20E-04 
Forebrain generation of neurons 21 5.53E-08 4.049 2.62E-04 1.05E-04 
Camera-type eye development 52 4.05E-08 2.255 1.91E-04 7.66E-05 
Diencephalon development 23 3.72E-08 3.821 1.76E-04 7.04E-05 
Forebrain neuron differentiation 20 3.71E-08 4.319 1.75E-04 7.02E-05 
Cell projection morphogenesis 114 2.51E-08 1.679 1.18E-04 4.74E-05 
G-protein coupled receptor signaling 
pathway 
93 1.90E-08 1.806 8.97E-05 3.59E-05 
Regul tion of neurogenesis 101 1.58E-08 1.762 7.46E-05 2.99E-05 
Positive regulation of nervous system 
development 
75 1.14E-08 1.980 5.39E-05 2.16E-05 
Vasculature development 90 6.84E-09 1.865 3.23E-05 1.29E-05 
Eye development 60 5.21E-09 2.226 2.46E-05 9.85E-06 
Axon development 75 4.74E-09 2.020 2.24E-05 8.98E-06 
Blood vessel development 87 3.63E-09 1.913 1.72E-05 6.87E-06 
Neural crest cell development 24 2.38E-09 4.180 1.12E-05 4.50E-06 
Regulation of neuron differentiation 91 1.94E-09 1.904 9.15E-06 3.66E-06 
Synapse assembly 35 1.65E-09 3.150 7.82E-06 3.13E-06 
Neuron projection morphogenesis 89 9.06E-10 1.949 4.28E-06 1.71E-06 
Central nervous system neuron 
differentiation 
40 3.66E-10 3.021 1.73E-06 6.93E-07 
Cell morphogenesis involved in neuron 
differentiation 
85 2.06E-10 2.044 9.74E-07 3.90E-07 
Neuro  projection guidance 50 1.35E-10 2.700 6.36E-07 2.55E-07 
Axon guidance 50 1.11E-10 2.713 5.26E-07 2.11E-07 
Regulation of nervous system development 120 1.66E-11 1.859 7.84E-08 3.14E-08 
Cell surface receptor signaling pathway 293 6.34E-13 1.463 2.99E-09 1.20E-09 
Neuron development 146 5.40E-13 1.812 2.55E-09 1.02E-09 
Forebrain development 75 8.54E-14 2.515 4.03E-10 1.62E-10 
Sensory organ morphogenesis 59 1.01E-14 3.034 4.77E-11 1.91E-11 
Brain development 118 6.16E-15 2.092 2.89E-11 1.15E-11 
Central nervous system development 149 1.80E-17 2.014 8.51E-14 3.41E-14 
Sensory organ development 100 7.02E-18 2.477 3.32E-14 1.33E-14 
Neurogenesis 221 1.81E-21 1.860 8.58E-18 3.43E-18 
Neuron differentiation 200 1.36E-22 1.980 6.45E-19 2.58E-19 
Nervous system development 320 6.13E-29 1.789 2.90E-25 1.16E-25 
 
Appendix. 3.7. Description of the significant GO results of the differentially up-regulated genes of 
cells induced with 2i-WNT media. Details of the GO analyses including the terms, the number of genes 
per term (count), the p-value, the adjusted p-value (Bonferroni) and the false discovery rate.   
 241 






Leukocyte activation 103 1.43E-05 1.508 4.91E-02 2.62E-
02 Inflammatory response 85 1.41E-05 1.583 4.85E-02 2.59E-
02 Regulation of intracellular signal 
transduction 
246 9.96E-06 1.286 3.44E-02 1.83E-
02 Response to decreased oxygen levels 61 8.24E-06 1.773 2.86E-02 1.51E-
02 Chemotaxis 87 5.77E-06 1.608 2.01E-02 1.06E-
02 NADH regeneration 13 5.59E-06 4.413 1.95E-02 1.02E-
02 Calcium ion transport into cytosol 31 5.53E-06 2.387 1.93E-02 1.01E-
02 ATP generation from ADP 22 3.55E-06 2.987 1.24E-02 6.50E-
03 Positive regulation of ion transport 46 3.06E-06 2.033 1.07E-02 5.60E-
03 Intracellular signal transduction 370 2.90E-06 1.230 1.02E-02 5.32E-
03 Sensory perception 85 2.69E-06 1.649 9.40E-03 4.92E-
03 Signal transduction by protein 
phosphorylation 
143 9.26E-07 1.475 3.25E-03 1.70E-
03 Regulation of secretion 110 5.37E-07 1.589 1.89E-03 9.84E-
04 Regulation of angiogenesis 49 4.73E-07 2.103 1.66E-03 8.68E-
04 Regulation of ion homeostasis 45 4.00E-07 2.197 1.41E-03 7.33E-
04 Blood circulation 92 1.66E-07 1.713 5.82E-04 3.03E-
04 Regulation of vasculature development 54 1.43E-07 2.090 5.02E-04 2.62E-
04 Synaptic signaling 107 1.35E-07 1.644 4.74E-04 2.47E-
04 Ion transmembrane transport 155 1.22E-07 1.496 4.30E-04 2.24E-
04 Positive regulation of phosphorus metabolic 
process 
164 8.41E-08 1.485 2.96E-04 1.54E-
04 MAPK cascade 142 8.28E-08 1.537 2.91E-04 1.52E-
04 Extracellular matrix organization 68 8.27E-08 1.931 2.91E-04 1.52E-
04 Regulation of response to external stimulus 51 5.54E-08 2.202 1.95E-04 1.02E-
04 Angiogenesis 81 4.92E-08 1.833 1.73E-04 9.01E-
05 Negative regulation of cell proliferation 115 4.69E-08 1.642 1.65E-04 8.59E-
05 Transmembrane transport 204 1.29E-08 1.448 4.55E-05 2.37E-
05 Regulation of phosphorus metabolic process 245 1.20E-08 1.395 4.21E-05 2.19E-
05 Muscle contraction 72 1.16E-08 1.977 4.08E-05 2.13E-
05 Regulation of cell migration 125 6.81E-09 1.655 2.40E-05 1.25E-
05 Oxoacid metabolic process 144 5.52E-09 1.596 1.94E-05 1.01E-
05 Response to other organism 116 5.51E-09 1.699 1.94E-05 1.01E-
05 Positive regulation of cell migration 85 7.57E-10 1.959 2.66E-06 1.39E-
06 Vasculature development 117 6.18E-10 1.755 2.17E-06 1.13E-
06 Regulation of cell motility 137 2.87E-10 1.688 1.01E-06 5.25E-
07 Cell-cell signaling 237 6.87E-11 1.481 2.42E-07 1.26E-
07 Cell motility 216 4.87E-11 1.520 1.71E-07 8.92E-
08 Positive regulation of cell motility 90 4.16E-11 2.019 1.46E-07 7.63E-
08 Regulation of ion transport 111 3.55E-11 1.867 1.25E-07 6.51E-
08 Small molecule biosynthetic process 101 3.03E-11 1.939 1.07E-07 5.56E-
08 G-protein coupled receptor signaling 
pathway 
124 1.64E-11 1.816 5.76E-08 3.00E-
08 Cell migration 203 1.92E-12 1.598 6.75E-09 3.51E-
09 Ion transport 254 5.98E-18 1.658 2.10E-14 1.10E-
14  
Appendix. 3.8. Description of the significant GO results of the differentially down-regulated genes 
of cells induced with 2i media. Details of the GO analyses including the terms, the number of genes 














Mesenchyme development 49 1.37E-05 
 
1.884 4.78E-02 2.52E-02 
 Coenzyme metabolic process 65 1.20E-05 1.718 4.19E-02 2.20E-02 
T cell activation 71 1.10E-05 1.677 3.84E-02 2.02E-02 
Regulation of signal transduction 380 1.01E-05 1.211 3.53E-02 1.85E-02 
Regulation of sequestering of calcium ion 28 1.00E-05 2.453 3.52E-02 1.84E-02 
Positive regulation of cell adhesion 69 6.62E-06 1.716 2.33E-02 1.21E-02 
Positive regulation of ion transport 46 6.60E-06 1.981 2.33E-02 1.21E-02 
Epithelium development 162 5.31E-06 1.395 1.87E-02 9.74E-03 
Response to cAMP 27 4.28E-06 2.608 1.51E-02 7.85E-03 
ATP generation from ADP 23 2.86E-06 2.937 1.02E-02 5.26E-03 
Leukocyte activation 109 2.59E-06 1.544 9.18E-03 4.75E-03 
Regulation of programmed cell death 216 1.66E-06 1.346 5.91E-03 3.05E-03 
Negative regulation of cell motility 51 1.64E-06 1.991 5.83E-03 3.01E-03 
Leukocyte cell-cell adhesion 58 1.49E-06 1.900 5.28E-03 2.73E-03 
Response to cytokine 124 1.18E-06 1.519 4.18E-03 2.16E-03 
Regulation of angiogenesis 50 8.73E-07 2.047 3.11E-03 1.60E-03 
Regulation of cell-cell adhesion 70 5.43E-07 1.825 1.94E-03 9.97E-04 
Transmembrane transport 203 3.16E-07 1.393 1.13E-03 5.80E-04 
Ion transmembrane transport 158 2.92E-07 1.470 1.04E-03 5.35E-04 
NADH regeneration 15 2.65E-07 4.709 9.43E-04 4.85E-04 
Regulation of vasculature development 55 2.55E-07 2.041 9.09E-04 4.68E-04 
Calcium ion transport into cytosol 35 1.97E-07 2.560 7.01E-04 3.61E-04 
Leukocyte cell-cell adhesion 83 1.44E-07 1.777 5.12E-04 2.64E-04 
Regulation of tube size 37 1.43E-07 2.512 5.11E-04 2.63E-04 
Cellular homeostasis 137 1.39E-07 1.538 4.97E-04 2.56E-04 
Inflammatory response 96 1.08E-07 1.706 3.87E-04 1.99E-04 
MAPK cascade 145 4.69E-08 1.543 1.67E-04 8.61E-05 
Cardiovascular system development 164 3.26E-08 1.505 1.16E-04 5.98E-05 
Regulation of blood circulation 67 2.79E-08 1.995 9.94E-05 5.12E-05 
Regulation of ion homeostasis 49 2.67E-08 2.293 9.52E-05 4.90E-05 
Angiogenesis 85 1.90E-08 1.840 6.76E-05 3.48E-05 
Positive regulation of cell migration 86 8.99E-10 1.946 3.20E-06 1.65E-06 
Regulation of phosphorus metabolic 
process 
256 6.07E-10 1.426 2.16E-06 1.11E-06 
Single-organism transport 470 5.43E-10 1.272 1.94E-06 9.97E-07 
Chemotaxis 104 2.66E-10 1.852 9.47E-07 4.87E-07 
Positive regulation of cell motility 91 7.04E-11 1.993 2.51E-07 1.29E-07 
Protein coupled receptor signaling 
pathway 
133 5.00E-12 1.802 1.78E-08 9.17E-09 
Regul tion of cell motility 145 8.56E-05 
 
1.751 1.79E-08 9.22E-09 
 Extracellular matrix organization 80 2.60E-12 2.232 9.28E-09 4.78E-09 
Cell-cell signaling 255 6.45E-14 1.549 2.30E-10 1.18E-10 
Cell migration 215 2.18E-14 1.641 7.76E-11 3.99E-11 
Ion transport 256 6.20E-16 1.607 2.37E-12 1.22E-12 
 
Appendix. 3.9. Description of the significant GO results of the differentially down-regulated genes 
of cells induced with 2i-WNT media. Details of the GO analyses including the terms, the number of 




































































Appendix. 3.10. Description of the GO results of the genes assigned to the profile 31 of cells 
induced with 2i media. Details of the GO analyses including the terms, the number of genes per term 








































Epithelial cell proliferation 46 2.52E-05 1.93
6561
2.94E-02 4.07E-02 




















Cell-cell adhesion 122 1.68E-06 1.531
9874
1.99E-03 2.71E-03 





































Appendix. 3.11. Description of the GO results genes assigned to the profile 31 of cells induced with 
2i-WNT media. Details of the GO analyses including the terms, the number of genes per term (count), 
























































































































Appendix. 3.12. Description of the significant GO results of the genes assigned to the profile 65 of 
cells induced with 2i media. Details of the GO analyses including the terms, the number of genes per 






































217 Synapse organization 24 3.09E-06 3.1 8
1163
0.002865 0.004834





























Appendix. 3.13. Description of the significant GO results genes assigned to the profile 65 of cells 
induced with 2i-WNT media. Details of the GO analyses including the terms, the number of genes per 





Appendix. 3.14. Description of the statistical results of genes differentially up-regulated in cells 
induced with 2i media compare with cells induced with 2i-WNT media (CD-ROM). Gene 
expression statistical analyses between cells induced with 2i and 2i-WNT media. The data has being 
organized in chronological order of the time points compared and includes d4 and d8, which were the 
days with significant differential expression between treatments.  
 
Appendix. 3.15. Description of the statistical results of genes differentially down-regulated in cells 
induced with 2i-WNT compare with cells induced with 2i- media (CD-ROM). Gene expression 
statistical analyses between cells induced with 2i-WNT and 2i media. The data has being organized in 
chronological order of the time points compared and includes d4 and d8, which were the days with 
































Appendix. 3.16. Description of the GO results of the differentially up-regulated genes of cells 
induced with 2i media compared with cells induced with 2i-WNT media at d4 and d8. Details of 
the GO analyses including the terms, the number of genes per term (count), the p-value, the adjusted p-





Appendix. 3.17. ZO1 immunofluorescence. The immunofluorescence analyses of the rosette 
marker ZO1 in cell induced with 2i after time point d8. The nuclei are stained with Hoescht 33342. 
 246 
Appendix. 4.1. Gene regulatory network (CD-ROM). Gene expression statistical analyses between 
cells induced with 2i-WNT and 2i media. The data has been organized in chronological order of the time 
points compared and includes d4 and d8, which were the days with significant differential expression 























































Appendix. 4.2. Description of the GO results of the genes in the regulatory network. Details of the 
GO analyses including the terms, the number of genes per term (count), the p-value, the adjusted p-value 






































Appendix. 4.3. Description of the GO results of the MYC module. Details of the GO analyses 
including the terms, the number of genes per term (count), the p-value, the adjusted p-value (Bonferroni) 





































Forebrain regionalization 3 4.98E-05 236.
375
2.79E-02 7.30E-02 
Regulation of RNA biosynthetic process 8 4.64E-05 4.156
0237 
2.60E-02 6.81E-02 
Transcription, DNA-templated 8 4.56E-05 4.166
9967 
2.56E-02 6.68E-02 
















Sensory organ morphogenesis 5 2.06E-06 39.45
625
1.17E-03 3.02E-03 









Appendix. 4.4. Description of the GO results of the PAX6 module. Details of the GO analyses 
including the terms, the number of genes per term (count), the p-value, the adjusted p-value (Bonferroni) 


















































































Appendix. 4.5. Description of the GO results of the SMAD2 module.  Details of the GO analyses 
including the terms, the number of genes per term (count), the p-value, the adjusted p-value (Bonferroni) 







































































Appendix. 4.6. Description of the GO results of the CDC6 module. Details of the GO analyses 
including the terms, the number of genes per term (count), the p-value, the adjusted p-value (Bonferroni) 
and the false discovery rate.   
 
 
